Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",A1BG,Alpha-1B-glycoprotein,2114,54,0.34 [0.08-1.50],0.1536906146643621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AAMDC,Mth938 domain-containing protein,2062,49,0.62 [0.36-1.10],0.1010679063103554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,2451,77,0.55 [0.38-0.80],0.0016024409475216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,2039,52,3.44 [2.37-4.99],6.954428266062258e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABHD14B,Protein ABHD14B,2436,76,0.93 [0.64-1.35],0.710745879043468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,2451,77,1.20 [0.89-1.62],0.2251488319579362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABO,Histo-blood group ABO system transferase,2120,55,0.96 [0.81-1.14],0.6364154120317349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,2039,52,0.89 [0.58-1.37],0.6032208167284077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",2398,75,1.15 [0.92-1.44],0.2187560757147273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",2085,52,1.18 [0.84-1.66],0.3523261658256726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",2108,54,0.78 [0.57-1.07],0.1181962572292791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAN,Aggrecan core protein,2431,76,2.61 [1.30-5.25],0.0069154053626441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE,Angiotensin-converting enzyme,2120,55,3.76 [1.58-8.94],0.0027522591040485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,2417,77,1.11 [0.83-1.49],0.4694933313078839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACHE,Acetylcholinesterase,2079,50,0.85 [0.40-1.81],0.6769419426482605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,2102,54,0.81 [0.63-1.03],0.0826855079584952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,2460,78,0.80 [0.52-1.22],0.3038808017277418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,2050,54,0.43 [0.21-0.86],0.0176798395439065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,2467,78,3.24 [1.78-5.89],0.0001198205908336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,2471,78,2.54 [1.70-3.80],5.749412594490781e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRBP,Acrosin-binding protein,2104,54,0.64 [0.30-1.35],0.2433282881926486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRV1,Acrosomal protein SP-10,2050,54,1.54 [1.21-1.95],0.0004046226232524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,2039,52,1.66 [0.98-2.78],0.0574430049826999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",2417,77,2.55 [2.08-3.12],1.0627840665642572e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN2,Alpha-actinin-2,2039,52,1.68 [1.19-2.37],0.0030456356521249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN4,Alpha-actinin-4,2398,76,1.69 [1.22-2.35],0.0018232103731553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,2440,76,14.83 [9.91-22.19],2.6198903231452e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY1,Aminoacylase-1,2460,78,0.81 [0.61-1.08],0.1509214230789616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,2039,52,1.95 [1.31-2.90],0.0009521945650296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACYP1,Acylphosphatase-1,2076,50,0.70 [0.46-1.08],0.1045362860311566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA,Adenosine deaminase,2482,77,1.22 [0.71-2.09],0.4738936692450149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,2439,77,3.04 [2.15-4.30],3.668725474043229e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2050,54,4.91 [3.41-7.07],1.0548968692195856e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,2417,77,1.71 [0.91-3.21],0.0934457478920657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2441,76,9.36 [5.74-15.27],3.315028060018813e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2482,77,13.93 [7.14-27.20],1.1692500561172088e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2477,77,4.44 [2.62-7.52],3.1658414332372735e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2102,54,8.68 [5.72-13.17],3.2768006751272783e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2050,54,5.23 [2.23-12.26],0.0001375267366741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,2486,78,0.36 [0.18-0.75],0.0056791895923545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2451,77,3.00 [2.14-4.22],2.3806122830069206e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2417,77,1.81 [1.22-2.68],0.0031288749254783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,2050,54,2.79 [1.67-4.65],9.04772965009048e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,2465,77,1.18 [0.76-1.84],0.4639400010906926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,2117,52,2.09 [1.18-3.70],0.0118871793014767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,2062,49,1.50 [0.48-4.67],0.4827156371709533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,2108,54,2.01 [1.22-3.30],0.0059244369385969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,2398,75,0.55 [0.25-1.22],0.139822180780073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADD1,Alpha-adducin,2079,50,0.58 [0.39-0.85],0.0052460960368371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,2440,76,4.92 [3.52-6.88],1.2110635858996787e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,2079,50,2.63 [1.49-4.63],0.0008678495221894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,2102,54,2.57 [1.77-3.75],8.906291569175485e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,2474,77,5.71 [3.17-10.28],6.412788219660637e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,2473,78,4.50 [2.86-7.09],8.657135784110102e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,2108,54,1.59 [0.58-4.37],0.3661680787679975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,2451,77,1.32 [1.12-1.55],0.0007285012457256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,2460,78,0.31 [0.16-0.62],0.0009608549587301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,2041,52,1.02 [0.71-1.46],0.9297564729440088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,2079,50,0.89 [0.65-1.23],0.4838739219203082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2417,77,0.81 [0.64-1.02],0.0754443534509502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADIPOQ,Adiponectin,2114,54,1.30 [0.93-1.80],0.1239412668972982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,2476,78,39.34 [18.53-83.54],1.1982994396609865e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,2039,52,0.77 [0.46-1.29],0.3258721430542891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFAP1,Actin filament-associated protein 1,2079,50,0.95 [0.67-1.35],0.7854302171942447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFM,Afamin,2114,54,0.10 [0.04-0.24],5.101419609379236e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFP,Alpha-fetoprotein,2434,76,0.47 [0.34-0.65],6.90165000058811e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,2041,52,1.06 [0.80-1.41],0.6705341113601091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,2457,77,3.56 [2.34-5.43],3.459117175461265e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,2379,72,1.74 [1.46-2.07],3.0862522798814315e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR3,Anterior gradient protein 3,2393,75,1.54 [1.10-2.15],0.0118370589210001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,2474,77,5.88 [4.25-8.14],1.1819702049051463e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,2482,77,2.95 [2.01-4.32],3.282743281544416e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGT,Angiotensinogen,2120,55,2.79 [1.27-6.12],0.0105879779640803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGXT,Serine--pyruvate aminotransferase,2460,78,1.17 [0.93-1.47],0.1926809452291268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHCY,Adenosylhomocysteinase,2460,78,0.77 [0.56-1.05],0.0958670641307839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,2062,49,3.50 [1.74-7.04],0.0004463610438124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK2,Protein AHNAK2,2062,49,3.28 [2.05-5.22],6.166148718156111e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,2104,54,0.67 [0.40-1.12],0.1277986850775332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,2120,55,0.54 [0.22-1.33],0.1796361088593918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,2462,77,0.74 [0.58-0.93],0.0120655387180718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",2067,53,0.93 [0.66-1.33],0.7071651594704539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1,Allograft inflammatory factor 1,2398,75,0.91 [0.61-1.36],0.6343979139295173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,2062,49,1.67 [1.24-2.24],0.0007114211968772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",2450,77,1.00 [0.82-1.21],0.9688122062343064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,2460,78,0.62 [0.44-0.86],0.00445159813725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",2109,53,0.79 [0.61-1.03],0.079733390991463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKAP12,A-kinase anchor protein 12,2079,50,3.22 [1.31-7.91],0.0107665218135725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,2398,75,0.68 [0.51-0.90],0.008204680771636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,2067,53,1.09 [0.81-1.48],0.5626808750630186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,2417,77,1.68 [1.32-2.14],2.2918666621848952e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,2050,54,1.20 [0.88-1.65],0.2525724590879034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,2394,74,0.67 [0.49-0.92],0.0124595137225388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,2107,54,0.83 [0.68-1.02],0.0776355358770472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,2388,75,0.85 [0.58-1.24],0.3932443355949147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,2486,78,8.04 [3.57-18.10],4.875787365625714e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,2467,77,0.61 [0.43-0.87],0.0060011967286739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",2104,54,0.97 [0.59-1.58],0.8899215059145775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",2449,76,0.95 [0.74-1.21],0.6684901455786134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",2107,54,1.30 [0.77-2.20],0.3280523428220078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALMS1,Alstrom syndrome protein 1,2085,52,1.11 [0.62-1.98],0.728817083989956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,2050,54,1.16 [0.95-1.42],0.1472968800814519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPP,"Alkaline phosphatase, placental type",2451,77,1.05 [0.87-1.26],0.6289255463000745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBN,Ameloblastin,2398,76,1.32 [0.85-2.03],0.2115434348251538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,2475,78,53.21 [27.49-102.98],4.100855565716553e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,2117,52,0.99 [0.34-2.88],0.9895158984000356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,2394,74,1.19 [0.86-1.64],0.2945390502128445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO1,Amphoterin-induced protein 1,2067,53,0.74 [0.39-1.39],0.3485925084244247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,2451,77,1.11 [0.50-2.45],0.7967691684644693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMN,Protein amnionless,2398,76,1.56 [1.05-2.33],0.0296471878305467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOT,Angiomotin,2079,50,0.85 [0.43-1.68],0.6469724563305987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOTL2,Angiomotin-like protein 2,2095,54,1.49 [0.93-2.40],0.1007215475082507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMPD3,AMP deaminase 3,2109,53,0.65 [0.45-0.94],0.0213087227194786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,1995,51,0.97 [0.57-1.63],0.9014057033371724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2A,Pancreatic alpha-amylase,2367,73,1.46 [1.00-2.14],0.0477122415534705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2B,Alpha-amylase 2B,2294,71,1.47 [1.01-2.13],0.041517972263613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,2454,77,4.18 [2.55-6.84],1.3483411714722962e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT1,Angiopoietin-1,2453,77,0.85 [0.67-1.08],0.1863954762869475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,2476,78,3.39 [2.21-5.20],2.2958596529585213e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,2418,77,3.98 [2.15-7.38],1.1564427402859555e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,2467,77,1.19 [0.74-1.94],0.4725489806587138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,2462,77,2.21 [1.34-3.65],0.0019096307714055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,2470,77,4.29 [2.84-6.49],5.147957421408122e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,2476,78,2.62 [1.65-4.15],4.383903769503755e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANK2,Ankyrin-2,2039,52,1.07 [0.76-1.51],0.6916739343556125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,2050,54,0.81 [0.58-1.14],0.2305338997284359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,2034,52,1.20 [0.74-1.92],0.4581373312852258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,2398,75,0.87 [0.61-1.26],0.4629501290419852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,2062,49,0.62 [0.26-1.52],0.2987619693889736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANPEP,Aminopeptidase N,2459,77,1.68 [0.87-3.24],0.1219878034786334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA1,Annexin A1,2071,50,0.88 [0.44-1.78],0.7321800175017051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA10,Annexin A10,2394,74,1.21 [0.98-1.50],0.0709944433882452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA11,Annexin A11,2451,77,0.73 [0.54-0.97],0.0294362421287608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA2,Annexin A2,2033,48,0.84 [0.55-1.27],0.4004261242738658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA3,Annexin A3,2477,77,0.73 [0.54-1.00],0.0464441737210255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA4,Annexin A4,2450,77,0.64 [0.47-0.88],0.0060387459255914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,2389,73,2.98 [2.14-4.14],9.524606074733316e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],2398,76,1.02 [0.70-1.47],0.931155173687012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,2464,77,8.24 [4.57-14.87],2.329594513158681e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,2104,54,0.95 [0.67-1.34],0.7635528334412267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP2B1,AP-2 complex subunit beta,2067,53,0.45 [0.23-0.88],0.0200526568090053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3B1,AP-3 complex subunit beta-1,2102,54,0.98 [0.68-1.41],0.9091835450745832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,2109,53,0.98 [0.55-1.74],0.9443233124589184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,2451,77,1.16 [0.76-1.79],0.4929175265324899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APCS,Serum amyloid P-component,2089,54,0.64 [0.30-1.38],0.2558161152013385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,2467,78,0.58 [0.40-0.85],0.0048593834741674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APLP1,Amyloid-like protein 1,2460,78,0.95 [0.65-1.40],0.8020387915241998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA1,Apolipoprotein A-I,2114,54,0.25 [0.11-0.55],0.0006741220039902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,2120,55,3.22 [2.05-5.05],3.474429838855117e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,2114,54,5.72 [3.50-9.35],3.5657865970124813e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOB,Apolipoprotein B-100,2120,55,1.02 [0.33-3.13],0.9684845594980824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOBR,Apolipoprotein B receptor,2062,49,1.15 [0.59-2.21],0.6840821736185962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOC1,Apolipoprotein C-I,2110,54,0.33 [0.18-0.61],0.0004330783239611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOD,Apolipoprotein D,2016,51,0.80 [0.39-1.66],0.5507479251860612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOE,Apolipoprotein E,2114,54,0.73 [0.44-1.21],0.2271400445797085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOF,Apolipoprotein F,2120,55,2.56 [1.00-6.56],0.0506165647037493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOH,Beta-2-glycoprotein 1,2467,77,1.75 [1.14-2.70],0.0109339604335895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOL1,Apolipoprotein L1,2120,55,0.82 [0.50-1.35],0.437199675778209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOM,Apolipoprotein M,2463,77,0.49 [0.26-0.91],0.0244202170304206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APP,Amyloid-beta precursor protein,2463,77,0.86 [0.63-1.17],0.3314760695709227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APPL2,DCC-interacting protein 13-beta,2079,50,0.80 [0.62-1.02],0.0705904200421975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APRT,Adenine phosphoribosyltransferase,2439,76,1.10 [0.70-1.72],0.6740877730257886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,2085,52,0.95 [0.63-1.43],0.803486343892615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,2451,77,3.68 [2.71-5.01],1.031309833368095e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARF6,ADP-ribosylation factor 6,2102,54,0.89 [0.69-1.13],0.3285143928469861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARFIP1,Arfaptin-1,2107,54,0.74 [0.50-1.12],0.1558884144438365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG1,Arginase-1,2426,77,0.59 [0.40-0.86],0.0056828787822339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG2,"Arginase-2, mitochondrial",2104,54,0.58 [0.27-1.24],0.15776556499761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,2398,75,0.55 [0.35-0.86],0.0090647471888727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,2398,75,0.83 [0.57-1.22],0.343186008450052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,2085,52,0.70 [0.27-1.81],0.4575528136613207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,2079,50,0.70 [0.49-1.00],0.0481655442320216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,2034,52,1.03 [0.74-1.44],0.8518507792108878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,2109,53,0.76 [0.56-1.03],0.0786033637565349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,2107,54,0.94 [0.71-1.24],0.6642259216364166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,2454,77,0.92 [0.76-1.12],0.4220985789083114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,2041,52,1.76 [1.34-2.32],5.006245597022929e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,2041,52,1.55 [0.80-2.99],0.1914409056932924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,2394,74,0.66 [0.36-1.22],0.1830268722243601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,2039,52,0.86 [0.57-1.29],0.4519247716138044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,2039,52,0.45 [0.21-0.95],0.0364264172834251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,2041,52,1.08 [0.70-1.67],0.7221625151429073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,2398,76,1.55 [0.99-2.42],0.0556434761836435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,2039,52,1.15 [0.76-1.75],0.5155760366727842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSA,Arylsulfatase A,2467,77,0.68 [0.43-1.08],0.1047296607661477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSB,Arylsulfatase B,2451,77,0.72 [0.49-1.05],0.0856571779540739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,2464,77,8.94 [6.02-13.28],2.0439367947853715e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,2041,52,1.15 [0.78-1.69],0.4839133717075091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARTN,Artemin,2398,76,0.74 [0.42-1.29],0.2876446832977172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH1,Acid ceramidase,2103,52,1.15 [0.68-1.93],0.6095905553119023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH2,Neutral ceramidase,2441,76,0.90 [0.63-1.28],0.5497345826332616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,2441,76,9.66 [6.08-15.36],9.022045238387662e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,2120,55,13.46 [7.33-24.72],5.0771945257236126e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPN,Asporin,2108,54,1.14 [0.46-2.81],0.7813785029831901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,2107,54,0.63 [0.41-0.96],0.0320854700768453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,2062,49,0.70 [0.52-0.94],0.0176777359800802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASS1,Argininosuccinate synthase,2039,52,0.93 [0.67-1.28],0.6495018681193845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,2394,74,1.03 [0.75-1.41],0.8691721050086278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,2034,52,0.62 [0.27-1.42],0.2573046150107114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG16L1,Autophagy-related protein 16-1,2102,54,0.83 [0.60-1.14],0.2487335406532745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG4A,Cysteine protease ATG4A,2398,75,0.60 [0.41-0.87],0.0071775280094211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATOX1,Copper transport protein ATOX1,2465,77,1.12 [0.82-1.51],0.4787420453591661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,2039,52,1.52 [1.01-2.29],0.0445013102568268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,2039,52,0.81 [0.33-1.97],0.6399760031806141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,2039,52,1.44 [0.79-2.62],0.2368192535234446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B4,Protein ATP1B4,2034,52,1.13 [0.62-2.08],0.683980144573872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,2039,52,0.90 [0.54-1.49],0.6733513207249209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",2039,52,1.36 [0.92-2.01],0.1180835185824559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",2474,77,0.90 [0.75-1.09],0.2762038162609496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",2394,74,0.76 [0.44-1.31],0.3231236992948859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6AP2,Renin receptor,2398,75,1.95 [1.37-2.79],0.0002412158441983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,2451,77,0.98 [0.48-1.99],0.947090916926868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,2392,74,0.73 [0.52-1.03],0.0724918963805749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,2062,49,0.63 [0.41-0.96],0.0308376902081939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,2039,52,1.02 [0.77-1.34],0.9158276901873452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,2102,54,9.13 [6.03-13.84],1.896678129467956e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRN,"Attractin, Isoform 2",2114,54,0.33 [0.09-1.17],0.0871938541051932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN10,Ataxin-10,2394,74,0.68 [0.51-0.90],0.007530464434239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2,Ataxin-2,2041,52,0.97 [0.76-1.24],0.7932658335516181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2L,Ataxin-2-like protein,2107,54,0.78 [0.42-1.45],0.4337642913995801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN3,Ataxin-3,2109,53,0.56 [0.36-0.87],0.0097367961844927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXIN1,Axin-1,2454,77,0.90 [0.72-1.11],0.3151595027354213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,2464,77,7.30 [4.11-12.96],1.1251663017315786e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZI2,5-azacytidine-induced protein 2,2107,54,0.78 [0.46-1.31],0.3438853523003393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZU1,Azurocidin,2391,77,0.91 [0.70-1.20],0.5200575723052747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,2114,54,11.86 [6.91-20.37],3.1396901039422373e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,2039,52,0.92 [0.25-3.43],0.9049090904758332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2062,49,3.55 [1.73-7.30],0.0005501408836585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",2474,77,17.86 [11.18-28.51],1.42729064963111e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",2467,77,5.91 [2.54-13.75],3.6771930196520814e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,2050,54,0.56 [0.18-1.71],0.3088414238813895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BACH1,Transcription regulator protein BACH1,2454,77,0.82 [0.61-1.10],0.181834219228695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,2440,76,2.34 [1.44-3.81],0.0006333301928861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,2050,54,1.24 [0.73-2.10],0.4332227693598122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG6,Large proline-rich protein BAG6,2417,77,0.75 [0.43-1.31],0.3120511188162213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,2398,75,1.29 [0.99-1.69],0.0602478763015631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,2398,75,5.79 [4.04-8.29],9.575363074654398e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,2454,77,0.84 [0.70-1.01],0.0692031135937158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAP18,Chromatin complexes subunit BAP18,2109,53,0.83 [0.54-1.28],0.4106473113995248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,2067,53,1.03 [0.76-1.38],0.8547803665229614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAX,Apoptosis regulator BAX,2389,73,0.89 [0.70-1.12],0.3189948475817149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAM,Basal cell adhesion molecule,2467,77,1.93 [0.87-4.26],0.1046781014450361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAN,Brevican core protein,2441,76,0.66 [0.38-1.14],0.1389740890393996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",2108,54,1.09 [0.47-2.54],0.8344200743119559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",2041,52,0.83 [0.46-1.52],0.5475399777679364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCHE,Cholinesterase,2082,55,0.49 [0.20-1.20],0.1167087649640369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2,Apoptosis regulator Bcl-2,2102,54,1.50 [1.07-2.10],0.0178183311015129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L1,Bcl-2-like protein 1,2109,53,0.75 [0.57-0.99],0.0406554416315429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2454,77,1.98 [1.13-3.47],0.0175597636031539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,2050,54,1.52 [1.08-2.14],0.0160717150446346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,2034,52,1.10 [0.76-1.60],0.6088005984790372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,2104,54,0.78 [0.38-1.59],0.4910457804991051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCR,Breakpoint cluster region protein,2454,77,0.86 [0.68-1.07],0.1802450659712096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BDNF,Brain-derived neurotrophic factor,2117,52,0.76 [0.56-1.04],0.0846907656696101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BECN1,Beclin-1,2062,49,0.71 [0.42-1.19],0.1941444126091246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BEX3,Protein BEX3,2034,52,0.91 [0.46-1.80],0.7814767677769402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGLAP,Osteocalcin,2117,52,1.06 [0.81-1.39],0.6875365750604348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGN,Biglycan,2397,75,1.06 [0.90-1.25],0.5126948027105718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,2041,52,0.96 [0.65-1.42],0.83770087711282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,2039,52,1.65 [0.55-4.94],0.3702956125862395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BID,BH3-interacting domain death agonist,2454,77,0.79 [0.57-1.09],0.1465167288566251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIN2,Bridging integrator 2,2467,77,0.83 [0.66-1.06],0.1339541245851115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,2398,75,0.91 [0.64-1.28],0.5838525730215323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLMH,Bleomycin hydrolase,2486,78,0.59 [0.33-1.05],0.0717026909484385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLNK,B-cell linker protein,2050,54,1.15 [0.63-2.10],0.6560779189789664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,2041,52,0.95 [0.65-1.37],0.7681286140837261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,2109,53,0.51 [0.23-1.12],0.0931745905743724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLVRB,Flavin reductase,2467,77,0.66 [0.48-0.92],0.0152180480212701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP10,Bone morphogenetic protein 10,2079,50,3.43 [1.84-6.39],0.0001063681385665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP4,Bone morphogenetic protein 4,2440,76,1.57 [1.09-2.27],0.0158135272621248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP6,Bone morphogenetic protein 6,2414,77,0.94 [0.56-1.58],0.8096579070378294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,2079,50,7.46 [3.99-13.94],3.1211469596860275e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,2108,54,0.45 [0.19-1.05],0.0655091980449753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2050,54,2.09 [1.24-3.53],0.0054888829228703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,2417,77,8.38 [4.20-16.73],1.6518284099317363e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA1,BolA-like protein 1,2041,52,1.31 [0.93-1.86],0.1260538004924234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,2062,49,0.50 [0.30-0.84],0.0085862658676601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFA2,BPI fold-containing family A member 2,1993,46,0.89 [0.69-1.14],0.3502423135987899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB1,BPI fold-containing family B member 1,2444,75,0.96 [0.70-1.31],0.7895814115765456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB2,BPI fold-containing family B member 2,2104,54,0.83 [0.58-1.18],0.2888198868317872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRAP,BRCA1-associated protein,2079,53,0.82 [0.64-1.05],0.1136974066654137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD1,Bromodomain-containing protein 1,2085,52,1.34 [0.59-3.06],0.4910505784148705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD2,Bromodomain-containing protein 2,2041,52,0.92 [0.42-2.02],0.8349769518248494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD3,Bromodomain-containing protein 3,2039,52,0.73 [0.37-1.44],0.3621277139879084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRDT,Bromodomain testis-specific protein,2039,52,0.46 [0.21-0.97],0.0424772620367823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRK1,Protein BRICK1,2394,74,1.78 [1.15-2.77],0.0100234608313876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,2041,52,0.57 [0.26-1.25],0.1600063052931383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,2107,54,1.15 [0.55-2.38],0.7086325431328195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,2477,77,30.37 [16.92-54.53],2.803501851055576e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSND,Barttin,2034,52,1.43 [0.80-2.56],0.2229819860268358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,2480,77,0.88 [0.60-1.31],0.5385539763498923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST2,Bone marrow stromal antigen 2,2480,77,1.51 [1.10-2.07],0.0101760544154438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTC,Probetacellulin,2398,75,0.79 [0.58-1.08],0.1453149597050018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTD,Biotinidase,2114,54,0.39 [0.12-1.25],0.1137006838762663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTLA,B- and T-lymphocyte attenuator,2034,52,1.11 [0.90-1.36],0.3171268890060443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,2101,54,1.05 [0.53-2.09],0.8854447457827801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,2474,77,11.04 [7.71-15.79],2.06626155670734e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,2454,77,4.81 [3.34-6.93],4.043662331060988e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTNL10,Butyrophilin-like protein 10,2034,52,0.81 [0.35-1.87],0.6176861509552407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C19orf12,Protein C19orf12,2394,74,0.78 [0.58-1.04],0.0900297080968317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,2039,52,1.13 [0.55-2.34],0.733950689522209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,2471,77,7.15 [3.86-13.24],4.0520978476838205e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",2107,54,0.76 [0.45-1.29],0.3161791223737176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QL2,Complement C1q-like protein 2,2050,54,1.02 [0.56-1.84],0.9605011004275728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2464,77,1.42 [1.00-2.02],0.0481149420092439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,2079,50,1.29 [0.61-2.74],0.5088627952497291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,2107,54,1.41 [0.74-2.69],0.2933292065768347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,2076,49,1.54 [0.83-2.86],0.1709751944284115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1R,Complement C1r subcomponent,2114,54,0.38 [0.08-1.73],0.2111829067418704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1RL,Complement C1r subcomponent-like protein,2109,54,0.85 [0.24-2.97],0.7954123494941877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1S,Complement C1s subcomponent,2114,54,0.77 [0.24-2.52],0.6685013597577296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2,Complement C2,2463,77,3.46 [1.28-9.37],0.0145850355524998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,2392,74,1.95 [1.39-2.74],0.0001095985293665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2orf69,UPF0565 protein C2orf69,2067,53,0.57 [0.30-1.08],0.0835056992674266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C3,Complement C3,2004,52,1.13 [0.61-2.08],0.7070338503148903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C4BPB,C4b-binding protein beta chain,2465,77,1.59 [0.99-2.54],0.0539494812321922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C5,Complement C5,2114,54,0.41 [0.07-2.40],0.3208334093054248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7,Complement component C7,2058,54,2.96 [1.55-5.63],0.0009860569031809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7orf50,Uncharacterized protein C7orf50,2109,53,0.21 [0.06-0.78],0.0200277345073583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C8B,Complement component C8 beta chain,2114,54,0.74 [0.31-1.78],0.5005248477459501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9,Complement component C9,2120,55,1.28 [0.83-1.98],0.2690273985750732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9orf40,Uncharacterized protein C9orf40,2102,54,0.64 [0.46-0.91],0.0123998924433779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA1,Carbonic anhydrase 1,2419,77,0.73 [0.52-1.03],0.0740161501752346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA11,Carbonic anhydrase-related protein 11,2398,75,0.95 [0.49-1.83],0.875394040434611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,2451,77,10.94 [7.30-16.38],3.971929859635739e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA13,Carbonic anhydrase 13,2438,76,0.80 [0.66-0.98],0.0287201707295649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,2476,78,4.90 [3.35-7.18],2.8857494852745733e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA2,Carbonic anhydrase 2,2460,77,0.62 [0.46-0.83],0.0016843850587484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA3,Carbonic anhydrase 3,2485,78,1.70 [1.28-2.26],0.0002709929868185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,2486,78,6.40 [3.35-12.21],1.9088409023353403e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",2417,77,1.37 [1.14-1.64],0.000933144114093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA6,Carbonic anhydrase 6,2459,76,0.75 [0.55-1.04],0.0840345326891882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA7,Carbonic anhydrase 7,2085,52,1.38 [0.76-2.51],0.2852858764028929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA8,Carbonic anhydrase-related protein,2050,54,0.61 [0.17-2.19],0.44381438546336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA9,Carbonic anhydrase 9,2476,78,1.94 [1.42-2.65],2.907967500893834e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CABP2,Calcium-binding protein 2,2067,53,0.72 [0.43-1.19],0.1982006443703517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,2041,52,1.22 [0.60-2.49],0.585578446196664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,2039,52,1.11 [0.75-1.62],0.6057187355468422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,2041,52,0.94 [0.60-1.48],0.7953778925412409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,2107,54,0.82 [0.60-1.11],0.2004930285291422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACYBP,Calcyclin-binding protein,2078,50,0.82 [0.62-1.08],0.154206510890361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CADPS,Calcium-dependent secretion activator 1,2067,53,0.84 [0.43-1.64],0.6072262008371034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,2451,77,3.16 [2.26-4.42],1.866599081994512e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,2394,74,4.16 [2.80-6.19],1.970325334832468e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,2439,76,2.03 [1.65-2.49],1.7608622701614066e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,2109,53,2.27 [1.75-2.95],6.302801502165596e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,2467,78,0.91 [0.74-1.11],0.3497422553634303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,2062,49,0.62 [0.41-0.94],0.0239307807624407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,2039,52,1.07 [0.50-2.32],0.8539522828805108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,2398,75,0.87 [0.53-1.42],0.5686711088696427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,2067,53,1.05 [0.63-1.74],0.8617127996733713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,2107,54,1.02 [0.78-1.33],0.8843693401153582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,2453,77,7.79 [3.22-18.86],5.290924497111272e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,2437,77,2.19 [1.65-2.91],5.34195392448111e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPN3,Calpain-3,2104,54,0.97 [0.45-2.11],0.9462746412435332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPS,Calcyphosin,2109,53,1.25 [1.06-1.48],0.0093598067244972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,2394,74,0.70 [0.46-1.08],0.1107664053563925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASC3,Protein CASC3,2067,53,0.54 [0.26-1.10],0.087801898931632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP1,Caspase-1,2394,74,0.94 [0.70-1.26],0.676636427276581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP10,Caspase-10,2394,74,0.86 [0.64-1.15],0.30166759808337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP2,Caspase-2,2454,77,0.75 [0.55-1.04],0.0833695937657281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP3,Caspase-3,2486,78,0.79 [0.63-1.00],0.0454903191865149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP4,Caspase-4,2085,52,0.96 [0.82-1.14],0.668034504821194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP7,Caspase-7,2109,53,0.78 [0.56-1.10],0.160479168218502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP8,Caspase-8,2470,78,0.76 [0.54-1.07],0.1178514810408158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP9,Caspase-9,2050,54,0.49 [0.30-0.81],0.0050480719615232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASQ2,Calsequestrin-2,2039,52,1.04 [0.55-1.94],0.9085376778266264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAT,Catalase,2083,55,0.37 [0.21-0.65],0.0005803248839178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,2460,78,1.44 [1.16-1.80],0.0011543345246603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN1,Cerebellin-1,2041,52,1.04 [0.78-1.38],0.7858894022280389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN4,Cerebellin-4,2476,78,0.53 [0.30-0.95],0.0334716772495816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBS,Cystathionine beta-synthase,2062,49,0.94 [0.58-1.54],0.8165339321614409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBX2,Chromobox protein homolog 2,2039,52,1.12 [0.54-2.32],0.7570896109650906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,2441,76,0.87 [0.65-1.17],0.3634435900905295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,2109,53,0.82 [0.45-1.49],0.52357252514699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,2104,54,1.15 [0.66-1.99],0.6309237997318813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,2067,53,0.76 [0.32-1.82],0.5445935622956368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,2107,54,0.80 [0.52-1.23],0.3190401735732861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,2460,78,4.39 [3.22-5.98],8.779189593755714e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,2062,49,1.79 [1.35-2.37],5.533018593704409e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,2482,77,4.10 [2.43-6.92],1.298230332038251e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL13,C-C motif chemokine 13,2479,77,0.89 [0.66-1.20],0.4557793048520125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,2454,77,4.17 [2.89-6.00],1.8593429632235085e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,2486,78,4.29 [3.05-6.02],4.0677281827035074e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL16,C-C motif chemokine 16,2486,78,2.18 [1.52-3.13],2.5506108312437808e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL17,C-C motif chemokine 17,2458,77,1.08 [0.87-1.34],0.4671191666355374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL18,C-C motif chemokine 18,2429,76,1.02 [0.77-1.37],0.8725084839511974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL19,C-C motif chemokine 19,2480,77,1.08 [0.95-1.23],0.229559738781032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL2,C-C motif chemokine 2,2440,76,1.41 [0.97-2.06],0.0698815370817046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL20,C-C motif chemokine 20,2482,77,1.43 [1.22-1.68],8.890827658821744e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL21,C-C motif chemokine 21,2474,77,1.69 [1.32-2.17],2.790950841092342e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL22,C-C motif chemokine 22,2440,77,1.24 [0.86-1.79],0.2450087528189656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,2474,77,2.81 [1.84-4.30],1.9493490971643403e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL24,C-C motif chemokine 24,2470,77,1.35 [1.07-1.71],0.0119845210574172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,2482,77,5.09 [3.28-7.90],4.416122160820569e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL26,C-C motif chemokine 26,2454,77,0.87 [0.69-1.10],0.2380437773765019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL27,C-C motif chemokine 27,2460,78,2.01 [1.43-2.83],6.596027052282052e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL28,C-C motif chemokine 28,2446,76,1.14 [0.82-1.59],0.4259402081624556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL3,C-C motif chemokine 3,2454,77,1.54 [1.28-1.84],3.322926161279372e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL4,C-C motif chemokine 4,2466,77,1.15 [0.90-1.47],0.2719495596045448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL5,C-C motif chemokine 5,2464,77,0.82 [0.67-1.01],0.0621027672474744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL7,C-C motif chemokine 7,2454,77,1.59 [1.17-2.15],0.0031481847975664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL8,C-C motif chemokine 8,2475,78,0.97 [0.70-1.36],0.8751154538028196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN1,CCN family member 1,2450,77,1.06 [0.79-1.42],0.7080183677927618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN2,CCN family member 2,2462,77,1.14 [0.79-1.64],0.4828111601064198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,2479,78,6.36 [4.59-8.80],6.84563955713101e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,2476,78,5.70 [3.93-8.26],4.634413747555045e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,2467,77,7.06 [4.70-10.61],5.843187338697415e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCND2,G1/S-specific cyclin-D2,2085,52,1.66 [0.79-3.50],0.1817119159442211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCNE1,G1/S-specific cyclin-E1,2050,54,0.95 [0.65-1.40],0.8037550879993665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,2441,76,0.35 [0.22-0.56],8.796199473051953e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,2398,75,0.49 [0.29-0.84],0.0097018665310099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD101,Immunoglobulin superfamily member 2,2102,54,0.94 [0.53-1.68],0.8348049356305759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD109,CD109 antigen,2467,77,2.87 [1.67-4.96],0.000145867699402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,2422,77,4.62 [3.23-6.62],5.811432029737626e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,2482,77,5.79 [4.28-7.84],4.50642926570881e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,2464,77,2.14 [1.40-3.28],0.0004271090040175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,2467,77,2.47 [1.68-3.64],4.5022694887565964e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,2067,53,1.12 [0.57-2.20],0.736777861161412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD177,CD177 antigen,2459,77,1.07 [0.91-1.25],0.4236493910780271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,2465,77,0.42 [0.20-0.89],0.0236227031293974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2,T-cell surface antigen CD2,2039,52,1.51 [1.03-2.21],0.0351062012059288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,2454,77,3.38 [2.22-5.14],1.2912650235662986e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,2448,77,1.52 [0.87-2.65],0.1369498300696276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,2408,74,5.13 [3.21-8.20],7.900153975605161e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD209,CD209 antigen,2468,77,2.53 [1.47-4.34],0.000760191145485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD22,B-cell receptor CD22,2482,77,0.66 [0.42-1.04],0.0723874274736954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD226,CD226 antigen,2050,54,1.09 [0.58-2.04],0.7825117543088028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD244,Natural killer cell receptor 2B4,2482,77,4.02 [2.21-7.28],4.746449721594573e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD248,Endosialin,2117,52,2.90 [1.58-5.33],0.0006266251159998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,2465,77,7.12 [5.34-9.49],9.164377436623035e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,2441,76,3.14 [2.29-4.29],9.526578898922765e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,2459,77,7.26 [4.76-11.06],2.90445016788595e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,2398,75,3.26 [2.21-4.82],3.028431521233625e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2AP,CD2-associated protein,2460,78,0.84 [0.61-1.15],0.2676473030287144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,2079,50,18.94 [10.03-35.74],1.1573262555038737e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,2480,77,12.04 [7.62-19.02],1.667039557627286e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,2469,78,5.75 [4.11-8.03],1.267089969199974e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,2476,78,3.43 [2.48-4.74],8.79848654717927e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,2467,77,6.76 [4.65-9.82],1.2313924619585746e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,2451,77,11.70 [8.17-16.76],3.8695573010759e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD33,Myeloid cell surface antigen CD33,2465,77,0.95 [0.74-1.22],0.6844577577974496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,2476,77,2.58 [1.17-5.70],0.0188106514479274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD36,Platelet glycoprotein 4,2050,54,1.18 [0.66-2.11],0.5725608316907086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2451,77,9.15 [6.09-13.77],2.0123360435867507e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,2041,52,1.48 [0.68-3.21],0.3215014349296946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,2085,52,0.48 [0.19-1.19],0.1142297291450382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,2050,54,1.06 [0.82-1.38],0.6560604592114976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,2451,77,3.72 [2.67-5.20],1.3135900694320974e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,2462,77,1.84 [1.32-2.56],0.0002847372713235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40LG,CD40 ligand,2482,77,0.89 [0.69-1.14],0.3509293244898066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,2445,77,7.94 [4.67-13.49],1.9249586763177133e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,2470,77,7.45 [4.43-12.54],3.6677493080985935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,2475,78,3.62 [2.61-5.01],9.912545111858267e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,2368,75,5.70 [3.97-8.18],3.6613756701718715e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,2454,77,5.67 [1.80-17.89],0.0030534081277508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,2350,75,15.52 [10.07-23.90],1.6350298400054397e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5L,CD5 antigen-like,2103,54,1.93 [1.15-3.26],0.0135629534926962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD6,T-cell differentiation antigen CD6,2477,77,0.83 [0.56-1.21],0.332210923923694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD63,CD63 antigen,2440,76,0.73 [0.49-1.11],0.1406227025573588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD69,Early activation antigen CD69,2447,78,0.79 [0.62-0.99],0.0420163401226228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,2045,54,3.76 [2.71-5.22],2.4320106988286565e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,2454,77,2.45 [1.67-3.62],5.550975764270335e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,2079,50,3.55 [2.07-6.09],4.06552980583165e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,2480,77,13.08 [8.27-20.70],4.604649415459179e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,2482,77,5.66 [4.28-7.49],6.2768357442412425e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,2108,54,3.12 [1.70-5.71],0.0002398387665328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD82,CD82 antigen,2085,52,0.75 [0.36-1.57],0.4493447021212353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,2454,77,5.65 [3.69-8.65],1.5758544798001012e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD84,SLAM family member 5,2454,77,0.93 [0.49-1.77],0.8206734699964572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD86,T-lymphocyte activation antigen CD86,2102,54,1.19 [0.50-2.87],0.6912135872827575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,2480,77,1.57 [1.13-2.19],0.0075983066549464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,2386,75,9.00 [5.90-13.73],2.1374893904780862e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,2467,77,46.48 [23.60-91.54],1.2079174641468336e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,2467,77,18.92 [9.60-37.27],1.958508869382557e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDA,Cytidine deaminase,2106,54,1.30 [0.80-2.11],0.293804205203348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDAN1,Codanin-1,2109,53,0.33 [0.08-1.32],0.11793682766365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC123,Cell division cycle protein 123 homolog,2034,52,0.84 [0.52-1.34],0.4573340251471981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC25A,M-phase inducer phosphatase 1,2034,52,0.46 [0.21-1.01],0.0541557526656608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,2098,54,1.04 [0.69-1.57],0.8540876736809386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC27,Cell division cycle protein 27 homolog,2398,75,0.84 [0.59-1.20],0.3424287520557158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,2465,77,0.78 [0.61-1.01],0.0564318997744745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,2102,54,0.94 [0.71-1.23],0.6408973627313412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDCP1,CUB domain-containing protein 1,2441,76,1.18 [0.84-1.65],0.3474679936272294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,2366,75,3.20 [2.50-4.09],3.360834216814665e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH15,Cadherin-15,2478,77,1.43 [1.15-1.78],0.0015257370113595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH17,Cadherin-17,2460,78,1.60 [1.26-2.03],0.0001030133143929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH2,Cadherin-2,2460,78,1.46 [0.90-2.36],0.1267622756001362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH22,Cadherin-22,2085,52,1.04 [0.39-2.74],0.9429220984969624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH23,Cadherin-23,2109,53,1.13 [0.40-3.22],0.8168972801753221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,2480,77,6.65 [4.68-9.44],4.250735220684031e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH4,Cadherin-4,2041,52,0.90 [0.49-1.67],0.7503100826470106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH5,Cadherin-5,2486,78,2.78 [1.51-5.12],0.0010518630426413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,2460,78,2.93 [1.89-4.53],1.344556262135058e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR1,Cadherin-related family member 1,2394,74,1.33 [0.91-1.93],0.1355742472664148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR2,Cadherin-related family member 2,2451,77,0.73 [0.55-0.97],0.0284476967949489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR5,Cadherin-related family member 5,2460,78,0.50 [0.32-0.78],0.0025050896270841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK1,Cyclin-dependent kinase 1,2034,52,1.03 [0.52-2.02],0.938043863242342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,2107,54,1.09 [0.69-1.71],0.7191631757686461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,2041,52,1.01 [0.62-1.66],0.9598554240653354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,2451,77,1.00 [0.82-1.21],0.9746949914705388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,2451,77,0.85 [0.69-1.05],0.1355737886982374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,2451,77,1.97 [1.65-2.35],9.227577121750096e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2466,77,1.71 [0.81-3.63],0.1605154791836617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,2471,77,5.93 [4.04-8.70],9.096595512534572e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,2457,77,1.41 [0.64-3.11],0.3899155773179829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,2102,54,0.73 [0.53-1.01],0.0598742121770886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,2085,52,0.82 [0.53-1.27],0.3724870023488923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2102,54,3.46 [2.32-5.15],1.0512087053206055e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,2085,52,1.62 [1.06-2.48],0.0269365162230337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2454,77,1.39 [1.13-1.73],0.0022229096142738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,2398,75,1.08 [0.71-1.66],0.712367868579578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2372,74,1.58 [1.20-2.07],0.0010270094027466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,2117,52,1.61 [0.87-2.99],0.1314946811386766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2417,77,2.57 [1.79-3.68],2.8712890859334945e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,2050,54,1.48 [0.82-2.69],0.1954886267430576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,2417,77,0.84 [0.48-1.46],0.540745890265206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,2117,52,0.78 [0.57-1.09],0.1418105270240022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,2482,78,0.86 [0.65-1.13],0.2714564602696574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2079,50,7.84 [4.27-14.37],2.914102843560506e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEMIP2,Cell surface hyaluronidase,2050,54,1.42 [0.71-2.81],0.3197705603140777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,2041,52,1.42 [1.10-1.82],0.0072975756163463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPF,Centromere protein F,2085,52,0.38 [0.21-0.67],0.0007945580187851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPJ,Centromere protein J,2085,52,0.86 [0.59-1.27],0.4548038572414008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP112,Centrosomal protein of 112 kDa,2039,52,1.03 [0.57-1.86],0.9147806256492124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP152,Centrosomal protein of 152 kDa,2034,52,1.95 [1.30-2.93],0.0012471290816326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP164,Centrosomal protein of 164 kDa,2398,76,0.98 [0.72-1.35],0.91840452911826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP170,Centrosomal protein of 170 kDa,2062,49,0.86 [0.57-1.31],0.4873057019171952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP20,Centrosomal protein 20,2398,75,0.92 [0.70-1.21],0.5473136569493205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP290,Centrosomal protein of 290 kDa,2085,52,0.54 [0.28-1.06],0.0720483101976745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP350,Centrosome-associated protein 350,2034,52,1.57 [1.05-2.36],0.027615492378219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP43,Centrosomal protein 43,2402,76,0.62 [0.45-0.86],0.0033865784235378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP85,Centrosomal protein of 85 kDa,2398,75,0.84 [0.60-1.18],0.3250755457957626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CERT,Ceramide transfer protein,2394,74,0.85 [0.60-1.22],0.3816290153872328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES1,Liver carboxylesterase 1,2467,78,0.72 [0.58-0.88],0.001757256924342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES2,Cocaine esterase,2451,77,1.48 [1.07-2.05],0.0168383289554265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES3,Carboxylesterase 3,2451,77,1.00 [0.74-1.35],0.98581268108596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN2,Centrin-2,2394,74,0.80 [0.58-1.12],0.1980332298167401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN3,Centrin-3,2102,54,0.84 [0.58-1.21],0.3430382951982276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFB,Complement factor B,2070,52,0.63 [0.28-1.44],0.2759835565417461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFC1,Cryptic protein,2398,75,1.85 [1.41-2.42],7.665112222869464e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,2114,54,17.92 [8.69-36.94],5.405660149567609e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFH,Complement factor H,1977,51,0.49 [0.14-1.67],0.2525072142139178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR2,Complement factor H-related protein 2,2098,54,1.91 [1.13-3.25],0.0162799983772837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR4,Complement factor H-related protein 4,2111,54,0.94 [0.66-1.33],0.7133887726388535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR5,Complement factor H-related protein 5,2089,55,1.55 [0.83-2.91],0.1673826250276563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFI,Complement factor I,2114,54,0.46 [0.12-1.71],0.2469120822597667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFP,Properdin,2114,54,0.25 [0.09-0.70],0.0077145416697034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,2467,77,2.10 [1.66-2.65],3.815495977507987e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2120,55,2.76 [1.35-5.61],0.005186997565793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGN,Cingulin,2067,53,1.49 [0.92-2.42],0.1089156730223723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,2460,78,4.50 [3.22-6.28],1.0856420596928718e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,2398,75,0.69 [0.47-1.01],0.0543987374508513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAD,Chondroadherin,2079,50,0.60 [0.37-0.97],0.0378795506642743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2109,53,7.93 [5.55-11.31],3.50763711184345e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,2104,54,4.15 [2.64-6.51],6.115866115179525e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,2417,77,0.80 [0.43-1.49],0.4849891750469191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,2117,52,1.58 [1.32-1.88],4.043189544454721e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,2473,77,5.64 [4.08-7.81],1.8448870363309345e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,2404,77,1.80 [1.48-2.19],4.712600923583753e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHIT1,Chitotriosidase-1,2462,76,0.93 [0.83-1.04],0.21840908893375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,2459,76,2.04 [1.18-3.51],0.0104451991043431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,2067,53,0.58 [0.36-0.94],0.0284854013348501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,2441,76,0.80 [0.61-1.05],0.1030287342939595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP6,Charged multivesicular body protein 6,2108,54,0.56 [0.34-0.89],0.0154942981133492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHP1,Calcineurin B homologous protein 1,2041,52,0.92 [0.60-1.41],0.6972459107761957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,2470,77,10.18 [6.45-16.06],2.1310226231910768e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL2,Chordin-like protein 2,2460,78,1.27 [0.85-1.88],0.2384324015589343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,2067,53,0.69 [0.30-1.61],0.3929993082472829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIAPIN1,Anamorsin,2465,77,0.87 [0.62-1.22],0.4201680320451202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,2117,52,2.08 [1.36-3.18],0.0007505559929555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,2085,52,0.79 [0.39-1.58],0.4998422152981679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,2102,54,0.78 [0.59-1.05],0.0970830190360523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIT,Citron Rho-interacting kinase,2067,53,0.67 [0.35-1.28],0.2258829954359855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,2470,77,4.81 [3.74-6.17],1.3101704796288475e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,2117,52,3.38 [2.42-4.71],7.281319991729128e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2450,77,1.29 [0.94-1.78],0.1093857755612409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLASP1,CLIP-associating protein 1,2034,52,0.67 [0.42-1.08],0.0976161338758054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,2457,78,1.95 [1.52-2.50],1.5249080381244093e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,2441,76,3.98 [2.32-6.82],5.326701229531523e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,2465,77,1.07 [0.72-1.60],0.7369806738915101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,2050,54,6.44 [2.41-17.21],0.0002015333329867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,2467,77,11.42 [7.70-16.94],8.829404972326288e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,2417,77,7.82 [5.35-11.45],3.590058967571802e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,2480,77,0.95 [0.76-1.17],0.6181003930649216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,2067,53,0.70 [0.35-1.42],0.328311134924773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC3B,Tetranectin,2058,52,0.19 [0.07-0.50],0.0007862193853125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,2454,77,0.86 [0.50-1.49],0.5857771927874472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,2454,77,1.16 [0.77-1.73],0.4774589201197065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,2454,77,2.39 [1.85-3.07],1.2474702086075604e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,2454,77,2.63 [1.44-4.79],0.0015846626049193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,2114,52,1.39 [0.79-2.45],0.2595439294789582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,2453,78,6.86 [4.17-11.26],2.950658076682522e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,2398,75,2.92 [2.09-4.10],4.2301779709368487e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,2482,77,7.32 [5.16-10.39],7.56619947981277e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLGN,Calmegin,2067,53,2.31 [1.48-3.61],0.0002461005640492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,2067,53,2.25 [1.55-3.27],2.169723986229732e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLINT1,Clathrin interactor 1,2034,52,0.98 [0.55-1.73],0.940635823961948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,2454,77,0.92 [0.76-1.10],0.351942342814427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,2476,78,42.43 [24.28-74.17],1.6098865340938093e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLNS1A,Methylosome subunit pICln,2067,53,0.58 [0.24-1.38],0.2172865911723735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",2439,76,0.93 [0.75-1.16],0.5405867058178895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPS,Colipase,2462,77,0.93 [0.72-1.18],0.5388419145358523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSPN,Claspin,2392,74,1.39 [0.90-2.15],0.1334656625925519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN1,Calsyntenin-1,2394,74,1.07 [0.74-1.55],0.7268654964344187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN2,Calsyntenin-2,2482,77,1.90 [1.30-2.79],0.0010282112424542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN3,Calsyntenin-3,2109,53,1.24 [0.55-2.82],0.60653348793378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLTA,Clathrin light chain A,2417,77,0.86 [0.54-1.35],0.5088601963319048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLU,Clusterin,2114,54,0.32 [0.07-1.36],0.1225163720077003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLUL1,Clusterin-like protein 1,2458,78,1.06 [0.70-1.61],0.7748983261371853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,2108,54,0.88 [0.64-1.19],0.3929609048077942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMIP,C-Maf-inducing protein,2104,54,0.77 [0.55-1.06],0.1051744201144893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,2464,77,0.74 [0.51-1.08],0.1229531298080689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,2041,52,1.19 [0.80-1.77],0.388704779282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",2055,49,0.60 [0.41-0.88],0.0088789823502325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY2,Protein canopy homolog 2,2417,77,0.88 [0.61-1.27],0.5028680798464685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY4,Protein canopy homolog 4,2451,77,0.97 [0.73-1.27],0.8067435959121008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNST,Consortin,2460,78,0.88 [0.73-1.05],0.152105073905451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTF,Ciliary neurotrophic factor,2041,52,0.87 [0.39-1.95],0.7404479790294232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN1,Contactin-1,2486,78,4.05 [2.00-8.20],0.0001005534317958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN2,Contactin-2,2476,78,1.88 [1.24-2.86],0.0030144347386937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN3,Contactin-3,2467,77,0.89 [0.46-1.70],0.7186889764487987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN4,Contactin-4,2467,77,2.05 [0.91-4.61],0.0831393964232769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN5,Contactin-5,2467,76,0.50 [0.29-0.85],0.0108510319930103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,2454,77,1.73 [1.18-2.54],0.0050089801952375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,2067,53,0.93 [0.69-1.25],0.6358788359836618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COCH,Cochlin,2108,54,1.63 [0.99-2.68],0.053151155464605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,2117,52,11.26 [5.98-21.19],6.198382922040442e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,2460,78,31.57 [17.02-58.54],6.224276658758628e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,2486,78,2.62 [1.36-5.03],0.0038424327717979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,2102,54,1.94 [1.20-3.15],0.0073471570574654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,2067,53,1.06 [0.77-1.47],0.7104119929516741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,2062,49,1.06 [0.76-1.49],0.7135567710606787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL3A1,Collagen alpha-1(III) chain,2117,52,2.91 [0.98-8.66],0.0550670803890295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,2460,78,2.52 [1.81-3.52],5.436676553624988e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,2082,52,1.04 [0.63-1.74],0.8682994989671626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,2079,50,1.88 [1.14-3.09],0.0136053225818409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,2486,78,8.80 [6.36-12.20],4.099090162510978e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,2454,77,1.29 [0.90-1.87],0.1705077355547446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,2085,52,0.75 [0.36-1.56],0.4400637858322427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,2459,77,17.44 [11.30-26.93],4.158150276921697e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD1,COMM domain-containing protein 1,2062,49,0.71 [0.42-1.17],0.1796811594180227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD9,COMM domain-containing protein 9,2104,54,0.95 [0.47-1.91],0.8892320087658482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMP,Cartilage oligomeric matrix protein,2423,77,1.24 [0.70-2.17],0.4584050329248607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMT,Catechol O-methyltransferase,2398,76,0.73 [0.56-0.96],0.0216921246137064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPB2,Coatomer subunit beta',2039,52,0.61 [0.31-1.19],0.1442771892594212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPE,Coatomer subunit epsilon,2394,74,0.89 [0.56-1.42],0.6212783237727856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",2062,49,0.78 [0.36-1.69],0.5287849565747605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO1A,Coronin-1A,2408,73,0.91 [0.71-1.18],0.4836327702720711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO6,Coronin-6,2041,52,2.14 [1.52-3.02],1.2977532586434931e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",2451,77,1.22 [0.91-1.64],0.1814518691066658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,2108,54,0.94 [0.41-2.15],0.8841491217337214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA1,Carboxypeptidase A1,2486,78,1.12 [0.87-1.46],0.379617476809441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA2,Carboxypeptidase A2,2477,77,1.72 [1.34-2.21],1.7037337548750615e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA4,Carboxypeptidase A4,2024,49,4.17 [2.31-7.54],2.342668991130256e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB1,Carboxypeptidase B,2486,78,1.28 [0.99-1.67],0.0618534630651109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB2,Carboxypeptidase B2,2110,54,0.47 [0.15-1.48],0.1956994951210015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPE,Carboxypeptidase E,2451,76,1.11 [0.64-1.93],0.6977546702276796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPLX2,Complexin-2,2034,52,1.99 [1.00-3.96],0.0515103441593727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPM,Carboxypeptidase M,2468,77,1.46 [0.85-2.53],0.1716747812339474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2050,54,0.67 [0.25-1.80],0.4251365014660004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,2480,77,0.99 [0.72-1.35],0.9336320263947216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPQ,Carboxypeptidase Q,2115,52,1.85 [0.90-3.81],0.0933709520071341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,2039,52,1.39 [0.77-2.52],0.2751157431782589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,2473,78,2.01 [1.19-3.40],0.0094234534567275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM1,Probable carboxypeptidase X1,2465,77,1.06 [0.80-1.41],0.6933489184667253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,2108,54,13.72 [6.54-28.79],4.383602451641073e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR1,Complement receptor type 1,2115,55,2.12 [1.10-4.10],0.0257477978337371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR2,Complement receptor type 2,2464,77,1.74 [1.19-2.54],0.0042839408662212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,2398,75,1.06 [0.83-1.35],0.6463426670981547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRADD,Death domain-containing protein CRADD,2439,76,0.73 [0.55-0.97],0.0314855973381213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,2034,52,0.86 [0.49-1.49],0.588852270414143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,2034,52,1.63 [0.56-4.73],0.3653468027852082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREG1,Protein CREG1,2434,75,0.77 [0.47-1.27],0.3042658711254107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,2079,50,4.58 [2.60-8.06],1.3393175710338834e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,2470,77,2.37 [1.72-3.26],1.2071740419560833e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRH,Corticoliberin,2396,75,0.91 [0.71-1.16],0.4436421748096324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,2459,77,7.41 [3.67-14.94],2.21983358714148e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,2417,77,0.96 [0.69-1.32],0.7844774669588481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,2474,77,18.14 [8.33-39.48],2.798803764005986e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,2441,76,3.64 [2.39-5.56],1.9832354430536198e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,2476,78,0.80 [0.59-1.09],0.1574018069664233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,2104,54,0.69 [0.26-1.84],0.4610459830862045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRKL,Crk-like protein,2465,77,0.83 [0.68-1.01],0.0602425638706526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,2474,77,1.31 [0.60-2.84],0.4921299214168121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRNN,Cornulin,2390,77,1.41 [1.09-1.82],0.0081322231864735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,2486,78,1.16 [0.60-2.23],0.6655577744536785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,2441,76,2.73 [1.88-3.97],1.294346398005223e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAP,Cartilage-associated protein,2067,53,0.80 [0.41-1.57],0.5195957630873408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRX,Cone-rod homeobox protein,2417,77,1.25 [1.10-1.43],0.000507941039399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB1,Beta-crystallin B1,2108,54,0.84 [0.54-1.29],0.4155154663514009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB2,Beta-crystallin B2,2109,53,1.11 [0.87-1.42],0.3843769069503066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYGD,Gamma-crystallin D,2109,53,0.90 [0.69-1.18],0.4483964786180939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYM,Ketimine reductase mu-crystallin,2041,52,1.01 [0.70-1.47],0.9523189979433916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,2062,49,0.63 [0.46-0.85],0.0024376994045206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSDE1,Cold shock domain-containing protein E1,2039,52,0.90 [0.68-1.18],0.4408253286693803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,2474,77,12.04 [7.29-19.89],2.4941313154348423e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,2120,55,2.59 [1.48-4.54],0.000845462326313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,2039,52,1.47 [0.78-2.74],0.2302630677581959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,2441,76,1.22 [0.88-1.69],0.2280027564740294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,2050,54,1.21 [0.64-2.31],0.5580993902537836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3,Granulocyte colony-stimulating factor,2398,76,1.29 [0.86-1.95],0.2187030479741861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,2050,54,1.96 [1.00-3.86],0.0512591137231065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,2120,55,0.95 [0.39-2.34],0.9169327292703422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK1D,Casein kinase I isoform delta,2050,54,0.85 [0.53-1.36],0.4879642522657149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,2107,54,0.50 [0.27-0.93],0.0294219487041602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,2117,52,5.21 [2.58-10.51],4.132410107565674e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,2041,52,1.71 [1.10-2.66],0.016723882275027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,2039,52,1.48 [1.21-1.82],0.0001913712822687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST1,Cystatin-SN,1857,43,1.67 [1.36-2.06],1.5770142485707796e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,2456,76,11.95 [7.88-18.11],1.3600667875213701e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST5,Cystatin-D,2418,75,1.93 [1.38-2.68],0.0001020895781237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,2389,77,4.02 [2.83-5.70],7.155520129035086e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST7,Cystatin-F,2466,77,1.11 [0.91-1.35],0.3008514283863001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,2428,76,3.23 [2.12-4.94],5.6786025688803455e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,2083,52,1.31 [0.81-2.12],0.271305280051675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTBS,Di-N-acetylchitobiase,2088,55,1.86 [0.70-4.98],0.2155825980450757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTF1,Cardiotrophin-1,2417,77,0.91 [0.71-1.17],0.4646142642909912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,2117,52,4.58 [2.72-7.71],1.1130325654752965e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,2117,52,0.90 [0.39-2.04],0.7949865822845694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTNNA1,Catenin alpha-1,2041,52,1.46 [0.71-3.01],0.3043509055200044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRB1,Chymotrypsinogen B,2467,77,1.13 [0.86-1.48],0.3762206691604783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRC,Chymotrypsin-C,2465,77,0.67 [0.53-0.84],0.0005905277395388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,2109,53,0.77 [0.58-1.02],0.0716457420805778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,2455,78,2.66 [1.94-3.65],1.2020815510532103e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSC,Dipeptidyl peptidase 1,2460,77,0.82 [0.52-1.30],0.4020338463586671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSD,Cathepsin D,2310,75,1.37 [0.91-2.07],0.1293329399597819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSE,Cathepsin E,2079,50,2.08 [1.28-3.38],0.0030325917961727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSF,Cathepsin F,2465,77,1.54 [0.98-2.43],0.0593543444241667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSH,Pro-cathepsin H,2413,77,1.62 [1.23-2.12],0.0005465547989554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,2460,78,4.20 [2.30-7.68],2.9777376596195853e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,2482,77,3.27 [1.94-5.50],8.097830320452516e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSS,Cathepsin S,1952,66,4.09 [1.57-10.64],0.0039310375411039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSV,Cathepsin L2,2468,78,0.58 [0.36-0.93],0.0243655061449758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,2457,77,6.02 [3.69-9.81],6.303514023419677e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,2067,53,0.89 [0.45-1.76],0.7448529776591546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,2091,53,1.24 [0.84-1.81],0.2762057954159361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,2441,76,5.73 [3.97-8.27],1.0894613540189915e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,2454,77,3.89 [2.83-5.35],7.556818307950482e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL1,Growth-regulated alpha protein,2462,77,1.08 [0.87-1.34],0.4872924174243584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL10,C-X-C motif chemokine 10,2474,77,1.36 [1.03-1.78],0.0282297920327455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL11,C-X-C motif chemokine 11,2480,77,1.05 [0.81-1.35],0.7165705073983445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL12,Stromal cell-derived factor 1,2398,76,0.75 [0.44-1.26],0.2774195766722619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,2480,77,1.39 [1.11-1.73],0.0034049919052428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,2398,76,1.43 [1.14-1.81],0.0024165536858279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,2483,78,15.20 [8.01-28.84],8.38334727499738e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL17,C-X-C motif chemokine 17,2482,77,1.32 [0.84-2.06],0.2316382464373415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL3,C-X-C motif chemokine 3,2462,77,0.79 [0.64-0.97],0.027974119606647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL5,C-X-C motif chemokine 5,2451,77,0.82 [0.69-0.98],0.0318954342527916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL6,C-X-C motif chemokine 6,2482,77,1.10 [0.84-1.43],0.4996303857499063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL8,Interleukin-8,2435,78,1.29 [1.00-1.67],0.0470366983532626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,2474,77,2.08 [1.67-2.58],3.650294718192287e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5A,Cytochrome b5,2034,52,1.14 [0.81-1.62],0.453993736267093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,2084,53,1.70 [1.08-2.67],0.0213980371971696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",2039,52,0.72 [0.48-1.08],0.115489782178877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTH3,Cytohesin-3,2034,52,1.12 [0.78-1.62],0.5370724302154722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,2117,52,10.51 [5.27-20.94],2.2936553160933718e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,2079,50,0.77 [0.54-1.09],0.1360622588710882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAB2,Disabled homolog 2,2476,78,0.89 [0.74-1.07],0.220380967712715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAG1,Dystroglycan,2474,77,1.09 [0.69-1.72],0.7175316914561779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAND5,DAN domain family member 5,2050,54,0.70 [0.44-1.09],0.1153812835411262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPK2,Death-associated protein kinase 2,2050,54,0.72 [0.41-1.26],0.2440476204275109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,2454,77,0.87 [0.74-1.01],0.0664112990010164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",2439,76,0.66 [0.51-0.87],0.0032103732005549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBH,Dopamine beta-hydroxylase,2118,55,0.97 [0.78-1.21],0.803960822706171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBI,Acyl-CoA-binding protein,2452,77,1.23 [0.93-1.62],0.1486834969139629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBN1,Drebrin,2050,54,1.44 [0.85-2.44],0.1716839599227204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBNL,Drebrin-like protein,2474,77,0.79 [0.63-0.99],0.0372683405393101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2465,77,5.50 [3.32-9.11],3.6690406749766685e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCC,Netrin receptor DCC,2067,53,0.33 [0.10-1.06],0.063408423265607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,2034,52,0.94 [0.60-1.48],0.7870403447696019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCLRE1C,Protein artemis,2034,52,0.92 [0.36-2.34],0.860649491071786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,2417,77,9.31 [5.07-17.10],6.45453274227166e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTD,Deoxycytidylate deaminase,2079,50,0.80 [0.60-1.08],0.1497727277849562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN1,Dynactin subunit 1,2476,78,0.79 [0.57-1.10],0.1565410628938856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN2,Dynactin subunit 2,2451,77,0.78 [0.62-0.99],0.0406312675458148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN6,Dynactin subunit 6,2394,74,0.86 [0.63-1.19],0.3659667938694302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,2460,78,1.83 [1.00-3.35],0.050867949663477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D1,DCN1-like protein 1,2041,52,1.10 [0.80-1.52],0.5431288241166408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D2,DCN1-like protein 2,2034,52,0.88 [0.61-1.27],0.4885898739204182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCXR,L-xylulose reductase,2465,77,0.62 [0.44-0.89],0.0100954850405009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,2039,52,0.79 [0.36-1.73],0.5567254480409604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",2451,77,2.11 [1.40-3.19],0.0003824694975583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,2460,78,0.98 [0.67-1.44],0.9355410199986642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDHD2,Phospholipase DDHD2,2107,54,0.62 [0.40-0.95],0.0283457657270498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDI2,Protein DDI1 homolog 2,2079,50,0.62 [0.43-0.89],0.0100045481485804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,2480,77,5.34 [2.80-10.18],3.73771107553271e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDT,D-dopachrome decarboxylase,2117,52,0.65 [0.34-1.25],0.2004331512636515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,2102,54,1.53 [0.99-2.39],0.0581006653338527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,2067,53,1.00 [0.49-2.04],0.9907332285337512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,2050,54,0.86 [0.27-2.74],0.7968940415618309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,2050,54,0.71 [0.37-1.34],0.2918868784550523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,2067,53,0.61 [0.28-1.32],0.2065769487315254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,2398,75,0.63 [0.41-0.98],0.0382093500830455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",2454,77,0.85 [0.68-1.06],0.155403803021664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,2398,75,2.43 [1.95-3.03],3.4383701874101853e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,2037,54,1.04 [0.61-1.76],0.8832772375694087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,2041,52,1.14 [0.72-1.81],0.5633341483478387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB116,Beta-defensin 116,2041,52,1.07 [0.76-1.51],0.6994858351036655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB118,Beta-defensin 118,2041,52,0.63 [0.32-1.22],0.1716963008987133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,2436,77,1.05 [0.92-1.20],0.4457197790295034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENND2B,DENN domain-containing protein 2B,2039,52,1.03 [0.60-1.76],0.925358937456561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENR,Density-regulated protein,2050,54,0.58 [0.33-1.01],0.0546815349677873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,2482,77,0.63 [0.45-0.89],0.0078542613238855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGCR6,Protein DGCR6,2041,52,1.25 [0.64-2.42],0.5103213997400113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKA,Diacylglycerol kinase alpha,2050,54,0.75 [0.44-1.28],0.2968564840439961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKZ,Diacylglycerol kinase zeta,2398,76,0.53 [0.29-0.97],0.0382540596077996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHODH,Dihydroorotate dehydrogenase,2039,52,1.01 [0.57-1.81],0.961736450168614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHPS,Deoxyhypusine synthase,2104,54,1.07 [0.56-2.03],0.8425830052830744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,2109,53,1.32 [0.82-2.12],0.2605809165105489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",2453,78,0.78 [0.65-0.94],0.0088786404181059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,2067,53,1.05 [0.54-2.01],0.8943785947363098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,2079,50,2.55 [1.22-5.30],0.0123122925125526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK1,Dickkopf-related protein 1,2480,77,0.90 [0.64-1.27],0.5426615822396426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,2486,78,6.72 [3.71-12.16],3.24346305669462e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,2438,76,4.02 [2.96-5.46],5.194331427817021e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKKL1,Dickkopf-like protein 1,2451,77,1.19 [0.92-1.54],0.192198385812648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLG4,Disks large homolog 4,2109,53,0.72 [0.47-1.10],0.1259782028178694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLGAP5,Disks large-associated protein 5,2107,54,1.41 [0.97-2.04],0.0729555173708693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,2486,78,2.56 [1.85-3.54],1.3932040083688956e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,2465,77,15.50 [10.30-23.31],1.4245635684369287e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL4,Delta-like protein 4,2062,49,0.57 [0.28-1.14],0.112915141072348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMD,Dystrophin,2062,49,2.34 [1.59-3.45],1.6181429340266813e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,2062,49,0.42 [0.30-0.60],1.021798991252014e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,2034,52,1.13 [0.61-2.12],0.6960867975177989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,2475,77,0.87 [0.67-1.12],0.2715589374400604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,2109,53,0.66 [0.45-0.96],0.0281666035190042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,2451,77,0.81 [0.64-1.03],0.0853567399796118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,2102,54,0.79 [0.50-1.26],0.3258485023954168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,2079,50,0.47 [0.27-0.82],0.0074087163612456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,2061,50,0.84 [0.59-1.19],0.3171078422323826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,2417,77,1.30 [0.95-1.77],0.0968948285885693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,2109,53,0.50 [0.22-1.13],0.095098059089266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,2062,49,0.70 [0.49-1.00],0.0519600874794416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,2102,54,0.73 [0.51-1.05],0.0901214057881343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,2462,77,0.67 [0.32-1.40],0.2819701743518713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNLZ,DNL-type zinc finger protein,2041,52,0.97 [0.69-1.36],0.8446181104038799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM1,Dynamin-1,2102,54,0.84 [0.66-1.06],0.1323969991301758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM3,Dynamin-3,2107,54,1.78 [1.17-2.73],0.0076127166273278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNMBP,Dynamin-binding protein,2441,76,1.41 [1.02-1.95],0.0350927586816179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPEP,Aspartyl aminopeptidase,2109,53,0.96 [0.63-1.46],0.844287911399001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,2469,77,0.55 [0.37-0.83],0.004791436996603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,2067,53,0.96 [0.45-2.03],0.9153463216370898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,2041,52,0.93 [0.72-1.21],0.6111909583838515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK1,Docking protein 1,2109,53,0.83 [0.69-1.00],0.0546430359805082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK2,Docking protein 2,2460,78,0.86 [0.72-1.02],0.0786072883789431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP1,Dipeptidase 1,2439,76,0.75 [0.51-1.12],0.160546090925625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP2,Dipeptidase 2,2451,77,1.89 [0.99-3.59],0.0531426614000893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,2454,77,0.73 [0.43-1.24],0.2403495174466396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,2420,76,0.43 [0.24-0.80],0.0070903720183511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,2451,77,1.65 [1.00-2.72],0.0494186189728705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP7,Dipeptidyl peptidase 2,2445,77,1.04 [0.75-1.45],0.8198351608329594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,2486,78,26.96 [11.98-60.66],1.7017366834392157e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,2467,78,2.08 [1.59-2.74],1.424531905756269e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,2441,76,4.46 [3.06-6.52],9.948534444555911e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,2451,77,0.73 [0.49-1.07],0.1079077826307185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,2444,76,14.35 [9.06-22.74],7.274612041282631e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,2107,54,1.51 [0.81-2.81],0.1990471400463642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,2467,77,4.90 [2.99-8.02],2.8011001183316197e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,2468,78,5.10 [3.14-8.28],4.4656856018955236e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG4,Desmoglein-4,2445,77,1.46 [0.97-2.19],0.0668761277686961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,2079,50,0.76 [0.54-1.06],0.1009481757164777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,2100,54,3.89 [2.69-5.64],6.609054332677401e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,2067,53,1.13 [0.73-1.74],0.5879893357203035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,2451,77,10.06 [5.61-18.03],9.499544864246424e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTYMK,Thymidylate kinase,2108,54,0.69 [0.46-1.04],0.0769194823284557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUOX2,Dual oxidase 2,2417,77,0.90 [0.65-1.23],0.4993201054888413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,2104,54,1.51 [0.91-2.52],0.1089068373248914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP29,Dual specificity phosphatase 29,2067,53,1.29 [0.93-1.81],0.1307153466295481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,2394,74,1.03 [0.81-1.31],0.8053261313271679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",2102,54,0.83 [0.64-1.08],0.1712794842823537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DXO,Decapping and exoribonuclease protein,2109,53,0.44 [0.23-0.82],0.0100046103605126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,2104,54,1.32 [0.76-2.30],0.331502201030397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,2067,53,0.84 [0.58-1.23],0.3759824541028175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,2104,54,0.52 [0.27-0.98],0.0430360097337672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,2441,76,0.79 [0.63-0.99],0.0380877011034181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,2471,78,7.11 [3.97-12.73],3.915620583197024e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECE1,Endothelin-converting enzyme 1,2394,74,0.97 [0.55-1.73],0.9280364240659806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",2108,54,0.99 [0.72-1.37],0.9624490408343416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",2062,49,0.85 [0.63-1.14],0.2847813895972135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,2039,52,0.97 [0.65-1.45],0.8724182800421811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECM1,Extracellular matrix protein 1,2053,53,0.53 [0.28-1.01],0.0545800354457141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,2041,52,1.33 [0.84-2.10],0.2223184067470792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,2476,78,6.69 [5.09-8.79],2.009684557852141e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,2454,77,1.04 [0.82-1.32],0.7668767745808551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,2104,54,1.65 [1.09-2.50],0.0186228703033727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,2039,52,1.50 [0.77-2.90],0.2324026377326243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDF1,Endothelial differentiation-related factor 1,2107,54,0.83 [0.52-1.30],0.4108589084364267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2417,77,2.33 [1.60-3.39],1.0365062374635875e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,2062,49,14.42 [6.55-31.74],3.368186497371439e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDNRB,Endothelin receptor type B,2050,54,1.76 [1.06-2.93],0.0286456906535127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EEF1D,Elongation factor 1-delta,2108,54,0.93 [0.69-1.26],0.6500213345972876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,2102,54,11.49 [7.18-18.39],2.6748479518870422e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,2085,52,0.77 [0.35-1.74],0.5348756691353804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2461,77,10.43 [6.70-16.24],2.7242572780109764e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,2107,54,5.23 [3.47-7.89],2.6587687186548346e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,2465,77,12.35 [8.66-17.62],1.1205674872956718e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,2440,76,10.67 [7.68-14.84],4.9669127997858416e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,2067,53,1.75 [1.38-2.23],4.385160907106408e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGF,Pro-epidermal growth factor,2461,77,0.87 [0.72-1.05],0.1546902526034415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,2398,75,2.36 [1.54-3.62],8.735274877723146e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFLAM,Pikachurin,2102,54,3.12 [1.73-5.60],0.0001445407088113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFR,Epidermal growth factor receptor,2486,78,0.30 [0.12-0.77],0.0119903052568589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGLN1,Egl nine homolog 1,2454,77,0.89 [0.60-1.32],0.5605409341036682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHBP1,EH domain-binding protein 1,2108,54,0.81 [0.55-1.19],0.2838379753229408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHD3,EH domain-containing protein 3,2062,49,0.79 [0.63-1.00],0.0495653327478428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",2109,53,0.59 [0.30-1.13],0.1099704396441651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",2091,54,0.78 [0.60-1.02],0.0715225815754031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,2039,52,0.94 [0.61-1.45],0.7716026568094576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,2062,49,0.30 [0.12-0.75],0.0096543506962584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,2441,76,0.54 [0.38-0.76],0.0004257648893996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,2050,54,0.73 [0.53-0.99],0.0441020155850798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,2460,78,0.81 [0.58-1.11],0.187474350053286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,2482,77,0.94 [0.76-1.16],0.5410992654250342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,2107,54,1.09 [0.72-1.65],0.6774611886331499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,2039,52,0.74 [0.38-1.47],0.3979320625210006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,2398,76,0.50 [0.24-1.05],0.0663277441834929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,2107,54,0.71 [0.52-0.98],0.0380828916735548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAVL4,ELAV-like protein 4,2041,52,1.08 [0.81-1.44],0.5806303899184018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,2108,54,5.67 [3.08-10.44],2.5682942318836404e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOA,Elongin-A,2451,77,0.71 [0.46-1.10],0.1246189905354539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOB,Elongin-B,2039,52,1.66 [1.11-2.48],0.0136562181200142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENAH,Protein enabled homolog,2398,76,1.80 [1.34-2.42],9.052928348470454e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,1957,47,4.97 [3.23-7.64],2.9245831748572253e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENG,Endoglin,2486,78,2.12 [0.74-6.11],0.1620571710498776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO1,Alpha-enolase,2464,76,0.76 [0.59-1.00],0.0477595917487251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO2,Gamma-enolase,2480,77,0.87 [0.63-1.20],0.388929767887845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO3,Beta-enolase,2062,49,0.63 [0.39-1.01],0.0541738721281991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOPH1,Enolase-phosphatase E1,2104,54,0.77 [0.46-1.28],0.3126447074807719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,2039,52,0.65 [0.24-1.76],0.3917117348571329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPEP,Glutamyl aminopeptidase,2039,52,1.08 [0.66-1.75],0.7706277997104246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,2486,78,1.45 [0.74-2.84],0.2811748548043664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,2474,77,0.62 [0.42-0.91],0.01423692002373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2062,49,1.82 [0.85-3.91],0.123428241131864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2375,74,1.00 [0.79-1.26],0.96824276139258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENSA,Alpha-endosulfine,2104,54,0.89 [0.52-1.53],0.6764436173489765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,2398,75,0.81 [0.51-1.29],0.372984389606626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,2417,77,1.03 [0.40-2.65],0.9463509701503512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,2417,77,2.74 [1.16-6.48],0.0220655294361426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,2062,49,0.70 [0.43-1.14],0.1565606524042301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EP300,Histone acetyltransferase p300,2050,54,1.62 [0.75-3.49],0.2158500957900622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPB41L5,Band 4.1-like protein 5,2067,53,1.27 [0.93-1.75],0.1379738365341141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPCAM,Epithelial cell adhesion molecule,2461,77,1.11 [0.89-1.38],0.3611218410018058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPGN,Epigen,2104,54,0.92 [0.45-1.85],0.8070301358612124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,2469,77,10.07 [5.76-17.59],5.011703725820112e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA10,Ephrin type-A receptor 10,2394,74,1.15 [0.89-1.50],0.2930406495028776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,2371,75,7.64 [5.67-10.30],8.831207023369282e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,2079,50,11.38 [4.91-26.40],1.4782942462719038e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,2486,78,13.40 [9.15-19.64],1.64175518095017e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,2439,76,10.25 [6.65-15.79],4.6439177294387677e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,2417,77,0.76 [0.52-1.12],0.1668736007084089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPN1,Epsin-1,2085,52,0.76 [0.37-1.55],0.4460029790203116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPO,Erythropoietin,2454,77,1.22 [0.97-1.55],0.0911902450855605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPPK1,Epiplakin,2062,49,1.11 [0.76-1.63],0.5829542102379006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2472,78,6.43 [4.12-10.03],2.448488532104056e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,2465,77,0.44 [0.20-0.97],0.0420721490394523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,2453,77,0.68 [0.24-1.96],0.478018827320816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,2465,77,1.20 [0.57-2.51],0.6320510194949625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBIN,Erbin,2451,77,0.85 [0.70-1.04],0.12356990736552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERC2,ERC protein 2,2067,53,1.09 [0.78-1.52],0.6310568754679236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,2034,52,1.12 [0.47-2.66],0.800701047804851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EREG,Proepiregulin,2439,76,0.78 [0.59-1.03],0.0845755714628166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERI1,3'-5' exoribonuclease 1,2085,52,0.47 [0.21-1.06],0.0671900715504796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,2050,54,2.39 [1.38-4.14],0.0018854988116901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,2104,54,0.36 [0.17-0.77],0.0081128985116499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,2079,50,0.83 [0.65-1.06],0.1294285338526183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,2450,77,0.46 [0.21-1.04],0.0621780972245253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,2039,52,0.67 [0.33-1.36],0.2725259805896673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,2486,78,8.77 [5.50-13.98],6.59106092970237e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESM1,Endothelial cell-specific molecule 1,2459,77,1.50 [0.85-2.64],0.1612907253388531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESPL1,Separin,2034,52,1.10 [0.76-1.60],0.5994165772081846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESR1,Estrogen receptor,2050,54,0.82 [0.43-1.57],0.5527196381121829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESYT2,Extended synaptotagmin-2,2109,53,1.00 [0.71-1.40],0.9949034264866424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI2B,Protein EVI2B,2034,52,0.86 [0.40-1.87],0.7084610987520561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,2050,54,0.72 [0.53-0.99],0.0427160773612771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVPL,Envoplakin,2085,52,1.31 [0.59-2.89],0.5108297820654109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXOSC10,Exosome component 10,2039,52,0.82 [0.48-1.41],0.4658190289724782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXTL1,Exostosin-like 1,2039,52,1.00 [0.58-1.72],0.9899488350554488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EZR,Ezrin,2480,77,0.62 [0.26-1.46],0.2707162020218485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F10,Coagulation factor X,2120,55,0.81 [0.35-1.89],0.6295816849749727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11,Coagulation factor XI,2088,54,0.91 [0.37-2.28],0.8489508331303289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11R,Junctional adhesion molecule A,2467,77,1.35 [0.94-1.94],0.1029900914814437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F12,Coagulation factor XII,2114,54,0.57 [0.31-1.04],0.0648709020799209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F13B,Coagulation factor XIII B chain,2103,54,1.11 [0.42-2.96],0.8277946694827939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2,Prothrombin,2114,54,0.53 [0.10-2.71],0.4478235459904658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2R,Proteinase-activated receptor 1,2470,77,1.70 [1.19-2.44],0.0039377611851418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,2462,78,10.41 [5.81-18.68],3.817663900812722e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F7,Coagulation factor VII,2459,77,1.78 [0.97-3.26],0.0621865202139722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F9,Coagulation factor IX,2463,77,1.07 [0.35-3.27],0.9094916691309154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",2459,77,2.21 [1.86-2.63],3.947023647509025e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",2460,78,1.84 [1.52-2.23],5.311260196304588e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",2108,54,3.65 [2.81-4.74],4.251890274908811e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",2486,78,3.09 [2.40-3.96],9.508211109591426e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP5,Fatty acid-binding protein 5,2474,77,1.29 [0.96-1.74],0.0901420932399083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,2415,77,2.10 [1.61-2.74],3.5815497615387253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP9,Fatty acid-binding protein 9,2454,77,1.97 [1.41-2.77],8.39231366723505e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FADD,FAS-associated death domain protein,2460,78,0.65 [0.49-0.87],0.0035342482380685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM13A,Protein FAM13A,2102,54,0.84 [0.55-1.28],0.4069886975897793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171A2,Protein FAM171A2,2107,54,1.07 [0.91-1.25],0.4290426269496513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171B,Protein FAM171B,2104,54,3.72 [2.00-6.90],3.1197455738015264e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,2062,49,0.59 [0.36-0.97],0.0390386694927221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM20A,Pseudokinase FAM20A,2108,54,1.98 [0.80-4.88],0.1378504512094548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,2451,77,8.16 [4.74-14.04],3.801015195522008e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,2460,78,16.95 [10.92-26.31],1.9084160673723304e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,2102,54,2.19 [1.62-2.97],4.479536998204012e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAP,Prolyl endopeptidase FAP,2486,78,1.60 [0.81-3.13],0.1733435114323935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,2067,53,0.57 [0.34-0.94],0.0288812338953398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,2478,78,2.34 [1.81-3.03],9.925981694203794e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,2482,77,2.02 [1.21-3.39],0.0071954810176768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,2117,52,7.65 [4.35-13.46],1.642979839376988e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBN2,Fibrillin-2,2067,53,1.78 [1.10-2.90],0.0197173794450967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",2460,78,0.92 [0.71-1.20],0.55302541671748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,2108,54,1.32 [0.93-1.87],0.1185140872342745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,2454,77,1.30 [0.90-1.88],0.1580644604174806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,2107,54,2.64 [1.27-5.49],0.0095639381560168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,2467,77,2.08 [1.62-2.68],1.2005199164610958e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,2452,77,1.36 [0.92-2.01],0.1219007582614421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,2398,75,1.08 [0.76-1.54],0.6717883785615952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,2457,77,1.91 [1.25-2.94],0.0030714263295885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN1,Ficolin-1,2118,55,1.35 [0.79-2.29],0.2688613397253446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN2,Ficolin-2,2445,77,0.58 [0.36-0.93],0.0229691578461421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL1,Fc receptor-like protein 1,2460,78,1.41 [0.92-2.15],0.1169163947609797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL2,Fc receptor-like protein 2,2476,77,1.79 [1.32-2.42],0.000158977702984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL3,Fc receptor-like protein 3,2398,76,0.94 [0.66-1.35],0.7490764626333974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL5,Fc receptor-like protein 5,2467,77,0.88 [0.63-1.23],0.4474658071301534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL6,Fc receptor-like protein 6,2454,77,2.05 [1.54-2.72],8.420291753194585e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRLB,Fc receptor-like B,2398,75,1.44 [1.06-1.94],0.0187501657963591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",2039,52,1.68 [1.30-2.17],7.30098623507519e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",2039,52,1.18 [0.70-2.01],0.529486247270972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FEN1,Flap endonuclease 1,2398,75,0.87 [0.62-1.23],0.4309569699425382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,2398,75,0.78 [0.50-1.23],0.2867807395027903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FETUB,Fetuin-B,2463,77,1.10 [0.62-1.97],0.7384125626710146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGA,Fibrinogen alpha chain,2057,52,2.53 [1.09-5.88],0.0304044498814942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",2107,54,0.79 [0.56-1.11],0.1695751366216585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF12,Fibroblast growth factor 12,2050,54,1.27 [0.83-1.93],0.264662001657453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF16,Fibroblast growth factor 16,2050,54,0.72 [0.38-1.35],0.3015132885376508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF19,Fibroblast growth factor 19,2474,77,1.34 [1.05-1.72],0.019040406644198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF2,Fibroblast growth factor 2,2454,77,0.86 [0.64-1.17],0.3478216906410417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF20,Fibroblast growth factor 20,2050,54,1.29 [0.80-2.10],0.3009064883672103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF21,Fibroblast growth factor 21,2471,78,1.31 [1.12-1.52],0.0005609147071688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,2471,78,2.16 [1.78-2.63],1.7412758311076002e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF3,Fibroblast growth factor 3,2050,54,2.74 [1.47-5.10],0.0015509914255451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,2398,76,4.80 [3.18-7.25],9.093131453174796e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF6,Fibroblast growth factor 6,2050,54,1.01 [0.58-1.75],0.9668105386944272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF7,Fibroblast growth factor 7,2034,52,1.12 [0.84-1.49],0.4324125805291823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF9,Fibroblast growth factor 9,2032,52,1.37 [0.70-2.66],0.3586029649234084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,2465,77,0.44 [0.25-0.77],0.004217225325212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,2117,52,0.52 [0.31-0.87],0.0128335401675029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,2109,53,0.63 [0.31-1.28],0.197298023509666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,2465,77,8.80 [4.76-16.27],4.012917214617117e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,2079,50,1.60 [0.95-2.68],0.0756853920915172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,2120,55,2.59 [1.82-3.69],1.286936459044096e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGR,Tyrosine-protein kinase Fgr,2394,74,0.79 [0.53-1.17],0.2367527695408501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FH,"Fumarate hydratase, mitochondrial",2041,52,0.93 [0.64-1.33],0.6746078283946562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,2039,52,0.76 [0.42-1.37],0.3655877492983951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,2394,74,0.61 [0.45-0.81],0.0008430943109547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FIS1,Mitochondrial fission 1 protein,2461,77,0.93 [0.70-1.22],0.5906406528045018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,2107,54,0.79 [0.60-1.04],0.0983218581519425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,2464,76,0.83 [0.68-1.00],0.0506007654555123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,2441,76,1.05 [0.63-1.75],0.8450300232419288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,2441,76,0.91 [0.72-1.14],0.3970486561320557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,2392,74,1.03 [0.66-1.62],0.8898887457271458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBPL,FK506-binding protein-like,2102,54,0.54 [0.33-0.87],0.0111824276877875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,2398,75,0.86 [0.71-1.05],0.1429020571847035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2441,76,5.61 [3.67-8.58],1.889616711263794e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,2447,77,2.48 [1.72-3.58],1.15811854953738e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,2398,75,1.24 [0.62-2.48],0.5436707553364818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,2482,77,1.86 [1.06-3.28],0.0319085566256617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,2465,77,1.02 [0.56-1.86],0.9422713436119764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMNL1,Formin-like protein 1,2394,74,0.88 [0.63-1.23],0.4583989967096317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMR1,Synaptic functional regulator FMR1,2398,75,0.89 [0.50-1.60],0.7005870589176311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FN1,Fibronectin,2114,54,0.31 [0.13-0.76],0.0100948772820725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,2109,53,3.57 [2.15-5.94],8.774880388955871e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2104,54,0.77 [0.31-1.89],0.5665849740081037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,2050,54,1.16 [0.91-1.48],0.2332813257000626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,2452,77,12.94 [7.91-21.18],2.2871177670166367e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,2480,77,6.59 [3.77-11.50],3.5457681017984314e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR3,Folate receptor gamma,2454,77,1.06 [0.96-1.16],0.2576557032593096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOS,Proto-oncogene c-Fos,2032,52,2.33 [1.06-5.14],0.035627854856987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOSB,Protein fosB,2394,74,1.20 [0.71-2.04],0.5000869784791269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXJ3,Forkhead box protein J3,2050,54,0.80 [0.42-1.52],0.4921184701971128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO1,Forkhead box protein O1,2454,77,0.80 [0.62-1.02],0.0767281306549607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO3,Forkhead box protein O3,2398,75,0.78 [0.61-1.00],0.0545984785430843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD4B,FERM domain-containing protein 4B,2039,52,0.98 [0.65-1.49],0.928023350776936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD7,FERM domain-containing protein 7,2067,53,0.45 [0.22-0.91],0.0261374455720736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRZB,Secreted frizzled-related protein 3,2437,76,0.41 [0.20-0.85],0.016972075037237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSHB,Follitropin subunit beta,2062,49,1.57 [0.95-2.61],0.0779193152564332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FST,Follistatin,2470,77,1.60 [1.05-2.45],0.0299400026747396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,2062,49,28.13 [9.90-79.89],3.730009639470491e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,2460,77,10.33 [7.20-14.83],1.0038472249795396e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,2105,53,0.97 [0.75-1.26],0.8230485404011318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,2475,78,0.93 [0.74-1.17],0.5234061557851976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUOM,Fucose mutarotase,2079,50,0.90 [0.61-1.33],0.6041274333160254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FURIN,Furin,2465,77,0.59 [0.32-1.08],0.0862401914591268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUS,RNA-binding protein FUS,2393,75,1.15 [0.66-2.00],0.6111468680433496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",2081,52,0.95 [0.62-1.44],0.7931248280690971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2480,77,2.27 [1.53-3.35],4.00236712905681e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",2441,76,0.90 [0.63-1.29],0.5606549016966773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXN,"Frataxin, mitochondrial",2476,78,0.81 [0.60-1.08],0.1524931843594807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,2398,76,0.73 [0.52-1.04],0.080537431920022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FYB1,FYN-binding protein 1,2462,77,0.80 [0.64-1.01],0.0557336878570478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD10,Frizzled-10,2067,53,0.95 [0.58-1.55],0.8328092786190002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD8,Frizzled-8,2041,52,1.60 [1.10-2.34],0.0150645405044155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,2104,54,1.57 [1.07-2.31],0.0216230448884272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,2085,52,0.58 [0.32-1.05],0.0707840261779121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,2041,52,1.28 [0.87-1.89],0.212136917221964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD1,Glutamate decarboxylase 1,2034,52,1.29 [0.46-3.65],0.6305559303943389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD2,Glutamate decarboxylase 2,2050,54,1.20 [0.77-1.86],0.4213319165369267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,2085,52,0.92 [0.49-1.73],0.792893296694219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,2062,49,0.57 [0.31-1.03],0.0645130246858601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAGE2A,G antigen 2A,2034,52,0.87 [0.55-1.38],0.5592833554762673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAL,Galanin peptides,2474,77,1.03 [0.77-1.39],0.8347558276478776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2451,77,1.50 [0.76-2.93],0.241281202622368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,2476,78,1.08 [0.53-2.18],0.8309783811055642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2398,76,1.43 [0.92-2.23],0.1104686942068906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,2108,54,1.04 [0.42-2.53],0.9393808907604912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,2451,77,1.54 [0.62-3.82],0.3488290582806335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,2039,52,1.30 [0.71-2.37],0.3953365528352378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,2021,49,0.49 [0.22-1.12],0.091047086403864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,2107,54,0.69 [0.22-2.11],0.5128649575299637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS2,Growth arrest-specific protein 2,2085,52,0.88 [0.52-1.51],0.6485817559372575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,2470,78,10.91 [5.30-22.46],8.923222907656385e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GASK1A,Golgi-associated kinase 1A,2039,52,0.67 [0.36-1.22],0.1918505817535979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAST,Gastrin,2109,53,1.19 [1.02-1.37],0.0234059576511372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,2034,52,1.72 [0.65-4.59],0.2770214608302925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",2062,49,0.81 [0.55-1.19],0.2780994874597411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBA,Lysosomal acid glucosylceramidase,2067,53,1.25 [0.88-1.79],0.213012220180187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP1,Guanylate-binding protein 1,2107,53,0.97 [0.64-1.47],0.8903608366240506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP2,Guanylate-binding protein 2,2398,76,1.11 [0.78-1.58],0.5648958824776815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP4,Guanylate-binding protein 4,2394,74,0.80 [0.50-1.26],0.3287146737716728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP6,Guanylate-binding protein 6,2039,52,0.82 [0.40-1.67],0.5787690921950157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GC,Vitamin D-binding protein,2114,54,1.36 [0.51-3.62],0.5394348985772479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,2109,53,0.85 [0.66-1.10],0.2193572348870964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,2398,75,1.55 [1.33-1.81],2.3024625737697483e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2019,48,2.03 [1.50-2.74],4.357597644702727e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,2039,52,0.75 [0.38-1.49],0.4122670811947695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2451,77,2.94 [1.72-5.02],7.491694040598965e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,2486,78,3.67 [2.94-4.57],6.097388637685907e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF2,Growth/differentiation factor 2,2460,78,0.97 [0.57-1.65],0.9180358234589858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,2394,74,2.07 [1.35-3.17],0.000808483809233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GET3,ATPase GET3,2108,54,0.90 [0.54-1.49],0.6774366947335909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFAP,Glial fibrillary acidic protein,2394,74,1.29 [0.85-1.98],0.2349864473674747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,2398,75,1.19 [0.86-1.66],0.2977579038557049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,2398,75,1.00 [0.83-1.20],0.9954990506607648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,2471,78,21.61 [14.00-33.34],8.431942046179414e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,2451,77,7.92 [3.40-18.41],1.561473851769446e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,2434,76,8.29 [4.99-13.77],3.287709965079245e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRAL,GDNF family receptor alpha-like,2036,51,0.63 [0.40-1.00],0.0511152428775709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,2394,74,0.92 [0.64-1.31],0.6407338452272295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,2108,54,0.74 [0.49-1.12],0.1487717368680935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,2106,54,0.63 [0.34-1.17],0.1438498097625693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGH,Gamma-glutamyl hydrolase,2409,76,0.87 [0.47-1.61],0.6575627593586318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,2465,77,0.76 [0.51-1.13],0.1793966814615381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,2441,76,11.77 [6.36-21.78],4.209465555668794e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH1,Somatotropin,2460,78,1.15 [1.03-1.29],0.0164421879514214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH2,Growth hormone variant,2398,75,0.94 [0.82-1.09],0.4263303633874487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHR,Growth hormone receptor,2079,50,0.36 [0.16-0.81],0.0138231220519642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,2394,74,1.36 [0.98-1.87],0.0625847722462173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRL,Appetite-regulating hormone,2460,78,1.75 [1.38-2.21],3.1763251715994e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,2107,54,1.65 [0.93-2.91],0.0861603505657062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,2107,54,1.39 [0.98-1.95],0.0626664822515245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP7,GTPase IMAP family member 7,2079,50,0.62 [0.23-1.66],0.3436943843867499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP8,GTPase IMAP family member 8,2034,52,0.83 [0.46-1.49],0.5304163337494324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIP,Gastric inhibitory polypeptide,2062,49,1.97 [1.32-2.95],0.0009640286619704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,2109,53,10.40 [6.05-17.86],2.1593968554970905e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,2102,54,0.84 [0.64-1.11],0.2236835232768341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,2050,54,1.45 [0.89-2.36],0.1374386507355064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,2050,54,0.82 [0.62-1.08],0.1601826601670556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GJA8,Gap junction alpha-8 protein,2034,52,1.31 [0.98-1.75],0.0647793481115031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GKN1,Gastrokine-1,2358,70,2.48 [1.30-4.73],0.0057666839767246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLA,Alpha-galactosidase A,2078,50,1.03 [0.51-2.10],0.9373035137074556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLB1,Beta-galactosidase,2441,76,0.53 [0.31-0.89],0.0159965294882703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLI2,Zinc finger protein GLI2,2050,54,1.34 [0.57-3.15],0.4956454249270676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLO1,Lactoylglutathione lyase,2417,77,0.80 [0.56-1.15],0.2223599466964204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,2457,77,0.61 [0.33-1.11],0.102182233013509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,2041,52,1.28 [0.71-2.31],0.4052824405201417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX,Glutaredoxin-1,2446,75,0.80 [0.55-1.15],0.2292069004097773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",2079,50,0.79 [0.56-1.11],0.1721694414441392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,2394,74,1.01 [0.65-1.57],0.9656126011610549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,2104,54,0.83 [0.48-1.46],0.522522310376758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GM2A,Ganglioside GM2 activator,2068,52,5.38 [3.90-7.41],7.608162869136432e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMFG,Glia maturation factor gamma,2108,54,0.66 [0.45-0.97],0.0328213304267063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR,GMP reductase 1,2482,77,0.63 [0.43-0.92],0.0173652798543386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR2,GMP reductase 2,2079,50,0.57 [0.37-0.88],0.0117248670238646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNAS,Neuroendocrine secretory protein 55,2107,54,1.24 [0.96-1.61],0.1000475788091406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,2398,75,0.77 [0.55-1.07],0.1226787833449334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,2067,53,0.88 [0.50-1.58],0.6751898413053339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNLY,Granulysin,2467,77,1.47 [1.01-2.13],0.0464667413280213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,2062,49,0.68 [0.25-1.84],0.4470712480625809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,2079,50,0.35 [0.19-0.65],0.0008940377705496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLGA3,Golgin subfamily A member 3,2107,54,0.85 [0.59-1.22],0.3764994641584647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLM2,Protein GOLM2,2480,77,1.74 [1.06-2.85],0.0290338572527003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,2454,77,0.79 [0.64-0.97],0.0222151477404708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,2102,54,0.67 [0.36-1.24],0.2064684339031046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",2117,52,0.89 [0.51-1.56],0.683811777250791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,2450,77,1.12 [0.62-2.01],0.7171523395881592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,2039,52,1.12 [0.76-1.66],0.5677857153406014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2390,77,1.17 [0.96-1.43],0.123079446740097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP5,Platelet glycoprotein V,2079,50,0.53 [0.26-1.09],0.0834091000685406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP6,Platelet glycoprotein VI,2462,77,0.90 [0.71-1.14],0.398275721660893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPA33,Cell surface A33 antigen,2451,77,0.91 [0.78-1.06],0.2217264341537561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,2476,78,9.79 [5.33-18.00],2.0415728815073289e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC5,Glypican-5,2441,76,0.69 [0.48-0.99],0.0425614113518541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,2104,54,1.44 [0.98-2.11],0.0650571823382813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,2102,54,1.77 [1.24-2.52],0.0017352516581356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPI,Glucose-6-phosphate isomerase,2120,55,0.59 [0.32-1.09],0.0911239780475809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,2102,54,2.25 [1.45-3.51],0.0003318422431646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,2394,74,1.80 [1.19-2.73],0.0053358614872027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,2403,74,6.78 [3.53-13.02],9.474277840855036e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR101,Probable G-protein coupled receptor 101,2041,52,0.95 [0.57-1.61],0.8544776009631669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR158,Probable G-protein coupled receptor 158,2107,54,2.63 [1.69-4.07],1.659086353879793e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR15L,Protein GPR15L,2102,54,1.84 [1.33-2.56],0.0002725768568879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,2417,77,3.96 [3.02-5.20],2.4702065094253985e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,2104,54,1.58 [1.10-2.25],0.0120253271443676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRAP2,GRB2-related adapter protein 2,2460,78,0.84 [0.72-0.98],0.0258327293680883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,2108,54,0.68 [0.44-1.05],0.0831878316793912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",2107,54,0.89 [0.46-1.70],0.7148515569227856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",2041,52,1.43 [0.92-2.22],0.1166690665480578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRK5,G protein-coupled receptor kinase 5,2417,77,0.56 [0.33-0.95],0.029909851446721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,2454,77,7.29 [3.79-14.00],2.494045468169013e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRP,Gastrin-releasing peptide,2062,49,2.08 [1.53-2.81],2.595782947782808e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",2451,77,1.57 [1.18-2.10],0.0020925280692328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRSF1,G-rich sequence factor 1,2023,52,0.82 [0.57-1.18],0.288635104178257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSAP,Gamma-secretase-activating protein,2398,75,0.96 [0.75-1.23],0.7325367953247758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSN,Gelsolin,2115,55,3.57 [0.90-14.17],0.0710546003108255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSR,"Glutathione reductase, mitochondrial",2112,55,0.49 [0.17-1.46],0.2013999407829476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA1,Glutathione S-transferase A1,2457,78,0.81 [0.64-1.02],0.0727354345097512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA3,Glutathione S-transferase A3,2398,75,0.80 [0.61-1.03],0.0810900822022678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,2039,52,1.05 [0.75-1.46],0.7778454417356244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTP1,Glutathione S-transferase P,2378,73,0.89 [0.64-1.24],0.484059621314458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,2109,53,1.02 [0.91-1.14],0.7165145129440267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,2085,52,1.18 [0.83-1.66],0.352118187408417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTPBP2,GTP-binding protein 2,2067,53,0.60 [0.42-0.87],0.0064231351620487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,2459,77,6.86 [5.09-9.26],2.0908902177790248e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,2085,52,1.12 [0.84-1.49],0.4453906898008838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUK1,Guanylate kinase,2039,52,1.53 [0.84-2.80],0.1673584614205985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUSB,Beta-glucuronidase,2467,78,0.69 [0.52-0.92],0.0121483843339989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",2417,77,0.87 [0.68-1.10],0.2327079523911558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMA,Granzyme A,2482,77,2.09 [1.18-3.67],0.0109722000451583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMB,Granzyme B,2454,77,0.97 [0.69-1.36],0.864206585577322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMH,Granzyme H,2417,77,1.29 [1.00-1.66],0.0519608691677905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",H2AP,Huntingtin-interacting protein M,2034,52,0.79 [0.40-1.56],0.5020255193531786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",2039,52,1.10 [0.84-1.46],0.4864185934975669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2470,78,0.70 [0.53-0.93],0.0146630389732363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAO1,Hydroxyacid oxidase 1,2476,78,1.00 [0.86-1.16],0.9858561256332726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",2467,77,0.71 [0.54-0.94],0.0165413982342726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,2475,78,3.63 [3.03-4.36],9.542228458169776e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,2467,77,9.47 [6.43-13.96],6.397917853816913e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,2470,78,0.80 [0.61-1.05],0.108415426951588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBQ1,Hemoglobin subunit theta-1,2476,78,0.63 [0.44-0.89],0.0097488422516812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBZ,Hemoglobin subunit zeta,2108,54,0.64 [0.48-0.85],0.0022233227773953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCG22,Protein PBMUCL2,2039,52,0.91 [0.55-1.49],0.6997238954231557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,2482,77,0.72 [0.49-1.04],0.0823319353168457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC8,Histone deacetylase 8,2050,54,0.47 [0.22-1.02],0.0547055555200949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC9,Histone deacetylase 9,2041,52,1.13 [0.82-1.56],0.4395479554133871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,2102,54,0.34 [0.18-0.65],0.0010696989708686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGF,Hepatoma-derived growth factor,2471,78,0.89 [0.71-1.10],0.2778889801117221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,2109,53,0.78 [0.49-1.23],0.2867595271022412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEBP1,Heme-binding protein 1,2417,77,0.68 [0.44-1.05],0.0816972534504412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEG1,Protein HEG homolog 1,2079,50,1.62 [0.66-3.97],0.2932475032781967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPACAM2,HEPACAM family member 2,2109,53,0.84 [0.47-1.49],0.5498273004564433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,2108,54,8.54 [3.30-22.11],9.718520910640603e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEXIM1,Protein HEXIM1,2454,77,0.83 [0.63-1.08],0.1631508462036482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGF,Hepatocyte growth factor,2482,77,1.60 [0.96-2.68],0.0736508652261388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGFAC,Hepatocyte growth factor activator,2103,55,2.03 [0.75-5.44],0.1613535758793382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,2398,75,0.68 [0.50-0.91],0.009960061669943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,2109,53,1.05 [0.72-1.53],0.7993064768801219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,2050,54,1.06 [0.72-1.57],0.7647475667060679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1,Huntingtin-interacting protein 1,2039,52,1.05 [0.43-2.59],0.9123179453378448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,2105,53,2.35 [1.76-3.14],6.590048246010598e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HJV,Hemojuvelin,2107,54,1.88 [1.38-2.56],6.968573246574337e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HK2,Hexokinase-2,2417,77,1.30 [0.64-2.63],0.4630145089980213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2107,54,3.84 [1.72-8.60],0.0010360935553851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",2446,76,1.42 [0.86-2.34],0.1753009901921425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2454,77,7.12 [5.06-10.02],2.0394623323332042e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMBS,Porphobilinogen deaminase,2476,78,0.42 [0.27-0.65],0.000118346594873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMCN2,Hemicentin-2,2075,50,2.45 [1.50-3.98],0.0003108521910415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",2062,49,0.73 [0.39-1.37],0.3239896736159126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",2039,52,0.59 [0.28-1.22],0.1565554476072766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMMR,Hyaluronan mediated motility receptor,2030,52,1.42 [0.96-2.09],0.078149608598782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX1,Heme oxygenase 1,2442,76,0.67 [0.45-1.02],0.0636346830227806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX2,Heme oxygenase 2,2394,74,1.72 [1.24-2.39],0.0012910183492783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,2067,53,1.06 [0.78-1.45],0.7135695323097169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,2436,76,2.78 [1.98-3.91],3.6395685341055116e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,2412,77,0.71 [0.53-0.95],0.0230501738663242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,2107,54,1.15 [0.68-1.97],0.5998045140043511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPCAL1,Hippocalcin-like protein 1,2482,77,0.87 [0.66-1.14],0.3080092307553536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,2398,75,0.45 [0.26-0.81],0.007121607819971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPSE,Heparanase,2092,52,0.95 [0.71-1.26],0.7174263396355305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRAS,GTPase Hras,2078,52,1.06 [0.85-1.34],0.5926878306413751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2062,49,2.46 [1.73-3.48],4.013551506404836e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRG,Histidine-rich glycoprotein,2103,54,0.37 [0.17-0.81],0.0129736532167189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS1BP3,HCLS1-binding protein 3,2062,49,0.87 [0.62-1.21],0.4062719309885201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,2451,77,2.20 [1.34-3.60],0.0017753935857104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,2476,78,1.52 [1.02-2.26],0.0394334636414991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2050,54,4.28 [2.90-6.33],2.9148766370367105e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSBP1,Heat shock factor-binding protein 1,2062,49,1.01 [0.74-1.38],0.9271626199749926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,2454,77,1.19 [0.75-1.91],0.4562912281347181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,2109,53,1.10 [0.74-1.63],0.6450412817580454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,2039,52,0.73 [0.39-1.35],0.3113751661077547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,2062,49,1.37 [0.77-2.43],0.2896230004039919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSP90B1,Endoplasmin,2383,73,1.30 [0.98-1.73],0.0645733122377648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,2469,77,0.81 [0.59-1.10],0.1791875228271034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,2104,54,5.43 [3.58-8.25],1.897265694626868e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB1,Heat shock protein beta-1,2424,75,0.72 [0.55-0.94],0.0170535982167073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,2476,78,5.19 [3.69-7.31],4.319648599158445e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2440,77,10.02 [6.90-14.55],8.626960640270262e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,2041,52,1.17 [0.90-1.53],0.2407974824243447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,2041,52,0.67 [0.32-1.42],0.2937589283807772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",2465,77,0.92 [0.65-1.30],0.6452495493272505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYAL1,Hyaluronidase-1,2441,76,3.41 [1.83-6.35],0.0001122756715031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,2486,78,36.04 [18.75-69.29],5.825672756546512e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICA1,Islet cell autoantigen 1,2398,76,0.79 [0.60-1.04],0.0894158926866857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,2444,77,1.54 [0.84-2.82],0.1638332875485248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,2486,78,3.79 [1.99-7.20],4.96079893870213e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,2486,78,2.32 [1.19-4.55],0.0137369736574893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM4,Intercellular adhesion molecule 4,2454,77,0.74 [0.51-1.08],0.1150063728551195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM5,Intercellular adhesion molecule 5,2460,78,1.62 [1.06-2.49],0.0270423859820603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICOSLG,ICOS ligand,2451,77,7.26 [2.92-18.08],2.0168539390782755e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,2085,52,1.38 [0.82-2.34],0.2245849699148664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,2394,74,1.57 [1.19-2.09],0.0017394053279786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",2062,49,1.06 [0.70-1.61],0.7723829509754414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDS,Iduronate 2-sulfatase,2482,77,1.45 [0.15-13.57],0.7469507139279373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDUA,Alpha-L-iduronidase,2476,78,1.16 [0.76-1.79],0.4933481135329305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2056,52,4.79 [2.81-8.15],8.462317070598729e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,2085,52,0.67 [0.38-1.20],0.1825948706044346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,2085,52,0.56 [0.25-1.24],0.152070142205983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,2102,54,2.41 [1.09-5.30],0.0288941627589285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNG,Interferon gamma,2398,76,1.45 [1.22-1.73],3.419837514780538e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,2474,77,22.90 [12.26-42.78],9.041096106692104e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR2,Interferon gamma receptor 2,2441,76,1.07 [0.74-1.55],0.7201375811183858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL1,Interferon lambda-1,2394,74,1.67 [1.21-2.32],0.001908934293963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL2,Interferon lambda-2,2041,52,1.20 [0.86-1.68],0.2809393104190968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNLR1,Interferon lambda receptor 1,2454,77,1.51 [0.95-2.41],0.0802967083447356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNW1,Interferon omega-1,2039,52,0.41 [0.15-1.18],0.0983097468095433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,2067,53,0.57 [0.27-1.20],0.1381845593169333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,2107,54,0.55 [0.35-0.87],0.0100395675686218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,2041,52,0.98 [0.55-1.74],0.945675235279924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,2117,52,3.23 [1.24-8.41],0.0161592516243818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,2451,77,10.53 [6.09-18.22],3.8263646535730506e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,2039,52,1.21 [0.68-2.16],0.5209246009395896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,2467,77,3.01 [1.29-7.04],0.0107003206915553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,2485,78,1.83 [1.55-2.15],3.228782964369084e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,2481,78,3.56 [2.71-4.67],4.631028989809995e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,2464,77,0.52 [0.34-0.80],0.0027179723725348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,2443,76,4.73 [3.82-5.86],9.463092500949704e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,2448,76,7.12 [5.19-9.76],4.492456103333313e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,2486,78,4.33 [3.16-5.94],7.096195360466579e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,2460,78,4.15 [2.85-6.04],9.934883834366688e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFL4,Insulin growth factor-like family member 4,2050,54,0.73 [0.44-1.20],0.207675294854304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,2039,52,1.19 [0.71-1.97],0.5084253674768545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,2109,54,4.05 [2.16-7.59],1.3009431855791426e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLON5,IgLON family member 5,2034,52,0.90 [0.62-1.30],0.5630994905647225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,2062,49,0.69 [0.32-1.46],0.3302559594559903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,2451,77,1.40 [0.92-2.12],0.1179449674248312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,2460,78,3.09 [2.22-4.31],2.79457204083134e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF9,Protein turtle homolog A,2108,54,0.75 [0.58-0.98],0.0377852031627883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKBKG,NF-kappa-B essential modulator,2454,77,0.84 [0.67-1.06],0.1480568651954521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKZF2,Zinc finger protein Helios,2398,75,1.02 [0.80-1.30],0.8612270902915999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10,Interleukin-10,2398,76,1.24 [1.01-1.53],0.0419887114231379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,2398,76,1.29 [0.95-1.76],0.102107798371781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,2474,77,9.62 [6.18-14.96],1.0916516696817657e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL11,Interleukin-11,2398,76,1.00 [0.72-1.40],0.9986717289847804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,2451,77,2.04 [1.65-2.51],4.399796158693917e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,2482,77,2.74 [1.97-3.82],2.8351176866748202e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,2398,76,4.85 [3.21-7.33],6.136788187594022e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,2050,54,1.29 [0.63-2.65],0.4865677075483063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13,Interleukin-13,2398,76,0.98 [0.64-1.49],0.9264987583935664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,2430,75,0.77 [0.32-1.84],0.5598438270375244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,2041,52,2.04 [0.77-5.41],0.1527818539481145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15,Interleukin-15,2454,77,3.32 [1.97-5.62],7.308796095990916e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,2398,76,9.05 [5.63-14.55],8.807889558944373e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL16,Pro-interleukin-16,2482,77,2.06 [1.49-2.85],1.4287082293863974e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17A,Interleukin-17A,2392,75,1.58 [1.13-2.22],0.00828524641726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,2398,76,1.99 [1.67-2.37],1.4494563967663464e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17D,Interleukin-17D,2398,76,1.54 [1.14-2.07],0.0048119882131004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17F,Interleukin-17F,2398,76,1.32 [1.04-1.66],0.0210438349794326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RA,Interleukin-17 receptor A,2467,77,1.12 [0.72-1.74],0.6233353180181123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RB,Interleukin-17 receptor B,2432,77,1.88 [1.30-2.70],0.00072891444486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18,Interleukin-18,2452,77,1.83 [1.19-2.83],0.0063398601147233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,2464,77,11.78 [7.53-18.43],3.708194511682764e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,2482,77,2.71 [1.58-4.65],0.0002876181197294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,2429,75,0.98 [0.86-1.11],0.7157120119938106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,2412,75,1.54 [1.30-1.83],8.164428589856892e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1A,Interleukin-1 alpha,2398,76,1.39 [1.10-1.77],0.0069043896317306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1B,Interleukin-1 beta,2384,76,1.20 [0.87-1.67],0.265826931883251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,2465,77,12.98 [6.94-24.26],9.45621451241907e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R2,Interleukin-1 receptor type 2,2454,77,0.51 [0.21-1.23],0.1331729718099879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,2467,77,1.14 [0.75-1.73],0.5313396587068397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,2478,78,2.43 [1.55-3.81],0.0001119635043348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,2398,76,0.97 [0.56-1.68],0.9100550100545916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,2458,77,1.25 [0.92-1.68],0.1556190540451494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2,Interleukin-2,2398,76,0.66 [0.35-1.23],0.18755527143727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20,Interleukin-20,2398,76,0.93 [0.61-1.43],0.7507595063743591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,2398,76,1.02 [0.64-1.63],0.9173355039408192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,2050,54,0.96 [0.49-1.87],0.9038610372217368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL21R,Interleukin-21 receptor,2050,54,0.97 [0.59-1.58],0.8908004698828665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22,Interleukin-22,2104,54,1.40 [0.99-1.98],0.0539213746674378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,2398,76,1.55 [1.12-2.14],0.0085226280713896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL24,Interleukin-24,2398,76,1.04 [0.71-1.52],0.844280872207815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL25,Interleukin-25,2029,52,1.77 [0.78-4.00],0.1699703322968759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,2436,76,3.68 [2.76-4.92],1.056777349166877e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,2398,76,1.45 [1.05-2.00],0.0256794899667908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,2104,54,2.05 [1.25-3.34],0.0042553193714069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3,Interleukin-3,2034,52,0.96 [0.61-1.51],0.8574335200536634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31,Interleukin-31,2050,54,1.24 [0.85-1.82],0.2698445711221426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,2041,54,1.84 [0.99-3.39],0.0528862299153205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL32,Interleukin-32,2454,77,1.41 [1.02-1.96],0.0398979585905868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL33,Interleukin-33,2398,76,1.42 [0.84-2.41],0.194014730892211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL34,Interleukin-34,2389,73,1.36 [0.77-2.42],0.2883508840521474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36A,Interleukin-36 alpha,2050,54,1.44 [1.03-2.02],0.0347250332397782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36G,Interleukin-36 gamma,2045,54,1.59 [1.22-2.09],0.0007187032765575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,2398,76,1.47 [0.81-2.64],0.2021637455280505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4,Interleukin-4,2398,76,0.92 [0.78-1.09],0.352311495193216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,2454,77,4.60 [3.31-6.39],9.413858209862716e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5,Interleukin-5,2398,76,0.96 [0.82-1.13],0.6444022591731751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,2454,77,1.78 [1.31-2.41],0.0002231352094438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6,Interleukin-6,2451,77,1.14 [0.92-1.41],0.2253224766913119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,2443,77,2.74 [1.54-4.86],0.0005826509644937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,2460,78,7.81 [2.94-20.73],3.740140972773822e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7,Interleukin-7,2454,77,0.70 [0.49-0.98],0.0392458155517958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,2467,77,1.23 [0.83-1.82],0.310637559336684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL9,Interleukin-9,2085,52,0.74 [0.42-1.32],0.3124810398501021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,2388,74,0.71 [0.48-1.07],0.0992068488993683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,2104,54,2.37 [1.70-3.31],3.534970544005767e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPA1,Inositol monophosphatase 1,2441,76,0.63 [0.43-0.92],0.0153776924228827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPACT,Protein IMPACT,2109,53,0.52 [0.32-0.85],0.0093455308925162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,2041,52,1.03 [0.40-2.69],0.9508876535635076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ING1,Inhibitor of growth protein 1,2392,74,0.96 [0.62-1.47],0.8457912834542674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,2079,50,3.52 [2.44-5.09],1.6723447315313105e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBC,Inhibin beta C chain,2467,77,1.58 [0.91-2.75],0.1053369222491963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,2451,77,1.30 [0.92-1.83],0.1438825566681225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",2062,49,0.52 [0.31-0.89],0.016057847807978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",2107,54,0.85 [0.42-1.72],0.6514673711195379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",2451,77,0.94 [0.76-1.16],0.5836985156975485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL3,Insulin-like 3,2109,53,1.16 [0.84-1.58],0.3680091932939123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,2104,54,2.59 [1.93-3.48],2.7440175877661656e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL5,Insulin-like peptide INSL5,2102,54,1.51 [1.20-1.90],0.000499855388959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSR,Insulin receptor,2050,54,6.58 [1.61-26.90],0.0087684516369563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,2440,76,0.82 [0.64-1.04],0.1040761367579182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,2451,77,1.10 [0.77-1.58],0.6057365008874568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",2417,77,1.06 [0.85-1.34],0.5888937672945034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,2398,76,0.82 [0.60-1.14],0.2362586579349337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,2454,77,0.84 [0.69-1.02],0.0808628297957209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2365,71,1.38 [0.81-2.35],0.2397663364685534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM1,Isthmin-1,2454,77,1.70 [1.24-2.31],0.0008323794130363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM2,Isthmin-2,2117,52,1.39 [0.80-2.41],0.2376019985176946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IST1,IST1 homolog,2087,54,0.78 [0.59-1.03],0.0842443444606995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA11,Integrin alpha-11,2454,77,0.72 [0.41-1.25],0.2404096416882516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA2,Integrin alpha-2,2079,50,0.42 [0.20-0.89],0.0238546682841277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA5,Integrin alpha-5,2467,77,1.06 [0.51-2.21],0.8744471616029752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA6,Integrin alpha-6,2454,77,1.07 [0.72-1.60],0.7325639406125917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAL,Integrin alpha-L,2050,54,2.49 [1.32-4.72],0.0049995092567346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAM,Integrin alpha-M,2467,77,1.13 [0.63-2.02],0.6818444889793349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAV,Integrin alpha-V,2476,78,0.58 [0.19-1.74],0.3289495109275834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAX,Integrin alpha-X,2085,52,0.85 [0.48-1.50],0.5715337839726657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1,Integrin beta-1,2452,77,1.20 [0.51-2.85],0.6752030128956699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,2398,75,1.01 [0.63-1.62],0.957122329531042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,2417,77,0.86 [0.72-1.03],0.1088193419205249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB2,Integrin beta-2,2447,76,1.62 [0.87-2.99],0.1270607004472717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB5,Integrin beta-5,2465,77,1.11 [0.68-1.81],0.6836091222839666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,2398,76,4.38 [2.35-8.17],3.4513302303769107e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB7,Integrin beta-7,2476,78,1.53 [1.04-2.26],0.0312908636266631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,2117,52,2.47 [1.71-3.55],1.3306860434330842e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,2114,54,1.34 [0.39-4.61],0.6476952752507006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2464,77,3.67 [2.12-6.36],3.46957362992097e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,2114,54,1.44 [0.53-3.95],0.4742586967397409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,2104,54,1.27 [0.76-2.13],0.3665659239697709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITM2A,Integral membrane protein 2A,2454,77,1.63 [1.19-2.24],0.0024570726100479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,2039,52,0.61 [0.40-0.93],0.0205748106736722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",2062,49,1.12 [0.76-1.63],0.5678995769902786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",2041,52,1.61 [0.92-2.82],0.0934046045294502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",2394,74,1.22 [0.86-1.74],0.2688774353965888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,2034,52,1.31 [0.82-2.09],0.2667677492348475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,2480,77,15.06 [10.25-22.15],2.875814372750292e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM3,Junctional adhesion molecule C,2079,50,1.88 [1.36-2.58],0.0001209231018528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JCHAIN,Immunoglobulin J chain,2398,76,1.54 [1.11-2.13],0.0089277343283744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,2034,52,1.29 [0.83-1.99],0.2587331010170218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,2102,54,0.77 [0.56-1.05],0.101690469790509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JUN,Transcription factor AP-1,2398,76,1.60 [1.28-2.00],3.779604686071594e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2451,77,3.04 [1.94-4.76],1.3123999797820326e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZN,Kazrin,2102,54,0.81 [0.62-1.05],0.1049803977572363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,2041,52,1.56 [1.14-2.14],0.0055540337072229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,2067,53,0.63 [0.37-1.06],0.0805007282298861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNIP4,Kv channel-interacting protein 4,2394,74,1.15 [0.81-1.63],0.4244094846684839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,2067,52,0.88 [0.47-1.63],0.6789526501482424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDM3A,Lysine-specific demethylase 3A,2050,54,1.06 [0.77-1.47],0.7257820644790026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,2465,77,1.19 [0.52-2.73],0.6834198214113079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KEL,Kell blood group glycoprotein,2394,74,0.61 [0.36-1.05],0.0754895192178859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHDC3L,KH domain-containing protein 3,2034,52,0.83 [0.52-1.32],0.4303621815531017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHK,Ketohexokinase,2062,49,0.88 [0.57-1.36],0.5706162906710539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,2109,53,7.13 [4.15-12.26],1.2308018835600198e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,2085,52,1.01 [0.69-1.47],0.9689720746382569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,2085,52,0.87 [0.32-2.38],0.786564069358776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,2104,54,0.93 [0.51-1.69],0.8021177052856144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,2039,52,2.52 [1.45-4.39],0.0010504574194556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF20B,Kinesin-like protein KIF20B,2041,52,1.07 [0.78-1.46],0.6649361635954351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF22,Kinesin-like protein KIF22,2039,52,0.81 [0.65-1.00],0.0487152350637499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIFBP,KIF-binding protein,2451,77,0.86 [0.67-1.09],0.2125236184281236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,2104,54,1.27 [0.97-1.68],0.0830014925654106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,2398,75,1.47 [1.16-1.86],0.0015711164329285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,2102,54,1.16 [1.00-1.34],0.0447834215440875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,2398,75,1.15 [0.99-1.34],0.0764461376088381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,2034,52,1.14 [0.84-1.54],0.4123355543949721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,2041,52,1.06 [0.64-1.76],0.8142691448636291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,2394,74,2.99 [2.00-4.46],8.294821795692602e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,2463,77,1.47 [0.78-2.80],0.2336352264934333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,2460,78,3.74 [2.30-6.07],1.0357843081803529e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLB,Beta-klotho,2394,74,1.49 [1.18-1.88],0.0007426754579128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLF4,Krueppel-like factor 4,2041,52,1.99 [1.24-3.19],0.0042423694038098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLHL41,Kelch-like protein 41,2107,54,1.80 [1.26-2.57],0.0012246598161854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK1,Kallikrein-1,2434,76,1.06 [0.91-1.23],0.4824532071580828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,2457,77,2.49 [1.68-3.69],5.666746135848738e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,2439,77,11.76 [7.62-18.14],7.95716335493854e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK12,Kallikrein-12,2398,75,1.15 [0.99-1.34],0.0717076722371102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK13,Kallikrein-13,2408,76,1.37 [0.93-2.00],0.1104095349007469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,2476,78,3.19 [2.09-4.86],6.384369198804247e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK15,Kallikrein-15,2099,54,2.12 [1.26-3.58],0.0046936225584379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK3,Prostate-specific antigen,2117,52,0.77 [0.60-1.00],0.0473139256672633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,2476,78,2.51 [2.08-3.02],3.9726877693359003e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,2461,77,6.03 [3.77-9.66],7.473982275909419e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK7,Kallikrein-7,2020,49,1.28 [0.66-2.49],0.4699452983329339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,2373,74,5.11 [3.55-7.37],2.42011337717646e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLKB1,Plasma kallikrein,2071,54,0.30 [0.13-0.69],0.0047417253840064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,2482,77,7.89 [5.65-11.03],1.1069049021925666e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,2041,52,1.18 [0.84-1.64],0.3379426669759315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,2482,77,3.78 [2.59-5.51],5.528780591093707e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,2050,54,1.82 [1.38-2.40],1.7911321808077597e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,2109,53,3.24 [2.19-4.80],4.074282451753122e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",2326,71,1.50 [0.80-2.81],0.2017318388331741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",2039,52,0.85 [0.40-1.77],0.6555767899539148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",2451,77,1.26 [1.05-1.52],0.0143963537148571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",2449,76,2.43 [1.98-2.97],9.655142423959242e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",2394,74,1.65 [1.20-2.27],0.0021224986742606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",2039,52,1.12 [0.59-2.12],0.72705153656896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",2041,52,1.14 [0.97-1.33],0.1122475411064886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,2457,78,0.54 [0.37-0.77],0.0008340820424694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYNU,Kynureninase,2482,77,0.67 [0.45-1.00],0.048838189638319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L1CAM,Neural cell adhesion molecule L1,2465,77,1.38 [0.73-2.61],0.3273748618570998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,2108,54,0.93 [0.68-1.27],0.6455208235515255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACRT,Extracellular glycoprotein lacritin,2096,54,1.06 [0.63-1.78],0.840054781992349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACTB2,Endoribonuclease LACTB2,2460,78,0.68 [0.48-0.94],0.0219073289986175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,2451,77,3.27 [2.37-4.52],7.158353827713475e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2459,77,3.97 [3.17-4.96],1.7413629151365846e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,2441,76,1.48 [1.20-1.81],0.0001882075352805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA1,Laminin subunit alpha-1,2039,52,0.92 [0.52-1.62],0.7624402894277137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA4,Laminin subunit alpha-4,2474,77,2.76 [1.65-4.62],0.0001114142595286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMB1,Laminin subunit beta-1,2062,49,4.03 [1.70-9.54],0.0015121873074966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,2063,52,0.99 [0.34-2.88],0.980492593072386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,2403,74,0.31 [0.12-0.81],0.0173604473579999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,2477,77,1.98 [1.38-2.85],0.0002381509335373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,2104,54,0.90 [0.44-1.84],0.7766661784084539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAP3,Cytosol aminopeptidase,2398,76,0.68 [0.42-1.09],0.1081835599714011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LARP1,La-related protein 1,2104,54,0.80 [0.50-1.30],0.375865578400392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT,Linker for activation of T-cells family member 1,2482,77,0.85 [0.66-1.10],0.2264527205104752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT2,Linker for activation of T-cells family member 2,2451,77,0.92 [0.78-1.08],0.3040232682869124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,2050,54,0.93 [0.67-1.29],0.6489290243079828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,2439,76,7.71 [5.85-10.16],1.2775053433883543e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,2464,77,1.91 [1.34-2.72],0.0003440865214587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,2480,77,1.09 [0.82-1.44],0.5610703152399329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,2120,55,0.49 [0.15-1.60],0.2362104064309875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,2107,54,1.85 [1.49-2.30],3.014183998495013e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,2378,76,3.51 [2.70-4.55],3.0713585070760787e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCP1,Plastin-2,2117,52,0.81 [0.45-1.44],0.4691278982445004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLR,Low-density lipoprotein receptor,2464,76,0.96 [0.65-1.42],0.8334451306654362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,2107,54,0.78 [0.59-1.02],0.0663798563929917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,2108,54,1.72 [1.34-2.20],1.7136508549369265e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEFTY2,Left-right determination factor 2,2471,78,1.53 [1.05-2.21],0.0258050838223802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEG1,Protein LEG1 homolog,2015,49,1.14 [0.78-1.67],0.4882945963011009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,2041,52,0.99 [0.65-1.51],0.9636553716339218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,2107,54,1.59 [1.07-2.36],0.021648358411065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEP,Leptin,2460,78,1.11 [0.80-1.54],0.5148436375617722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEPR,Leptin receptor,2460,78,2.34 [1.28-4.25],0.0054361717647565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,2107,54,2.48 [1.61-3.82],4.182405070270158e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,2460,78,4.80 [3.01-7.65],4.704419581567363e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,2456,77,5.16 [2.76-9.65],2.732402580276804e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3BP,Galectin-3-binding protein,2114,54,0.89 [0.39-2.00],0.7695922930387442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,2459,77,3.70 [2.83-4.85],2.041918629050612e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,2447,77,3.60 [2.63-4.94],1.5784498783458646e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS8,Galectin-8,2480,77,0.93 [0.65-1.32],0.681432664825899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,2462,77,8.72 [5.18-14.65],3.120845203889978e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGMN,Legumain,2474,77,1.40 [0.81-2.42],0.2241535855815637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHB,Lutropin subunit beta,2398,75,1.15 [0.92-1.42],0.2213491970887297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2466,77,0.71 [0.53-0.97],0.0291836912491335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIF,Leukemia inhibitory factor,2394,74,0.96 [0.60-1.54],0.8724749861040748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,2454,77,6.46 [3.75-11.14],1.7526845761721595e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,2467,77,1.34 [0.77-2.36],0.3029524616481395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,2117,52,1.05 [0.86-1.29],0.6274828446020022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,2039,52,0.72 [0.38-1.37],0.3163873951695102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2460,78,4.91 [2.71-8.88],1.4102555220928717e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,2108,54,1.31 [0.92-1.85],0.1350533074054838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,2486,78,1.78 [0.88-3.60],0.1056259101937165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2473,78,2.56 [1.43-4.57],0.0014738509323444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2398,76,4.72 [3.33-6.69],2.828082491746879e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,2486,78,0.95 [0.71-1.26],0.6982528449203893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIPF,Gastric triacylglycerol lipase,2062,49,0.83 [0.56-1.24],0.3665153475617539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB1,Lamin-B1,2100,54,1.08 [0.74-1.56],0.6916864058943499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,2109,53,15.42 [8.44-28.17],5.452434554549914e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,2107,54,9.37 [5.85-15.03],1.504108869117432e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD2,Leiomodin-2,2041,52,0.99 [0.62-1.60],0.9795468716239054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",2062,49,0.77 [0.54-1.09],0.1356139840376189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPA,Apolipoprotein(a),2062,53,1.00 [0.87-1.15],0.9584039879967782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,2451,77,1.24 [0.88-1.75],0.2238459510339826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPL,Lipoprotein lipase,2460,78,1.35 [0.87-2.08],0.1762111204178347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPO,Lactoperoxidase,2374,73,1.14 [0.83-1.56],0.4143681773865717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPP,Lipoma-preferred partner,2039,52,0.70 [0.46-1.08],0.110948760279355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,2039,52,0.90 [0.58-1.38],0.6174558772648728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,2067,53,0.96 [0.50-1.85],0.9024811047308992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,2114,54,8.17 [3.24-20.58],8.360122394750591e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2470,78,2.71 [1.73-4.26],1.392513186074637e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,2046,54,2.45 [1.31-4.58],0.0049661147382248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,2451,77,1.56 [0.80-3.06],0.1907614215889964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,2460,78,9.28 [6.22-13.84],9.393575222254212e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,2067,53,1.10 [0.53-2.30],0.7905063991740235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2BP,LRP2-binding protein,2067,53,1.09 [0.81-1.45],0.5765950768736144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,2480,77,0.87 [0.58-1.30],0.4976437002706341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,2451,77,1.71 [1.32-2.21],3.915093686461525e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,2102,54,1.10 [0.59-2.04],0.7601126683749184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,2067,53,1.14 [0.67-1.94],0.6375421152655307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,2108,54,0.79 [0.43-1.43],0.4329989089070579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,2104,54,0.77 [0.43-1.40],0.395600810770273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,2398,76,0.50 [0.30-0.81],0.0054099993127397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,2067,53,1.26 [0.73-2.17],0.4036444282415962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,2107,54,1.64 [0.60-4.48],0.3362905379026628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,2398,75,0.92 [0.62-1.37],0.6801793193275412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,2085,52,0.75 [0.49-1.14],0.1796684326372859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,2454,77,1.40 [0.85-2.30],0.1817855426127941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA,Lymphotoxin-alpha,2454,77,1.27 [0.75-2.15],0.3720263184612167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,2476,78,1.17 [0.85-1.62],0.3324211522149725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTB,Lymphotoxin-beta,2104,54,1.49 [0.85-2.61],0.163048036382095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,2486,78,6.50 [4.16-10.15],2.020987256065975e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,2398,75,1.59 [1.26-2.00],8.770096285012735e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,2446,77,9.12 [6.50-12.80],1.6260377355685297e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTO1,Protein LTO1 homolog,2398,76,1.05 [0.62-1.77],0.8686846294857724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LUZP2,Leucine zipper protein 2,2104,54,1.69 [1.29-2.21],0.0001235452051541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LXN,Latexin,2425,76,0.59 [0.43-0.82],0.0013937620166464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,2452,77,4.50 [3.39-5.96],1.2617740528324442e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY75,Lymphocyte antigen 75,2454,77,1.73 [1.04-2.89],0.0363198000847783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,2430,76,2.78 [1.55-4.98],0.0006176550124403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY96,Lymphocyte antigen 96,2441,76,1.43 [0.81-2.53],0.2210264674921099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,2398,75,0.60 [0.36-1.01],0.0567275686887705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYN,Tyrosine-protein kinase Lyn,2451,77,0.83 [0.65-1.05],0.1188360711088919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,2394,74,0.92 [0.62-1.37],0.6733089969306143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,2439,76,0.95 [0.54-1.66],0.8613979312814246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,2398,75,1.24 [0.96-1.59],0.0966078586638569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,2041,52,0.89 [0.67-1.18],0.400556228286908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,2067,53,0.97 [0.75-1.25],0.7927315126926315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,2114,54,7.57 [2.19-26.24],0.0014048107029315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYZL2,Lysozyme-like protein 2,2034,52,1.57 [0.79-3.13],0.199068010605951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,2079,50,0.64 [0.41-0.98],0.0411103051980104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,2062,49,0.60 [0.25-1.42],0.2472172093895783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,2430,76,1.71 [1.35-2.17],1.146255897323913e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,2398,75,0.62 [0.35-1.12],0.1130429650377922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAG,Myelin-associated glycoprotein,2067,53,0.94 [0.53-1.65],0.8199941952448967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGEA3,Melanoma-associated antigen 3,2085,52,0.90 [0.70-1.16],0.4124697232704849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGED1,Melanoma-associated antigen D1,2398,75,0.99 [0.65-1.50],0.9676362067517952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,2108,54,4.75 [2.75-8.22],2.5191647919931443e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC4,Apical endosomal glycoprotein,2104,54,1.14 [0.73-1.77],0.5627003641984731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",2062,49,4.88 [1.67-14.29],0.0038403019724013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,2108,54,0.84 [0.55-1.26],0.3962985246849477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",2034,52,0.86 [0.50-1.49],0.5905436701876907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,2474,77,0.88 [0.75-1.03],0.1050291339306613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,2465,77,11.29 [6.67-19.13],1.9835301247519732e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC4,MANSC domain-containing protein 4,2039,52,1.33 [0.95-1.84],0.0928683023169301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,2041,52,1.63 [0.70-3.84],0.2603937450981828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,2039,52,1.10 [0.78-1.56],0.5916047167555893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2,Microtubule-associated protein 2,2109,53,1.26 [0.72-2.22],0.4192132593198128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,2102,54,1.14 [0.75-1.75],0.5342298628485392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,2454,77,0.83 [0.68-1.02],0.0803962121723192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,2398,75,0.95 [0.75-1.19],0.6308910434189803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,2439,76,0.86 [0.71-1.04],0.1219517983004465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,2034,52,1.66 [1.08-2.54],0.0198806351499036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,2454,77,1.47 [0.91-2.38],0.1134840605273653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,2085,52,0.70 [0.48-1.02],0.0662996644762368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,2034,52,0.90 [0.71-1.14],0.3889135984059371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPT,Microtubule-associated protein tau,2394,74,1.70 [1.22-2.36],0.001558457481239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARCO,Macrophage receptor MARCO,2460,78,2.75 [1.29-5.86],0.0085351741376519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",2078,50,0.82 [0.58-1.17],0.2750212688067007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,2439,76,0.60 [0.26-1.40],0.2373316461583218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,2466,77,5.99 [3.11-11.54],8.997837916142838e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN3,Matrilin-3,2440,76,1.57 [0.87-2.85],0.1374557586475731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,2398,75,0.96 [0.76-1.23],0.768081681778157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAX,Protein max,2394,74,0.87 [0.71-1.06],0.1640531983556285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,2486,78,2.13 [1.65-2.75],6.1211672334242735e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MBL2,Mannose-binding protein C,2081,53,1.05 [0.83-1.33],0.6842584746025313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,2464,77,2.19 [1.39-3.47],0.0007984305310325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",2107,54,0.55 [0.25-1.17],0.1209727491160704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,2050,54,0.76 [0.55-1.06],0.1108505376516871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,2451,77,1.87 [1.20-2.91],0.0057784941896071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,2102,54,1.60 [0.79-3.24],0.1938272431056976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,2441,76,1.28 [0.97-1.69],0.0837855135513819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",2109,55,0.37 [0.19-0.73],0.0042048246835311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,2458,77,2.05 [1.62-2.60],3.313684827095855e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDM1,Nuclear protein MDM1,2067,53,0.59 [0.23-1.51],0.271857471804668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",2062,49,0.87 [0.63-1.19],0.3804725183808785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,2398,75,0.82 [0.62-1.08],0.1567873277501847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,2039,52,1.16 [0.73-1.86],0.5282220583931387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,2459,77,1.73 [1.06-2.83],0.0277801942054469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,2039,52,1.16 [0.48-2.81],0.744999361628774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,2478,78,2.93 [1.09-7.87],0.0328600889840259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MELTF,Melanotransferrin,2108,54,4.82 [2.27-10.24],4.244912884891103e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MENT,Protein MENT,2079,50,0.35 [0.14-0.91],0.0304535230032545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1A,Meprin A subunit alpha,2102,54,0.77 [0.54-1.10],0.1518259538260245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1B,Meprin A subunit beta,2460,78,0.78 [0.66-0.91],0.0019563378794534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,2459,77,2.37 [1.09-5.17],0.0301998855704531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,2482,77,4.94 [2.51-9.72],3.709301592005845e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MESD,LRP chaperone MESD,2467,77,0.85 [0.71-1.01],0.0596622796552565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MET,Hepatocyte growth factor receptor,2466,75,3.30 [1.32-8.29],0.0109613725958076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1,Methionine aminopeptidase 1,2394,74,0.81 [0.39-1.70],0.5793024239905702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",2454,77,0.81 [0.62-1.05],0.1160734089641205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP2,Methionine aminopeptidase 2,2471,78,0.71 [0.49-1.02],0.0672057531658924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,2417,77,1.30 [0.94-1.80],0.1133800715814051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,2067,53,0.97 [0.65-1.46],0.8920873442070543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,2079,50,3.09 [1.43-6.67],0.004073586813604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,2486,78,6.74 [4.43-10.25],4.2584849171473743e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFGE8,Lactadherin,2467,77,1.51 [1.01-2.26],0.0455447344019911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGLL,Monoglyceride lipase,2470,77,0.85 [0.67-1.06],0.1500128362428746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,2454,77,0.89 [0.75-1.05],0.1663518570724408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,2465,77,3.47 [2.23-5.40],3.8514814459116644e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICALL2,MICAL-like protein 2,2067,53,1.12 [0.75-1.68],0.5737204861444358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2454,77,1.51 [1.17-1.95],0.0014907778218814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIF,Macrophage migration inhibitory factor,2463,77,0.63 [0.47-0.85],0.0027994149617584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MILR1,Allergin-1,2398,76,2.06 [1.45-2.92],5.569292686499049e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,2104,54,0.81 [0.63-1.04],0.1029844451943389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINK1,Misshapen-like kinase 1,2109,53,0.77 [0.57-1.04],0.0924853902154918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MITD1,MIT domain-containing protein 1,2441,76,0.84 [0.68-1.03],0.0986187994464234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MKI67,Proliferation marker protein Ki-67,2050,54,1.16 [0.60-2.23],0.6582740976312551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLLT1,Protein ENL,2034,52,1.03 [0.70-1.53],0.869838994049393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLN,Promotilin,2454,77,1.88 [1.47-2.41],4.917416374395871e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MME,Neprilysin,2451,77,1.12 [0.89-1.41],0.344186097482081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP1,Interstitial collagenase,2365,74,1.28 [1.01-1.62],0.0387650724777975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,2458,77,2.92 [2.18-3.92],6.722657708681754e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,2461,78,2.69 [1.97-3.65],3.029004479780181e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP13,Collagenase 3,2394,74,2.90 [1.69-5.00],0.0001216025593502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP15,Matrix metalloproteinase-15,2108,54,1.10 [0.63-1.91],0.7434266333570616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,2467,77,2.59 [1.91-3.50],6.06062668624301e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,2413,77,7.10 [4.98-10.12],2.4717448432774448e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP8,Neutrophil collagenase,2477,77,1.26 [0.98-1.63],0.0754423976936011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP9,Matrix metalloproteinase-9,2465,77,1.23 [0.88-1.71],0.2276094144758574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",2039,52,0.73 [0.40-1.35],0.3175995745646651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MN1,Transcriptional activator MN1,2067,53,0.88 [0.53-1.46],0.6129679966357995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,2085,52,1.07 [0.58-1.97],0.8268582608751487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,2457,78,0.91 [0.73-1.13],0.3702514413216488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,2079,50,0.93 [0.60-1.44],0.7568224664794089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,2476,78,6.46 [4.06-10.27],3.501287400391878e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,2109,53,0.56 [0.18-1.76],0.3193821200218173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,2085,52,0.68 [0.31-1.51],0.3489755508976211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,2034,52,0.98 [0.45-2.15],0.964832435893392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORN4,MORN repeat-containing protein 4,2034,52,0.81 [0.55-1.19],0.2756402564545367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,2417,77,0.72 [0.53-0.96],0.0247110518336524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPI,Mannose-6-phosphate isomerase,2451,77,1.04 [0.81-1.33],0.7472744603105547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,2470,77,0.86 [0.67-1.11],0.250452806212661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPO,Myeloperoxidase,2467,77,1.03 [0.67-1.60],0.8784086789735003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,2100,54,0.68 [0.36-1.29],0.2382142500736225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,2120,55,8.84 [4.09-19.09],2.8982537313608933e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,2067,53,0.64 [0.45-0.91],0.0137584937160787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",2039,52,1.44 [0.87-2.38],0.1558851760787645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",2107,54,1.17 [0.58-2.38],0.6635514159231506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",2394,74,0.44 [0.19-1.01],0.0525063865818203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",2030,52,1.55 [0.63-3.80],0.3404071997559432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",2107,54,0.59 [0.36-0.98],0.0406220161686439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",2050,54,0.54 [0.16-1.79],0.3114371306262611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLN,Mesothelin,2442,76,1.70 [1.28-2.28],0.0003059224746917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLNL,Mesothelin-like protein,2067,53,0.94 [0.44-1.99],0.862405478173043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,2454,76,2.31 [1.79-2.97],8.13902609764927e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,2480,77,3.29 [2.19-4.94],9.880198157184313e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,2465,77,0.78 [0.58-1.05],0.0976244510166984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MST1,Hepatocyte growth factor-like protein,2088,55,1.89 [1.01-3.53],0.0456872296147866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSTN,Growth/differentiation factor 8,2417,77,1.62 [1.12-2.34],0.0111873274782657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTDH,Protein LYRIC,2050,54,0.97 [0.73-1.29],0.8254049301094469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",2109,53,0.89 [0.30-2.67],0.8350397288882692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,2085,52,0.72 [0.56-0.93],0.0108732184115169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",2102,54,0.88 [0.64-1.21],0.4374168659981019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTPN,Myotrophin,2417,77,0.64 [0.31-1.32],0.2223186551401498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTR,Methionine synthase,2039,52,0.79 [0.48-1.29],0.3466469214125591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS1,Protein MTSS 1,2102,54,0.89 [0.70-1.13],0.342530127197194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS2,Protein MTSS 2,2104,54,0.91 [0.69-1.19],0.4751676485678158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,2085,52,1.22 [0.79-1.89],0.3734262812898525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,2394,74,2.12 [1.65-2.74],6.0432978644209234e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC16,Mucin-16,2451,77,1.03 [0.92-1.16],0.6133526012257431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC2,Mucin-2,2117,52,0.85 [0.64-1.14],0.2768157927100976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUCL3,Mucin-like protein 3,2034,52,1.41 [0.93-2.13],0.106365581433733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MVK,Mevalonate kinase,2398,76,1.00 [0.79-1.25],0.9751038591884182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,2079,50,5.33 [2.39-11.87],4.236637576406224e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",2108,54,1.82 [1.38-2.42],2.893623067807368e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",2062,49,1.51 [1.23-1.86],6.788592692366844e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,2107,54,0.73 [0.47-1.16],0.1835920973523783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYDGF,Myeloid-derived growth factor,2108,54,0.90 [0.67-1.20],0.4599803193393136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH4,Myosin-4,2039,52,0.97 [0.53-1.77],0.9158069899872558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH7B,Myosin-7B,2034,52,1.48 [0.92-2.38],0.106373812273449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH9,Myosin-9,2117,52,0.84 [0.65-1.07],0.1576328977779329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",2039,52,1.64 [1.24-2.17],0.0005057691418136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL3,Myosin light chain 3,2062,49,1.78 [1.25-2.52],0.0013495955769307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL4,Myosin light chain 4,2062,49,1.04 [0.63-1.71],0.886368270503822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL6B,Myosin light chain 6B,2067,53,0.97 [0.71-1.33],0.867995273538431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2067,53,2.03 [1.57-2.63],9.32578222979856e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO6,Unconventional myosin-VI,2107,54,2.06 [1.36-3.12],0.0006373204280068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO9B,Unconventional myosin-IXb,2398,76,1.16 [0.85-1.58],0.3528464272320749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOC,Myocilin,2467,77,1.90 [1.22-2.97],0.0045189985345517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM1,Myomesin-1,2041,52,1.39 [0.88-2.20],0.1521690073568139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM2,Myomesin-2,2039,52,1.72 [1.18-2.52],0.0053292964951271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM3,Myomesin-3,2079,50,1.09 [0.81-1.46],0.567314619853496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,2470,77,2.18 [1.55-3.07],7.287748073819467e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,2398,75,0.80 [0.51-1.26],0.3382546766971037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA10,N-alpha-acetyltransferase 10,2039,52,1.09 [0.65-1.81],0.7491852971283122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA80,N-alpha-acetyltransferase 80,2067,53,0.81 [0.64-1.02],0.069808917844036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,2428,76,1.28 [0.91-1.78],0.1511078038574923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,2104,54,1.06 [0.65-1.72],0.8288167279380918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NADK,NAD kinase,2460,78,1.05 [0.73-1.50],0.7928121142020732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,2045,54,1.16 [0.70-1.91],0.5593026342832008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,2055,49,0.30 [0.18-0.50],3.876500160160571e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,2079,50,0.73 [0.23-2.32],0.5938934871748212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,2398,75,0.92 [0.63-1.35],0.6784236446220189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,2098,54,0.38 [0.23-0.62],0.0001288844422118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,2109,53,0.48 [0.20-1.18],0.1106597471239241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",2107,54,0.54 [0.32-0.93],0.0273645671704183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,2465,77,21.24 [13.29-33.95],2.3697666410440903e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBN,Nibrin,2398,76,0.67 [0.40-1.11],0.1171667190499632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,2464,77,1.31 [0.74-2.31],0.360148710098396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM2,Neural cell adhesion molecule 2,2467,77,1.43 [0.70-2.89],0.3243062566655743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAN,Neurocan core protein,2480,77,0.52 [0.32-0.84],0.0078313754328481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCF2,Neutrophil cytosol factor 2,2450,77,0.92 [0.72-1.17],0.4897951577712467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCK2,Cytoplasmic protein NCK2,2474,77,0.82 [0.67-0.99],0.0433760760899979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCLN,Nicalin,2398,76,0.91 [0.56-1.47],0.6943792294969939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,2451,77,6.75 [4.85-9.39],1.1977132367232272e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2102,54,12.22 [6.99-21.37],1.6581049660097134e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,2476,78,14.06 [7.76-25.46],2.742949411162785e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDRG1,Protein NDRG1,2394,74,0.90 [0.63-1.29],0.5683326828060289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,2104,54,1.20 [0.84-1.71],0.3178261812913333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,2046,54,2.46 [1.20-5.07],0.0142727981627873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,2102,54,0.73 [0.53-1.00],0.0529688291090587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2398,75,1.39 [1.17-1.66],0.0002557691995914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEB,Nebulin,2039,52,1.76 [1.09-2.85],0.0212381094349928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,2039,52,1.05 [0.69-1.59],0.8217078442583345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN1,Nectin-1,2050,54,1.14 [0.54-2.41],0.7318067406122181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,2460,78,10.47 [7.30-15.01],2.359759544967465e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,2465,77,4.71 [3.72-5.96],7.563172883602781e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,2050,54,0.57 [0.36-0.89],0.0137756152586527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD9,Enhancer of filamentation 1,2050,54,1.68 [0.87-3.24],0.1239516999229277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,2387,73,3.57 [2.86-4.44],1.1225927703539909e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,2085,52,0.58 [0.36-0.94],0.0284646772047671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,2465,77,0.34 [0.23-0.51],2.0686458230762089e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,2474,77,0.86 [0.44-1.67],0.6540888724464659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NENF,Neudesin,2104,54,0.87 [0.65-1.18],0.3754020467343192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEO1,Neogenin,2107,54,2.70 [1.50-4.86],0.000940029740142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEXN,Nexilin,2120,55,0.94 [0.64-1.38],0.745887050184002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,2482,77,5.87 [3.37-10.21],3.887446008549554e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,2050,54,1.03 [0.75-1.42],0.8415280281198434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",2454,77,0.86 [0.69-1.07],0.1716728519111709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",2398,76,1.03 [0.75-1.42],0.847716302290671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,2062,49,0.70 [0.47-1.07],0.0975505354720286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFIC,Nuclear factor 1 C-type,2107,54,1.17 [0.75-1.82],0.4902376808842891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,2039,52,0.66 [0.44-0.98],0.0408327017924073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,2085,52,1.31 [0.90-1.90],0.1577376790670372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,2398,75,0.94 [0.61-1.46],0.7993837884336009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",2102,54,0.90 [0.69-1.19],0.4633428470620419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFX1,Transcriptional repressor NF-X1,2039,52,0.91 [0.62-1.34],0.6261029729383749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,2039,52,0.93 [0.42-2.04],0.8572301719660094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGF,Beta-nerve growth factor,2441,76,2.23 [0.45-10.98],0.3226838013676599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,2108,54,1.71 [1.11-2.62],0.0142496938330695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGRN,Neugrin,2109,53,5.04 [2.12-12.00],0.0002558717690684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,2024,48,2.44 [0.98-6.10],0.0562209328504416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID1,Nidogen-1,2462,77,1.22 [0.70-2.10],0.4824854224357744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID2,Nidogen-2,2467,77,1.07 [0.82-1.39],0.6337780207591577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NINJ1,Ninjurin-1,2398,75,1.08 [0.76-1.55],0.6558773658808073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT1,Deaminated glutathione amidase,2062,49,0.35 [0.21-0.60],9.220352102477604e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT2,Omega-amidase NIT2,2093,54,0.68 [0.47-0.99],0.0466779907745266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN1,Neuroligin-1,2067,53,0.85 [0.52-1.41],0.534086691311052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN2,Neuroligin-2,2041,52,0.74 [0.36-1.52],0.4087900902256101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME1,Nucleoside diphosphate kinase A,2050,54,1.59 [0.50-5.09],0.4332134355305388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME3,Nucleoside diphosphate kinase 3,2466,77,1.03 [0.44-2.42],0.9410962645550957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMI,N-myc-interactor,2098,54,0.83 [0.56-1.25],0.3793801675968496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,2441,76,0.83 [0.62-1.11],0.2122495603976704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,2034,52,0.91 [0.44-1.89],0.8076687224162137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,2107,54,0.50 [0.29-0.86],0.0117062128842945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOMO1,Nodal modulator 1,2467,77,1.67 [0.73-3.82],0.2285099985263974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOP56,Nucleolar protein 56,2039,52,1.09 [0.86-1.38],0.4918902953574557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",2394,74,2.71 [2.10-3.48],9.925234088096404e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS2,"Nitric oxide synthase, inducible",2039,52,1.36 [0.73-2.51],0.329493744212834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",2394,74,1.15 [0.81-1.64],0.4262994628406744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,2486,78,12.21 [4.06-36.73],8.406711944979933e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,2117,52,14.08 [6.07-32.64],7.09278416269465e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,2486,78,4.23 [2.63-6.82],2.988425177460161e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,2082,52,16.43 [9.37-28.80],1.4781647143711574e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,2460,78,6.39 [4.73-8.64],1.351252594355321e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS1,Nephrin,2050,54,0.31 [0.16-0.60],0.0005641945706843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS2,Podocin,2050,54,0.95 [0.72-1.24],0.6808789363690392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPL,N-acetylneuraminate lyase,2108,54,1.12 [0.67-1.90],0.6594696885174289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,2417,77,1.44 [1.27-1.64],9.541917817718724e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,2454,77,2.20 [1.71-2.84],1.031657992534278e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,2039,52,0.47 [0.19-1.15],0.0967434104280893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTN,Neuroplastin,2398,75,1.03 [0.78-1.35],0.8293960680256851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX1,Neuronal pentraxin-1,2467,77,1.32 [0.84-2.08],0.2308636668052246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX2,Neuronal pentraxin-2,2117,52,2.00 [0.92-4.32],0.0790950095387886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTXR,Neuronal pentraxin receptor,2460,78,1.39 [0.85-2.25],0.1859854221647547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,2476,78,2.45 [1.76-3.41],9.336417570135093e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,2460,78,2.35 [1.37-4.05],0.0020300861748106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRGN,Neurogranin,2120,55,0.76 [0.57-1.03],0.0743184470636448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRN1,Neuritin,2107,54,0.75 [0.29-1.95],0.5534007404705334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,2464,77,5.15 [2.74-9.71],3.858371113027575e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP2,Neuropilin-2,2467,77,1.65 [0.87-3.13],0.1282930116808924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRTN,Neurturin,2398,76,0.80 [0.51-1.25],0.3235193407619481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRXN3,Neurexin-3,2067,53,0.75 [0.29-1.92],0.5495366560517113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NSFL1C,NSFL1 cofactor p47,2480,77,0.61 [0.44-0.84],0.0027103359002664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",2108,54,0.78 [0.53-1.15],0.21428013589597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,2109,53,3.99 [2.85-5.59],7.559880221511814e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,2451,77,0.67 [0.54-0.85],0.0008326516058683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5E,5'-nucleotidase,2465,77,1.11 [0.76-1.61],0.5943574023984597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF3,Neurotrophin-3,2454,77,1.36 [0.85-2.17],0.2055217509634248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF4,Neurotrophin-4,2398,75,1.38 [0.92-2.07],0.1172383409767617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,2460,78,1.23 [0.60-2.55],0.5738485310276347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK3,NT-3 growth factor receptor,2480,77,1.48 [0.62-3.56],0.3799101780109106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,2460,78,1.61 [1.43-1.82],1.4439621205733323e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUB1,NEDD8 ultimate buster 1,2454,77,0.68 [0.52-0.91],0.0081677302590407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,2104,54,0.74 [0.52-1.05],0.087387194666572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,2474,78,4.60 [2.94-7.20],2.2593877942272525e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDC,Nuclear migration protein nudC,2482,77,0.82 [0.59-1.13],0.2250487357533722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,2062,49,1.21 [0.43-3.43],0.7163166975064339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,2039,52,0.79 [0.44-1.43],0.4366061561994543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,2100,54,1.02 [0.74-1.40],0.9005843962392306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],2451,77,0.66 [0.44-0.98],0.0407754289197829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,2467,77,1.15 [0.76-1.74],0.5233056983213697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUMB,Protein numb homolog,2050,54,0.81 [0.58-1.12],0.20081841182775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUP50,Nuclear pore complex protein Nup50,2039,52,0.79 [0.28-2.25],0.6602729169670598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPE4,NXPE family member 4,2039,52,1.33 [0.68-2.59],0.4019352311406813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH1,Neurexophilin-1,2394,74,2.31 [1.59-3.34],9.382838440321018e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,2050,54,16.22 [7.18-36.67],2.148791277953423e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OBP2B,Odorant-binding protein 2b,2437,76,1.92 [1.36-2.70],0.0002182198822348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,2107,54,7.09 [4.60-10.93],6.6007901497117675e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,2389,73,1.52 [1.10-2.09],0.011512953408228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,2085,52,0.84 [0.52-1.36],0.4825527142526471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGA,Protein O-GlcNAcase,2102,54,0.72 [0.48-1.08],0.1121725076609315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGFR,Opioid growth factor receptor,2451,77,2.56 [1.44-4.55],0.0013508035092717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,2467,77,6.42 [4.85-8.50],1.7711153230325576e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,2085,52,0.65 [0.37-1.15],0.1408066728333049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLFM4,Olfactomedin-4,2002,47,1.27 [1.00-1.60],0.0476098777927122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,2438,78,1.33 [0.99-1.80],0.0590321209905762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMD,Osteomodulin,2474,77,0.88 [0.57-1.36],0.5592013407508181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,2451,77,0.63 [0.47-0.84],0.0015138981457532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMP,Olfactory marker protein,2041,52,1.18 [0.75-1.88],0.4749760547486581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPHN1,Oligophrenin-1,2109,53,0.88 [0.69-1.13],0.3046222956618247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPLAH,5-oxoprolinase,2062,49,0.72 [0.46-1.13],0.1511122341909512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPTC,Opticin,2451,77,1.94 [1.41-2.68],5.384944591235711e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,2109,54,4.47 [1.34-14.86],0.0146667901820095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,2109,53,0.67 [0.28-1.62],0.3755048732161024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,2466,77,6.77 [3.96-11.57],2.594475661030024e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSM,Oncostatin-M,2443,77,1.26 [0.95-1.67],0.1098055618637108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,2464,77,2.05 [0.85-4.93],0.1090000644923695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSTN,Osteocrin,2067,53,1.17 [0.70-1.96],0.5435763153671965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTOA,Otoancorin,2041,52,1.15 [0.77-1.72],0.4797191516320948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,2102,54,0.56 [0.34-0.93],0.0254378324283198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD7B,OTU domain-containing protein 7B,2107,54,1.27 [0.81-1.97],0.2953691969164369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",2062,49,0.61 [0.41-0.90],0.0138274808108331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXT,Oxytocin-neurophysin 1,2480,77,1.04 [0.90-1.20],0.6288153672808334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",P4HB,Protein disulfide-isomerase,2442,76,2.09 [1.24-3.52],0.0058383045694622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,2039,52,0.89 [0.57-1.41],0.633038773727103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,2398,76,1.28 [1.01-1.61],0.0415393577591665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI4,Protein-arginine deiminase type-4,2389,73,0.86 [0.65-1.16],0.3314656964814174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAEP,Glycodelin,2441,76,1.01 [0.82-1.24],0.9458593816755504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,2107,54,0.93 [0.71-1.22],0.6195992308180154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",2085,52,0.62 [0.34-1.12],0.1146274087987257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,2417,77,1.04 [0.71-1.50],0.8515243593011427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,2062,49,0.33 [0.15-0.74],0.007322292375267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,2032,52,0.77 [0.45-1.32],0.3399485704426601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,2394,74,0.74 [0.51-1.08],0.1153874340380877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALLD,Palladin,2050,54,1.23 [0.72-2.13],0.4501375609422856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,2093,54,9.73 [6.08-15.57],2.251021202157936e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,2109,53,8.30 [5.17-13.33],1.8291285847434614e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM3,Paralemmin-3,2039,52,0.94 [0.60-1.46],0.7698302949647183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,2477,78,14.99 [7.21-31.19],4.357360672974902e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAMR1,Inactive serine protease PAMR1,2467,77,1.25 [0.61-2.57],0.5467773255302786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAPPA,Pappalysin-1,2398,76,0.70 [0.45-1.07],0.0966759524377388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARD3,Partitioning defective 3 homolog,2085,52,0.78 [0.51-1.19],0.2530416751335264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARK7,Parkinson disease protein 7,2467,77,0.61 [0.40-0.93],0.0208774834052302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,2454,77,0.95 [0.65-1.41],0.8144242866091014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAXX,Protein PAXX,2079,50,1.43 [0.79-2.61],0.2361324370799458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,2034,52,1.02 [0.43-2.45],0.962102674597684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,2394,74,0.76 [0.51-1.14],0.1858167264447014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2102,54,5.42 [3.11-9.45],2.412609726668419e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCARE,Photoreceptor cilium actin regulator,2041,52,0.92 [0.64-1.33],0.6731483676573611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2076,50,0.98 [0.61-1.59],0.9469533450864472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBP2,Poly(rC)-binding protein 2,2107,54,0.66 [0.45-0.96],0.0320040633977257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,2470,77,3.71 [2.14-6.42],3.0073582017963724e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH12,Protocadherin-12,2107,54,1.91 [0.69-5.27],0.2141671635325598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH17,Protocadherin-17,2460,78,1.35 [0.85-2.14],0.1983810152939462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,2102,54,3.90 [2.67-5.71],2.286251237681009e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH9,Protocadherin-9,2102,54,0.71 [0.35-1.41],0.3212780974172911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDHB15,Protocadherin beta-15,2104,54,2.17 [1.39-3.38],0.0006032628974959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCNA,Proliferating cell nuclear antigen,2034,52,0.83 [0.50-1.39],0.4870408398318976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,2104,54,0.80 [0.44-1.46],0.4714898827454213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,2486,78,1.88 [1.15-3.06],0.0118456085146152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,2102,54,0.78 [0.53-1.15],0.2104962682411916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,2108,54,0.76 [0.57-1.01],0.0558830862620524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,2474,78,2.56 [1.86-3.53],1.0070535795168333e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,2451,77,6.39 [4.43-9.22],3.263939549913661e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD5,Programmed cell death protein 5,2480,77,0.99 [0.69-1.42],0.9596457273629164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD6,Programmed cell death protein 6,2460,78,1.11 [0.81-1.52],0.5123554332278004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCL2,Phosducin-like protein 2,2034,52,0.90 [0.50-1.61],0.7261465506916127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",2034,52,1.49 [1.05-2.12],0.026625234192738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",2039,52,1.05 [0.72-1.54],0.798602904444057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",2079,50,0.76 [0.59-0.98],0.0377842004673311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,2486,78,0.74 [0.57-0.97],0.031985575690483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,2474,77,0.82 [0.65-1.03],0.0856285348674519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFC,Platelet-derived growth factor C,2398,75,1.21 [0.62-2.33],0.5784403322511034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,2460,78,5.72 [3.44-9.53],1.9712281257380912e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,2486,78,1.07 [0.60-1.89],0.8227747341076355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA2,Protein disulfide-isomerase A2,2034,52,0.96 [0.47-1.99],0.9220523692143922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,2079,50,6.41 [3.25-12.64],8.242622260474634e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA4,Protein disulfide-isomerase A4,2117,52,0.77 [0.48-1.24],0.285267857228935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA5,Protein disulfide-isomerase A5,2034,52,0.92 [0.59-1.44],0.715240272359428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,2107,54,0.84 [0.68-1.05],0.1358294212056603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,2474,77,1.01 [0.86-1.20],0.891643910855676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",2398,75,1.05 [0.70-1.56],0.8193279966591289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,2067,53,0.60 [0.31-1.15],0.1241702813139483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,2034,52,0.92 [0.56-1.51],0.7410778411685066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZD2,PDZ domain-containing protein 2,2039,52,1.32 [0.88-1.98],0.1796900923889027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,2050,54,1.92 [1.33-2.76],0.0005084834219708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,2486,78,4.87 [2.12-11.22],0.0001981889599722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,2467,77,0.74 [0.51-1.08],0.1228037071202659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,2467,77,0.61 [0.31-1.19],0.1481349203213154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,2062,49,0.37 [0.11-1.20],0.0966304528993709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,2079,50,9.41 [5.69-15.58],2.7427602284767232e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEPD,Xaa-Pro dipeptidase,2120,55,0.61 [0.24-1.58],0.3124061537735619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PER3,Period circadian protein homolog 3,2050,54,0.79 [0.63-0.99],0.0384634314282104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PF4,Platelet factor 4,2098,54,0.76 [0.57-1.01],0.0560587810321509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN2,Prefoldin subunit 2,2394,74,1.03 [0.69-1.55],0.8731408705206278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN4,Prefoldin subunit 4,2034,52,0.52 [0.27-1.00],0.0483997057978362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN6,Prefoldin subunit 6,2067,53,0.36 [0.18-0.72],0.0035898832024285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",2450,77,0.76 [0.58-0.98],0.0365408530109153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGA4,Pepsin A-4,2120,55,1.53 [1.17-2.00],0.0019597650594769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",2108,54,0.70 [0.41-1.18],0.1792342673715992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,2482,77,13.39 [8.98-19.98],4.764816405512365e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,2473,78,3.07 [2.21-4.27],2.9281024626354186e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,2090,54,0.53 [0.22-1.27],0.1537572103759236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,2039,52,0.94 [0.56-1.59],0.8179355094518801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGM2,Phosphoglucomutase-2,2067,53,0.62 [0.32-1.19],0.1523393077723944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGR,Progesterone receptor,2050,54,1.01 [0.74-1.36],0.9681986244018804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,2107,54,0.83 [0.65-1.06],0.1308668276377133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,2102,54,4.65 [3.07-7.03],3.605644807354688e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,2034,52,1.09 [0.84-1.41],0.5320026161042863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2441,76,7.66 [4.59-12.81],7.656645684159309e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,2079,50,0.82 [0.44-1.51],0.5189379043599185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,2120,55,23.43 [8.40-65.36],1.6913283659351683e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,2424,77,2.17 [1.78-2.64],8.094898391284595e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",2107,54,0.82 [0.57-1.18],0.2900812179208483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,2435,76,4.77 [3.08-7.40],3.0620073178592162e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,2454,77,0.57 [0.40-0.81],0.0018468678177613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2467,77,13.02 [9.29-18.25],3.90445176249782e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,2050,54,0.90 [0.53-1.53],0.6944431852998094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,2467,77,7.61 [4.73-12.23],5.534039467915005e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,2460,78,3.66 [2.44-5.50],3.626544811436136e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2079,50,1.01 [0.68-1.50],0.9716983031193008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PITHD1,PITH domain-containing protein 1,2032,52,0.93 [0.67-1.29],0.6703643558230082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD1,Polycystin-1,2108,54,4.86 [1.98-11.96],0.0005708121143834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD2,Polycystin-2,2039,52,1.68 [1.08-2.64],0.0227981123605984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKLR,Pyruvate kinase PKLR,2465,77,0.70 [0.50-0.97],0.0348931859706696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKN3,Serine/threonine-protein kinase N3,2085,52,0.75 [0.51-1.11],0.151019948893928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,2441,76,2.02 [1.44-2.84],4.527959130256845e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,2465,77,1.98 [1.04-3.77],0.0366552420081823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G1B,Phospholipase A2,2485,78,1.24 [0.86-1.80],0.2483366337811131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",2449,76,1.41 [1.09-1.84],0.0099356262942467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,2474,77,0.80 [0.64-1.02],0.0673942999260468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,2467,77,0.32 [0.19-0.54],1.579864070655156e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAT,Tissue-type plasminogen activator,2478,78,0.63 [0.44-0.89],0.0091885560954499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAU,Urokinase-type plasminogen activator,2467,77,1.48 [0.82-2.68],0.1930670820932623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,2446,77,12.21 [7.53-19.81],3.5577012202215464e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",2109,53,1.01 [0.64-1.60],0.9683517913082036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",2050,54,0.42 [0.17-1.05],0.0622834581203383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",2109,53,0.73 [0.55-0.97],0.0272462390534595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,2109,53,0.79 [0.53-1.17],0.2364841803198604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLG,Plasminogen,2051,52,0.33 [0.10-1.10],0.0714314807740199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN1,Perilipin-1,2394,74,1.77 [1.18-2.66],0.0062319921032538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN3,Perilipin-3,2460,78,2.19 [1.45-3.30],0.000179444746093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,2460,78,0.64 [0.47-0.87],0.0043154124661326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLSCR3,Phospholipid scramblase 3,2104,53,1.31 [0.79-2.15],0.290745590518095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLTP,Phospholipid transfer protein,2479,78,1.24 [0.75-2.07],0.4023338803703193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,2398,75,1.63 [1.02-2.63],0.0430363308521175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,2109,53,1.41 [0.64-3.11],0.3873662962745948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNA4,Plexin-A4,2454,77,0.80 [0.62-1.03],0.0814956614803804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,2472,77,4.20 [2.42-7.28],3.359458003564805e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB3,Plexin-B3,2450,78,0.61 [0.38-0.97],0.0350372300411979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,2452,78,1.02 [0.91-1.13],0.7594877541094273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMCH,Pro-MCH,2039,52,1.06 [0.76-1.47],0.7367219754975387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMM2,Phosphomannomutase 2,2039,52,0.79 [0.49-1.28],0.3383308479975889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMS1,PMS1 protein homolog 1,2067,53,1.13 [0.70-1.82],0.6072440772488312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMVK,Phosphomevalonate kinase,2392,74,0.88 [0.74-1.05],0.1598119639974342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,2120,55,1.04 [0.75-1.44],0.8349594937848817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,2109,53,1.66 [1.28-2.17],0.000149255702308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,2459,77,0.98 [0.91-1.04],0.4540402033015593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,2062,49,0.61 [0.35-1.05],0.0764851315952887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,2041,52,1.11 [0.62-1.96],0.7303741107145705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",2398,76,1.01 [0.85-1.21],0.8943130345052278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL,Podocalyxin,2451,77,1.45 [0.42-5.06],0.5561642179296236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,2465,77,5.85 [3.31-10.33],1.127668700912481e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,2050,54,2.83 [1.90-4.22],3.513249995214787e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,2050,54,0.98 [0.37-2.65],0.9758656574228654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2451,77,2.39 [1.72-3.31],2.0432238216656202e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POMC,Pro-opiomelanocortin,2062,49,1.15 [0.80-1.67],0.449169090232236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,2120,55,0.28 [0.14-0.56],0.0003266989276099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,2417,77,0.91 [0.52-1.60],0.7540539486086811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON3,Serum paraoxonase/lactonase 3,2474,77,0.63 [0.37-1.08],0.0921040296109217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POSTN,Periostin,2117,52,1.70 [0.89-3.25],0.1080733998683713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPBP,Platelet basic protein,2097,54,0.84 [0.61-1.15],0.2739876856708784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,2480,77,0.58 [0.37-0.90],0.01543887621037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,2455,77,0.84 [0.67-1.04],0.1107985019281876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,2085,52,0.99 [0.63-1.57],0.972925106777593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",2117,52,0.59 [0.34-1.01],0.0540229311758814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,2050,54,4.19 [2.44-7.21],2.280083980380127e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1A,Protein phosphatase 1A,2398,75,0.66 [0.32-1.37],0.2645050532338682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1B,Protein phosphatase 1B,2050,54,1.02 [0.62-1.68],0.9316216482233232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1F,Protein phosphatase 1F,2108,54,0.61 [0.36-1.05],0.0756744012209098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPME1,Protein phosphatase methylesterase 1,2451,77,0.63 [0.45-0.88],0.0066238876914979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,2104,54,0.68 [0.48-0.97],0.0332893870461033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,2465,77,0.93 [0.74-1.15],0.4831393110587794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,2085,52,0.93 [0.62-1.39],0.7257109035278806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,2107,54,0.73 [0.51-1.06],0.098884202253481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2107,54,3.16 [2.33-4.28],1.620184068901805e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,2460,78,0.83 [0.63-1.09],0.1884234278995722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R9B,Neurabin-2,2482,77,0.99 [0.80-1.23],0.9260270068047562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,2102,54,0.90 [0.71-1.14],0.3742000226009913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP3R1,Calcineurin subunit B type 1,2441,76,1.05 [0.64-1.74],0.8389595583048839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,2067,53,0.91 [0.62-1.33],0.6213682186789833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPY,Pancreatic prohormone,2452,74,1.44 [1.21-1.73],5.310079527547333e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PQBP1,Polyglutamine-binding protein 1,2398,75,1.05 [0.73-1.51],0.7862736037322116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,2034,52,1.26 [0.43-3.67],0.6697031798628934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,2117,52,6.35 [3.08-13.10],5.467595071803112e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRC1,Protein regulator of cytokinesis 1,2104,54,0.75 [0.36-1.58],0.4532973015903403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,2474,78,1.80 [1.07-3.01],0.0266125500618036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX1,Peroxiredoxin-1,2384,75,0.73 [0.56-0.93],0.0124635854458252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX2,Peroxiredoxin-2,2084,55,0.50 [0.31-0.80],0.0040789730025238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",2398,76,0.91 [0.68-1.24],0.5596075165853205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",2482,77,0.81 [0.60-1.11],0.1877126968783244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX6,Peroxiredoxin-6,2476,78,0.55 [0.39-0.78],0.0008633001477428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,2398,76,2.49 [1.69-3.69],4.593051284822814e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,2459,77,6.60 [3.80-11.46],2.118047122113754e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,2117,52,3.90 [2.61-5.82],2.8773856222697427e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG3,Proteoglycan 3,2117,52,1.69 [0.99-2.88],0.0530076573859439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,2398,76,1.20 [0.83-1.72],0.3378257552261495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,2067,53,0.91 [0.40-2.04],0.8104704290679872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,2460,78,0.75 [0.59-0.97],0.0256237131168604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,2106,52,0.78 [0.54-1.12],0.1718547862152921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKCQ,Protein kinase C theta type,2398,76,0.75 [0.44-1.28],0.286688965668731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,2039,52,0.46 [0.18-1.17],0.104656054868115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,2079,50,0.91 [0.73-1.14],0.4231775435934694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,2398,75,0.68 [0.49-0.95],0.0227748964627428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRL,Prolactin,2480,77,1.18 [0.92-1.50],0.192890229822772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRND,Prion-like protein doppel,2109,53,2.83 [1.88-4.28],7.458576902573998e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROC,Vitamin K-dependent protein C,2463,77,0.39 [0.19-0.82],0.012631520433961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROCR,Endothelial protein C receptor,2039,52,1.43 [0.77-2.68],0.2611239215921832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROK1,Prokineticin-1,2454,77,1.69 [1.23-2.31],0.0010635417218626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROS1,Vitamin K-dependent protein S,2114,54,0.36 [0.15-0.88],0.0252668029990448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR4,Proline-rich protein 4,2055,49,1.72 [1.26-2.33],0.0005669317767251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR5,Proline-rich protein 5,2050,54,0.85 [0.47-1.53],0.5929525279826937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,2062,49,4.83 [3.31-7.07],4.3605386358133774e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS2,Trypsin-2,2464,77,1.60 [1.28-2.00],3.671659703833719e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,2050,54,2.31 [1.67-3.20],4.4375620320167573e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,2453,78,3.34 [2.12-5.27],1.937164037110573e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS53,Serine protease 53,2109,53,1.34 [0.69-2.59],0.3836933396747775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,2456,77,5.44 [3.56-8.33],6.138263602213541e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,2394,74,0.82 [0.69-0.98],0.0336966976373747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTG,Protogenin,2476,78,2.16 [1.03-4.54],0.0419214055195814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTN3,Myeloblastin,2395,75,1.36 [0.93-2.00],0.1114163377514911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRUNE2,Protein prune homolog 2,2085,52,0.93 [0.38-2.23],0.8652847907114677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,2098,52,13.62 [6.64-27.95],1.0836763635721765e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,2102,54,2.70 [1.83-3.97],5.429677817436311e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSCA,Prostate stem cell antigen,2102,54,1.19 [1.05-1.33],0.0048123600727043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,2441,76,1.40 [1.15-1.70],0.0009599710152131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,2454,77,0.82 [0.58-1.16],0.257415521965298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMA1,Proteasome subunit alpha type-1,2398,75,0.56 [0.33-0.94],0.0296914193639423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,2034,52,1.02 [0.43-2.44],0.96561732319497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,2107,54,1.24 [0.79-1.94],0.3588259880606653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,2067,53,1.13 [0.71-1.80],0.6152423012777051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,2451,77,0.59 [0.39-0.88],0.0093380675753934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME1,Proteasome activator complex subunit 1,2439,76,0.61 [0.34-1.09],0.0934776460487861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME2,Proteasome activator complex subunit 2,2429,74,0.62 [0.34-1.15],0.1302633223038712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG3,Proteasome assembly chaperone 3,2454,77,0.55 [0.36-0.84],0.005849760094856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG4,Proteasome assembly chaperone 4,2050,54,0.66 [0.39-1.12],0.1211048155326334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSPN,Persephin,2454,77,1.15 [0.93-1.42],0.1991000109181966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,2398,75,1.10 [0.81-1.48],0.5509169135876342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,2009,50,0.84 [0.65-1.08],0.1672204087489769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2394,74,0.96 [0.49-1.89],0.9064313208057764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,2435,77,6.78 [5.04-9.12],1.5621029962298928e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGES2,Prostaglandin E synthase 2,2035,54,1.23 [0.75-2.03],0.4050805782928288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGR1,Prostaglandin reductase 1,2108,54,1.06 [0.81-1.39],0.6719526292198521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH,Parathyroid hormone,2067,53,1.54 [1.21-1.98],0.0005523034631989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2454,77,2.18 [1.65-2.89],5.75101930930807e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,2394,74,4.85 [3.10-7.60],5.20126736111063e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTN,Pleiotrophin,2417,77,1.23 [0.86-1.77],0.2640838610147731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,2050,54,1.48 [0.99-2.21],0.0536409438166552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,2441,76,0.87 [0.65-1.16],0.3306298612031249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,2470,77,0.79 [0.64-0.99],0.0364563574950473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,2049,54,1.02 [0.48-2.16],0.9537498283317928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,2108,54,0.40 [0.17-0.94],0.0354266932731648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,2117,52,2.85 [0.91-8.96],0.0731358033312096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,2486,78,3.85 [2.04-7.28],3.157784666252557e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,2102,54,1.81 [1.11-2.96],0.0172768475818008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,2102,54,2.87 [1.26-6.56],0.0121608119626577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,2449,76,0.62 [0.28-1.37],0.2373924213430897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2436,76,6.87 [4.64-10.17],6.7092396811247485e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,2109,53,4.93 [3.13-7.77],6.319174455223049e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,2486,78,7.24 [4.54-11.56],1.0266065708984842e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,2108,54,1.76 [0.80-3.86],0.161829103844214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,2079,50,0.54 [0.33-0.88],0.0126971647057028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,2381,74,0.77 [0.54-1.08],0.1310530020641678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTTG1,Securin,2085,52,0.89 [0.44-1.79],0.7465376183931591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTX3,Pentraxin-related protein PTX3,2454,77,2.05 [1.22-3.44],0.0063839694800155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVALB,Parvalbumin alpha,2465,78,1.06 [0.88-1.27],0.5257485332627723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVR,Poliovirus receptor,2480,77,1.63 [1.00-2.63],0.0481951291954899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXDNL,Peroxidasin-like protein,2104,54,1.15 [0.75-1.77],0.5282332692361764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXN,Paxillin,2394,74,1.58 [1.13-2.22],0.0077923280689756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYDC1,Pyrin domain-containing protein 1,2062,49,1.91 [1.26-2.87],0.0020689849133242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYY,Peptide YY,2039,52,1.49 [1.22-1.82],9.885686119633536e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PZP,Pregnancy zone protein,2114,54,1.44 [0.82-2.52],0.2011534849166115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QDPR,Dihydropteridine reductase,2449,76,0.50 [0.30-0.84],0.0081446269173229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,2460,78,15.39 [8.45-28.04],4.027536495234735e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QSOX1,Sulfhydryl oxidase 1,2070,53,1.38 [0.78-2.45],0.2669149915730322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB10,Ras-related protein Rab-10,2108,54,0.62 [0.36-1.06],0.0781872752465357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,2108,54,0.85 [0.67-1.09],0.1928970690126514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB27B,Ras-related protein Rab-27B,2108,54,0.77 [0.57-1.05],0.0972642898216689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB2B,Ras-related protein Rab-2B,2104,54,0.62 [0.39-0.99],0.0470065376753919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB33A,Ras-related protein Rab-33A,2039,52,0.73 [0.46-1.14],0.1671090547230333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB37,Ras-related protein Rab-37,2398,76,0.98 [0.77-1.26],0.8957108078813323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB39B,Ras-related protein Rab-39B,2039,52,0.50 [0.28-0.89],0.0177950621654428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,2041,52,1.21 [0.82-1.77],0.3373019589776298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB44,Ras-related protein Rab-44,2104,54,1.34 [0.91-1.98],0.1430052932128132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,2454,77,0.54 [0.37-0.79],0.0015137813586205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6B,Ras-related protein Rab-6B,2394,74,1.41 [1.00-1.99],0.0525600108747191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,2079,50,0.62 [0.42-0.92],0.0172692809652376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,2398,75,0.74 [0.49-1.11],0.1470238624550824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,2398,76,0.70 [0.49-1.00],0.0526935377385191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,2067,53,0.78 [0.49-1.25],0.3033185998618732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,2398,75,0.76 [0.47-1.23],0.270070501640503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,2085,52,0.90 [0.48-1.71],0.7582518480841995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALB,Ras-related protein Ral-B,2050,54,1.36 [0.56-3.30],0.5005031142405817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALY,RNA-binding protein Raly,2104,54,1.30 [0.82-2.07],0.2645266437365625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,2062,49,0.36 [0.20-0.63],0.0003381835755803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,2041,52,1.53 [0.70-3.37],0.2882501394918225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,2398,75,1.16 [0.78-1.72],0.4589256770925497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAP1A,Ras-related protein Rap-1A,2050,54,1.13 [0.80-1.59],0.4945816778596555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,2085,52,0.53 [0.29-0.98],0.0420465196086691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,2398,75,3.15 [2.06-4.80],1.0384400965339985e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,2464,77,2.41 [1.70-3.39],5.880008996857919e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASA1,Ras GTPase-activating protein 1,2394,74,1.18 [0.65-2.14],0.5774538035247392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,2034,52,0.85 [0.47-1.56],0.6032162218007646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,2398,75,1.14 [0.83-1.55],0.4236892028748232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,2107,54,2.88 [2.32-3.57],5.136907117897478e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBKS,Ribokinase,2410,76,0.54 [0.40-0.72],2.8108018239337103e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM17,Splicing factor 45,2107,54,0.96 [0.68-1.38],0.8421122922095368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM19,Probable RNA-binding protein 19,2039,52,1.67 [0.95-2.93],0.0769485875151664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM25,RNA-binding protein 25,2034,52,1.49 [0.90-2.47],0.1179806058966907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP1,Retinol-binding protein 1,2067,53,1.23 [0.89-1.69],0.2088459663071963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,2451,77,2.16 [1.80-2.59],8.988970930317133e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,2451,77,2.23 [1.66-3.00],1.0212227184331841e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP7,Retinoid-binding protein 7,2102,54,1.57 [1.15-2.16],0.0048936398171986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,2050,54,0.90 [0.54-1.51],0.6921745653649012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,2062,49,0.85 [0.63-1.13],0.2590317654226482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCC1,Regulator of chromosome condensation,2104,54,1.57 [1.09-2.27],0.0158315078145543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCOR1,REST corepressor 1,2417,77,1.20 [0.81-1.79],0.3548892514159475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,2062,49,2.96 [0.78-11.29],0.111863454536879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REEP4,Receptor expression-enhancing protein 4,2107,54,0.97 [0.61-1.55],0.9116858578849252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,2440,76,3.98 [3.15-5.02],5.848226004062251e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,2486,78,2.99 [2.39-3.74],7.773499022192588e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,2486,78,2.77 [2.23-3.44],3.006453129455829e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,2104,54,1.57 [0.84-2.94],0.1538580079776448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,2466,77,4.00 [3.00-5.34],5.648731566061972e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELB,Transcription factor RelB,2050,54,0.67 [0.35-1.28],0.2269090391878142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,2467,77,11.83 [8.09-17.30],3.366695753051725e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,2460,78,1.80 [1.52-2.14],2.0402477647141848e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,2050,54,1.05 [0.50-2.21],0.9022781419053602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REST,RE1-silencing transcription factor,2034,52,1.27 [0.63-2.56],0.5061816982757859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,2451,77,0.72 [0.44-1.18],0.1861635806061171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,2456,78,2.94 [2.19-3.95],6.457235595506613e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",2039,52,1.01 [0.57-1.79],0.9632587905381966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RFC4,Replication factor C subunit 4,2104,54,0.52 [0.13-2.02],0.3458532133193164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGCC,Regulator of cell cycle RGCC,2107,54,0.71 [0.50-1.01],0.0547950291384009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2085,52,0.82 [0.50-1.34],0.4266511323737328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,2480,77,6.22 [3.55-10.90],1.6261765546820834e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,2480,77,12.11 [7.64-19.18],2.4297693507830527e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS10,Regulator of G-protein signaling 10,2107,54,0.65 [0.40-1.08],0.0968851094815047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS8,Regulator of G-protein signaling 8,2398,76,0.78 [0.52-1.16],0.2225695107707252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,2431,76,0.93 [0.78-1.11],0.4367958221635434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,2050,54,0.84 [0.45-1.55],0.5718757535596379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,2079,50,1.78 [1.16-2.75],0.0088719477166543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILP,Rab-interacting lysosomal protein,2470,78,0.64 [0.45-0.90],0.0111687629199404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILPL2,RILP-like protein 2,2108,54,0.84 [0.64-1.10],0.203916314312545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,2039,52,1.15 [0.83-1.61],0.4043132546856828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN1,Prorelaxin H1,2107,54,1.39 [1.00-1.93],0.0521182245376378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN2,Prorelaxin H2,2071,50,1.91 [1.34-2.74],0.0003866434036655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,2120,55,14.18 [7.70-26.10],1.6777219835503954e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,2062,49,3.17 [2.05-4.92],2.3138192266975965e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE3,Eosinophil cationic protein,2450,78,1.14 [0.97-1.34],0.1217389989720177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,2044,54,7.09 [4.31-11.66],1.2471433452621756e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,2106,55,2.75 [2.08-3.64],1.5681373900580002e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,2107,54,0.63 [0.31-1.29],0.2057405440262282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,2478,78,5.07 [3.81-6.75],1.118280112956568e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,2062,49,13.33 [7.74-22.96],9.324560813249914e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,2050,54,0.87 [0.41-1.86],0.72051272639475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,2050,54,0.87 [0.42-1.82],0.7187597293353225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,2085,52,1.01 [0.66-1.55],0.9468922024412076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,2398,75,0.76 [0.54-1.05],0.0995567581335238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,2085,52,1.21 [0.81-1.79],0.3487990852630105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,2062,49,0.62 [0.43-0.90],0.0113038161964171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO1,Roundabout homolog 1,2466,77,1.42 [0.71-2.86],0.3220755219061454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO2,Roundabout homolog 2,2480,77,1.64 [0.73-3.69],0.2269392489443283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO4,Roundabout homolog 4,2062,49,17.53 [4.17-73.60],9.182298007630004e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2460,78,11.48 [6.83-19.29],3.127592334520652e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RP2,Protein XRP2,2451,77,0.62 [0.38-1.02],0.0602729493480226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPA2,Replication protein A 32 kDa subunit,2050,54,1.06 [0.44-2.57],0.8937411029407271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,2085,52,0.50 [0.32-0.80],0.0036166574114973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,2067,53,1.06 [0.60-1.89],0.8325084985850686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPL14,60S ribosomal protein L14,2062,49,1.30 [0.63-2.71],0.4801736588152894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPS10,40S ribosomal protein S10,2039,52,0.71 [0.31-1.59],0.3999474461488769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRAS,Ras-related protein R-Ras,2067,53,0.82 [0.66-1.03],0.0942366989808337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,2398,75,1.21 [0.89-1.66],0.2301873430143973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,2398,75,0.82 [0.60-1.12],0.2124491367926731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRP15,RRP15-like protein,2041,52,0.94 [0.71-1.23],0.6523034418451992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,2441,76,3.85 [2.24-6.63],1.1226809387836158e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,2476,78,8.89 [5.90-13.38],1.365218161523455e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,2451,77,9.32 [5.53-15.71],5.208911933321532e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTKN2,Rhotekin-2,2039,52,1.18 [0.78-1.79],0.4275043770832287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",2107,54,0.73 [0.54-0.99],0.0460208086257581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,2476,78,6.54 [4.40-9.74],1.9649870835056904e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RUVBL1,RuvB-like 1,2398,75,0.98 [0.80-1.20],0.8417212156934701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RWDD1,RWD domain-containing protein 1,2480,77,0.66 [0.47-0.93],0.0178272936108167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RYR1,Ryanodine receptor 1,2039,52,1.44 [0.80-2.58],0.2228431591067483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A11,Protein S100-A11,2438,77,1.24 [0.85-1.81],0.2717616186181756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A12,Protein S100-A12,2427,76,0.99 [0.75-1.31],0.9612919018669196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A13,Protein S100-A13,2050,54,1.78 [0.99-3.22],0.0550709487104622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A14,Protein S100-A14,2107,54,1.04 [0.65-1.68],0.8570691137782127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A16,Protein S100-A16,2389,73,1.04 [0.74-1.46],0.8129222984561046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A3,Protein S100-A3,2104,54,0.96 [0.54-1.70],0.8804309647027061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A4,Protein S100-A4,2465,77,0.46 [0.33-0.65],9.05166690265263e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100G,Protein S100-G,2107,54,2.23 [1.53-3.26],3.2938313141277254e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100P,Protein S100-P,2417,77,1.55 [1.21-1.99],0.0005545876884494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAA4,Serum amyloid A-4 protein,2114,54,0.71 [0.23-2.17],0.5507374880793137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAFB2,Scaffold attachment factor B2,2107,54,1.44 [0.54-3.84],0.4627260855483662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAG,S-arrestin,2041,52,1.26 [0.79-1.99],0.3335983482940846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,2454,77,0.88 [0.65-1.20],0.4290464684581239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,2085,52,0.74 [0.56-0.98],0.0357741035618463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SARG,Specifically androgen-regulated gene protein,2102,54,0.84 [0.67-1.07],0.1521903376340583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,2039,52,1.80 [1.15-2.80],0.0095974086145268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT1,Diamine acetyltransferase 1,2039,52,0.86 [0.46-1.61],0.6347530631058007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,2085,52,1.27 [0.92-1.76],0.1515711751096108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SATB1,DNA-binding protein SATB1,2107,54,1.27 [0.53-3.04],0.5879532435098189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,2110,52,4.58 [2.60-8.04],1.2340080121784237e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,2451,77,1.07 [0.84-1.37],0.5703575621613199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,2480,77,13.11 [8.54-20.12],5.123694496888035e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB1,Scavenger receptor class B member 1,2394,74,1.21 [0.90-1.62],0.2009751297680658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,2389,76,8.38 [6.17-11.37],2.671501047788652e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,2486,78,2.47 [1.60-3.81],4.54001768754785e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,2480,77,7.20 [5.03-10.31],3.5137053768028034e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,2468,78,12.12 [7.78-18.86],2.144306149364766e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,2466,77,4.01 [2.28-7.07],1.4589345942903117e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,2466,77,4.05 [2.74-5.96],1.7069290353046117e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB2A2,Mammaglobin-A,2039,52,1.10 [0.44-2.76],0.8339504758892198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,2079,50,4.13 [1.53-11.14],0.0051155701075435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,2470,77,1.28 [1.10-1.48],0.0013198963606046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,2398,76,3.52 [2.54-4.86],2.7258267416717526e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCIN,Adseverin,2041,52,1.23 [0.86-1.75],0.2588389832583664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCLY,Selenocysteine lyase,2470,78,0.92 [0.62-1.35],0.6606874008841999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,2041,52,0.76 [0.40-1.45],0.4052007326872158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2B,Sodium channel subunit beta-2,2067,53,1.51 [0.72-3.18],0.2741095451323916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,2067,53,0.52 [0.21-1.27],0.1496351434606573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3B,Sodium channel subunit beta-3,2041,52,0.89 [0.48-1.66],0.713259732268652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,2062,49,5.01 [3.31-7.59],2.5481037015969743e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCP2,Non-specific lipid-transfer protein,2398,75,1.11 [0.87-1.41],0.4071357920957674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,2054,49,0.93 [0.52-1.66],0.8003769928422397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,2108,54,9.23 [4.72-18.05],8.519664554682379e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRIB,Protein scribble homolog,2062,49,1.18 [0.91-1.53],0.2029513297451667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRN1,Secernin-1,2454,77,0.84 [0.57-1.24],0.373055697282771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCT,Secretin,2067,53,2.21 [1.41-3.48],0.0005942847624584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,2460,78,3.56 [2.60-4.88],2.5407002988496207e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC4,Syndecan-4,2460,78,0.40 [0.27-0.60],8.968551028826305e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,2104,54,0.89 [0.70-1.13],0.3366483688305848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDHB,Succinate dehydrogenase,2102,54,0.74 [0.45-1.22],0.2368051860896321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDK2,Protein sidekick-2,2079,50,0.87 [0.45-1.71],0.6933565249036244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEC31A,Protein transport protein Sec31A,2062,49,0.68 [0.47-0.97],0.0347938417481858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,2062,49,3.87 [2.62-5.70],8.963126171912193e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELE,E-selectin,2486,78,1.29 [0.90-1.85],0.1638142121097522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELENOP,Selenoprotein P,2114,54,0.60 [0.21-1.71],0.3397279581919019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELL,L-selectin,2114,54,0.32 [0.12-0.87],0.0253340280736212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELP,P-selectin,2464,77,0.77 [0.53-1.11],0.1562152302273093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,2454,77,0.76 [0.42-1.36],0.3497995623345434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,2460,78,12.36 [6.47-23.60],2.6033361582245352e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3G,Semaphorin-3G,2079,50,1.18 [0.67-2.07],0.5726973649298391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4C,Semaphorin-4C,2451,77,1.54 [1.01-2.34],0.0426580971318731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4D,Semaphorin-4D,2480,77,0.70 [0.35-1.39],0.305982856239272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA6C,Semaphorin-6C,2050,54,2.25 [1.21-4.20],0.0106274700766679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA7A,Semaphorin-7A,2478,78,2.17 [1.25-3.75],0.0058740816296419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN3,Neuronal-specific septin-3,2107,54,1.06 [0.77-1.47],0.7225616447394314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN7,Septin-7,2085,52,1.22 [0.89-1.68],0.2169543265198866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,2106,53,6.26 [3.90-10.04],2.966788989109935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN9,Septin-9,2451,77,0.67 [0.32-1.41],0.2871128634852119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA1,Alpha-1-antitrypsin,2080,54,5.50 [0.19-156.66],0.3185865496398629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA11,Serpin A11,2486,78,0.99 [0.62-1.58],0.968814322667062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA12,Serpin A12,2395,72,0.84 [0.68-1.05],0.132222397050463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,2107,54,2.12 [0.47-9.50],0.3260146445363843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA4,Kallistatin,2068,53,0.31 [0.12-0.83],0.0204216431077788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA5,Plasma serine protease inhibitor,2084,54,1.07 [0.45-2.53],0.88462535898406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA6,Corticosteroid-binding globulin,2114,54,0.69 [0.14-3.51],0.656471425223581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA7,Thyroxine-binding globulin,2114,54,0.12 [0.04-0.38],0.0003197378047455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA9,Serpin A9,2443,77,1.16 [0.89-1.50],0.2754566144396665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,2461,77,0.87 [0.68-1.10],0.2339805871973106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB5,Serpin B5,2417,77,1.67 [1.10-2.52],0.0155308179712368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB6,Serpin B6,2473,77,1.16 [0.81-1.65],0.4142167104953881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB8,Serpin B8,2482,77,1.60 [1.29-1.99],1.692631431121397e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB9,Serpin B9,2441,76,0.79 [0.43-1.47],0.4633415313316968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINC1,Antithrombin-III,2110,54,0.47 [0.09-2.58],0.3848681686049362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPIND1,Heparin cofactor 2,2110,54,0.87 [0.35-2.12],0.7510995679852162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,2486,78,0.73 [0.54-0.98],0.0384120278729248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE2,Glia-derived nexin,2108,54,0.80 [0.53-1.22],0.306032674549533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,2081,54,8.19 [3.34-20.07],4.31013891174027e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF2,Alpha-2-antiplasmin,2074,54,0.13 [0.03-0.63],0.0115963304101434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPING1,Plasma protease C1 inhibitor,2110,54,1.56 [0.39-6.18],0.5285331516004409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINH1,Serpin H1,2085,52,1.01 [0.82-1.25],0.9245006091793788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI1,Neuroserpin,2078,50,1.37 [0.57-3.29],0.4829410816645537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI2,Serpin I2,2102,54,1.18 [0.77-1.82],0.4480294380138695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,2394,74,0.86 [0.61-1.21],0.3923099806785145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,2434,76,0.58 [0.29-1.19],0.1395075502669135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6,Seizure protein 6 homolog,2067,53,2.30 [1.37-3.87],0.0016741420670329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,2465,77,7.38 [4.76-11.43],3.965529111003236e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,2451,77,5.84 [2.66-12.84],1.0896854066221584e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SF3B4,Splicing factor 3B subunit 4,2451,77,0.76 [0.56-1.01],0.0620770412491538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,2437,76,2.32 [1.80-2.98],4.9070387476162166e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,2079,50,3.01 [1.65-5.51],0.0003293700495235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,2398,75,1.34 [1.00-1.81],0.0522801026228379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,2398,75,1.25 [0.86-1.82],0.2359647156520558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,2460,78,1.10 [0.83-1.47],0.4964728461325866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,2075,53,1.10 [0.70-1.74],0.6827636275766572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2B3,SH2B adapter protein 3,2398,75,0.86 [0.70-1.06],0.1613616422045916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,2454,77,1.03 [0.72-1.49],0.8575228940060914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,2041,52,1.01 [0.65-1.56],0.9701709441234858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BP1,SH3 domain-binding protein 1,2102,54,0.65 [0.34-1.25],0.1951934411464851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GL3,Endophilin-A3,2074,52,0.98 [0.70-1.36],0.891103565897731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GLB2,Endophilin-B2,2109,53,0.77 [0.51-1.15],0.1985433437689196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHBG,Sex hormone-binding globulin,2120,55,1.38 [0.83-2.30],0.2191576339891205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHC1,SHC-transforming protein 1,2034,52,0.87 [0.66-1.14],0.3033186493136611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHD,SH2 domain-containing adapter protein D,2034,52,1.14 [0.87-1.49],0.34379505255873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHH,Sonic hedgehog protein,2050,54,0.73 [0.37-1.42],0.3467943945781176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,2117,52,11.34 [7.38-17.44],1.799306237505181e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",2470,77,0.84 [0.66-1.08],0.1738826829990839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHPK,Sedoheptulokinase,2085,52,0.95 [0.47-1.92],0.8907445638080773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIAE,Sialate O-acetylesterase,2464,77,1.29 [0.84-1.98],0.246367920428983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,2474,77,3.79 [2.59-5.52],5.162329439248556e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,2454,77,4.45 [3.17-6.25],5.5535408999989794e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,2394,74,1.22 [1.00-1.48],0.0450849636018556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,2467,77,2.11 [1.63-2.74],2.0283829653459856e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,2476,78,4.52 [2.67-7.64],1.9560206998899483e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,2460,78,2.21 [1.13-4.35],0.0213301035048824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,2062,49,1.92 [1.13-3.27],0.0162783223100002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,2475,78,1.32 [0.68-2.58],0.4085921551417982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIL1,Nucleotide exchange factor SIL1,2062,49,1.29 [0.70-2.37],0.4127126538452892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2458,77,1.75 [1.16-2.64],0.0072966532662628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,2454,77,4.91 [3.51-6.87],1.6305493170228046e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,2050,54,1.07 [0.76-1.51],0.6929452047150515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,2451,77,0.73 [0.58-0.93],0.0107816398647541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",2394,74,0.92 [0.63-1.36],0.6758515854414355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,2398,76,0.86 [0.60-1.23],0.4056603219110219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,2439,76,0.65 [0.49-0.87],0.0038137727676647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,2474,77,0.86 [0.70-1.05],0.1327436228988211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKIV2L,Helicase SKI2W,2039,52,1.03 [0.50-2.13],0.9407093699148664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLA2,Src-like-adapter 2,2107,54,0.84 [0.64-1.09],0.1782710971386485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,2398,76,2.52 [1.88-3.37],6.54589192734074e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF6,SLAM family member 6,2398,75,1.52 [0.95-2.45],0.0835454935998102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,2454,77,2.13 [1.61-2.82],1.1939740717992993e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF8,SLAM family member 8,2398,75,2.31 [1.61-3.33],6.65903128320411e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC12A2,Solute carrier family 12 member 2,2039,52,1.01 [0.34-3.05],0.9839909389778996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC13A1,Solute carrier family 13 member 1,2104,54,1.22 [0.82-1.81],0.3262100738142132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC16A1,Monocarboxylate transporter 1,2394,74,1.02 [0.70-1.49],0.929434676413668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC1A4,Neutral amino acid transporter A,2067,53,1.18 [0.72-1.93],0.515810606800901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,2394,74,0.92 [0.64-1.33],0.6669557633532281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,2034,52,0.95 [0.59-1.54],0.8336251338848727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,2034,52,1.21 [0.71-2.07],0.4827606633282688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,2394,74,2.09 [1.67-2.62],1.493025973321636e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,2454,77,3.42 [2.53-4.62],9.257172244760517e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC44A4,Choline transporter-like protein 4,2067,53,0.87 [0.56-1.35],0.5410048197346254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC4A1,Band 3 anion transport protein,2117,52,0.72 [0.39-1.32],0.2855870650994424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC51B,Organic solute transporter subunit beta,2039,52,1.24 [0.95-1.62],0.1181756558614415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,2079,50,0.82 [0.58-1.15],0.2478906823798944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,2102,54,1.18 [0.76-1.83],0.4617299430546547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2034,52,1.30 [0.87-1.96],0.2043321053349792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIT2,Slit homolog 2 protein,2394,74,1.21 [0.84-1.75],0.3115074681200849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,2050,54,3.22 [1.60-6.48],0.0010089084679199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,2476,78,3.73 [2.29-6.07],1.3222882824156278e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,2417,77,5.94 [4.03-8.76],2.034374040822192e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,2085,52,0.89 [0.59-1.35],0.5879124738918287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,2102,54,1.49 [1.10-2.02],0.0104958919263137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,2099,52,4.15 [2.89-5.94],1.0361862858835051e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,2398,75,0.86 [0.66-1.11],0.2336833438673843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,2104,54,0.67 [0.44-1.01],0.0554369117144416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,2104,54,0.93 [0.55-1.57],0.7761247917431244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,2451,77,0.41 [0.15-1.15],0.0905577380588324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,2394,74,0.93 [0.69-1.27],0.668039829375042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,2034,52,0.66 [0.35-1.23],0.191382883694267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,2102,54,0.87 [0.54-1.40],0.5551582821539893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,2476,78,4.24 [2.66-6.74],1.1047072336282748e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,2474,77,5.14 [3.77-7.00],4.93516277133859e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,2475,77,1.54 [1.09-2.19],0.0157733157377084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,2050,54,1.41 [0.98-2.05],0.0661435725213928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,2469,77,1.03 [0.76-1.40],0.8269923344619442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2104,54,0.74 [0.46-1.19],0.2155747497531973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMS,Spermine synthase,2041,52,0.99 [0.62-1.58],0.9642930275109736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMTN,Smoothelin,2105,53,1.49 [1.15-1.93],0.0023406366180766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP23,Synaptosomal-associated protein 23,2460,78,0.79 [0.64-0.99],0.0365038941154256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP25,Synaptosomal-associated protein 25,2041,52,0.75 [0.43-1.33],0.328314154629265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP29,Synaptosomal-associated protein 29,2465,77,0.89 [0.71-1.12],0.3139578984675139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,2107,54,0.56 [0.35-0.90],0.0175140002173261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCA,Alpha-synuclein,2079,50,0.82 [0.65-1.04],0.1099448747084027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,2441,76,3.81 [2.95-4.93],1.5058229276274547e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2062,49,1.62 [0.77-3.41],0.1996110471245557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',2109,53,1.46 [1.05-2.02],0.023514344375256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNU13,NHP2-like protein 1,2039,52,0.50 [0.24-1.04],0.064549617911341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX15,Sorting nexin-15,2079,50,0.67 [0.39-1.13],0.128883607333413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX18,Sorting nexin-18,2102,54,0.98 [0.52-1.84],0.9533466026893244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX2,Sorting nexin-2,2104,54,0.82 [0.58-1.15],0.252305148173082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX5,Sorting nexin-5,2062,49,0.29 [0.11-0.73],0.0087063760325666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX9,Sorting nexin-9,2460,78,0.96 [0.70-1.30],0.7824810162504756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],2409,76,0.54 [0.35-0.85],0.0081979485769819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",2467,77,0.73 [0.45-1.17],0.1925836062050533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD3,Extracellular superoxide dismutase,2120,55,1.13 [0.83-1.55],0.4380714882021775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,2107,54,1.77 [1.32-2.37],0.0001323985680779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,2398,75,7.78 [5.39-11.22],5.567426625252602e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORD,Sorbitol dehydrogenase,2465,77,0.61 [0.48-0.78],8.069270320804187e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORT1,Sortilin,2460,78,0.75 [0.44-1.27],0.2848632656255486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOST,Sclerostin,2460,78,2.43 [1.48-3.99],0.000467313039586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,2067,53,0.90 [0.54-1.51],0.698456696477383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX2,Transcription factor SOX-2,2103,54,0.35 [0.12-1.01],0.0513585865526133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX9,Transcription factor SOX-9,2067,53,6.49 [2.50-16.81],0.0001178142640782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2107,54,2.79 [1.72-4.53],2.991103712696985e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPAG1,Sperm-associated antigen 1,2107,54,0.79 [0.46-1.35],0.3816129261886184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARC,SPARC,2465,77,0.83 [0.63-1.09],0.189683904527926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,2452,76,4.58 [2.57-8.18],2.591591180469294e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPART,Spartin,2079,50,0.85 [0.58-1.26],0.4267337782593077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPESP1,Sperm equatorial segment protein 1,2108,54,2.40 [1.26-4.56],0.0077235697185129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,2467,77,4.97 [3.83-6.46],3.975120105377612e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,2079,50,7.33 [4.12-13.05],1.2336178716627732e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,2454,77,3.00 [2.43-3.72],5.275459193022264e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,2467,77,7.28 [4.53-11.71],2.7872790589126543e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,2476,78,3.16 [2.14-4.68],8.065780297178156e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,2039,52,0.93 [0.39-2.18],0.8610915939083209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,2461,77,3.86 [2.20-6.75],2.327174731507156e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,2474,77,3.49 [2.32-5.24],1.836441655518789e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,2102,54,1.02 [0.85-1.21],0.834846660998109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPOCK1,Testican-1,2441,76,0.25 [0.14-0.47],1.23504369702947e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,2466,77,6.05 [4.14-8.82],9.904496125140191e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,2453,78,12.37 [7.92-19.33],2.2252683920367153e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,2481,78,3.81 [2.77-5.23],1.4848547339148108e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",2050,54,0.92 [0.45-1.89],0.8193437539256294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRING1,SREBP regulating gene protein,2034,52,1.29 [0.87-1.92],0.2116709249553989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR1B,Cornifin-B,2085,52,1.15 [0.91-1.46],0.2494573156876054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,2109,53,2.16 [1.59-2.93],7.958182158600204e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRY2,Protein sprouty homolog 2,2398,76,0.77 [0.60-0.97],0.0299864628640781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",2041,52,0.81 [0.34-1.91],0.6330769422880056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,2109,53,1.61 [1.07-2.43],0.0236989532319343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,2461,77,0.86 [0.73-1.02],0.0934374188369421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,2451,77,0.86 [0.60-1.23],0.4009396417346883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPK2,SRSF protein kinase 2,2454,77,0.80 [0.61-1.05],0.1033439532683233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,2108,54,2.04 [1.05-3.99],0.0363960134422892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSB,Lupus La protein,2394,74,0.96 [0.69-1.33],0.7866564888371732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",2050,54,1.37 [0.73-2.59],0.3253179878011411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2460,78,0.78 [0.67-0.92],0.0023959368713455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,2464,77,1.03 [0.65-1.66],0.8881945612257395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,2034,52,1.15 [0.45-2.91],0.7732572224231312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,2102,54,0.81 [0.48-1.39],0.4436843526411117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST13,Hsc70-interacting protein,2079,50,0.47 [0.29-0.76],0.0020818011427092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2451,77,1.98 [1.47-2.67],6.367710393934739e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2486,78,2.99 [1.60-5.59],0.000583209049008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",2050,54,1.25 [0.77-2.02],0.3667625312055985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAB2,Stabilin-2,2117,52,2.27 [0.87-5.93],0.0937385019968909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAM,Signal transducing adapter molecule 1,2104,54,1.40 [0.67-2.90],0.3682688664580424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAMBP,STAM-binding protein,2439,76,0.66 [0.47-0.94],0.019772892801205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT2,Signal transducer and activator of transcription 2,2050,54,0.95 [0.66-1.37],0.7857484827456165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,2451,77,0.85 [0.73-0.99],0.0336490640648936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,2034,52,0.72 [0.43-1.20],0.2111889607349822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC1,Stanniocalcin-1,2480,77,1.74 [1.18-2.56],0.0053827626623151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC2,Stanniocalcin-2,2462,76,4.11 [1.79-9.45],0.0008650604207391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STEAP4,Metalloreductase STEAP4,2041,52,1.26 [0.91-1.73],0.1605100250047586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,2463,77,0.61 [0.43-0.86],0.0043173732917659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK11,Serine/threonine-protein kinase STK11,2417,77,0.78 [0.59-1.04],0.0919738714667049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK24,Serine/threonine-protein kinase 24,2394,74,0.70 [0.49-1.01],0.0546812223097313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK4,Serine/threonine-protein kinase 4,2460,78,0.72 [0.56-0.92],0.0075672573845972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",2034,52,0.83 [0.60-1.14],0.2388854398129865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX16,Syntaxin-16,2398,75,0.97 [0.66-1.43],0.8775510087095459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX1B,Syntaxin-1B,2067,53,1.52 [0.96-2.39],0.0719999102965437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX3,Syntaxin-3,2109,53,0.50 [0.19-1.35],0.1728357732022255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX4,Syntaxin-4,2451,77,1.42 [1.05-1.91],0.0214272004114889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX5,Syntaxin-5,2050,54,0.53 [0.23-1.25],0.1471795381024609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX6,Syntaxin-6,2398,75,0.95 [0.66-1.35],0.7579997976213856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX7,Syntaxin-7,2050,54,1.39 [0.80-2.40],0.2448416001000694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX8,Syntaxin-8,2454,77,1.60 [1.06-2.41],0.0249819731841573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP1,Syntaxin-binding protein 1,2107,54,0.75 [0.53-1.06],0.1038909102529096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP3,Syntaxin-binding protein 3,2398,75,0.67 [0.38-1.17],0.1607013537924403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,2102,54,0.67 [0.31-1.44],0.3052663333543234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGT1,Protein SGT1 homolog,2398,75,0.76 [0.59-0.99],0.0414630420878572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT1A1,Sulfotransferase 1A1,2480,77,0.89 [0.76-1.03],0.1236616382267483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT2A1,Bile salt sulfotransferase,2454,77,1.39 [1.09-1.78],0.0076873460139099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF1,Formylglycine-generating enzyme,2050,54,1.16 [0.81-1.65],0.4225323045956015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,2480,77,1.20 [0.79-1.82],0.3818162574851839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",2107,54,0.96 [0.65-1.41],0.830800052118915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD1,Sushi domain-containing protein 1,2417,77,0.64 [0.43-0.96],0.0308082523134601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,2467,77,1.46 [0.74-2.88],0.2766987348291705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,2104,54,2.03 [1.43-2.88],7.183698630722606e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,2070,50,9.20 [4.74-17.87],5.711664606819503e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,2067,53,0.86 [0.54-1.37],0.5341615071636931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SWAP70,Switch-associated protein 70,2102,54,0.89 [0.40-2.00],0.7858711190830276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYAP1,Synapse-associated protein 1,2079,50,0.74 [0.44-1.25],0.2618984375525532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,2041,52,0.95 [0.58-1.55],0.8351450352752838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,2109,53,2.20 [1.64-2.95],1.487325422090747e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYTL4,Synaptotagmin-like protein 4,2108,54,0.76 [0.51-1.13],0.1790091871383562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,2085,52,0.88 [0.67-1.16],0.3746683968814556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,2451,77,0.89 [0.74-1.06],0.186405539107308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,2174,70,5.27 [2.90-9.57],4.6329301418523913e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TADA3,Transcriptional adapter 3,2104,54,0.88 [0.45-1.73],0.7162478208214904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,2451,77,7.85 [5.59-11.02],1.0829972236376308e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAGLN3,Transgelin-3,2034,52,1.18 [0.78-1.79],0.4425252757412866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TALDO1,Transaldolase,2113,52,0.64 [0.32-1.24],0.1861604150512944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,2398,76,0.68 [0.50-0.93],0.0171899600409356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAP1,Antigen peptide transporter 1,2085,52,1.16 [0.83-1.60],0.3869018474541359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,2394,74,0.92 [0.69-1.22],0.5650459372781393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",2067,53,1.07 [0.74-1.55],0.7048168731925434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",2104,54,0.35 [0.16-0.75],0.0069411323650349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAX1BP1,Tax1-binding protein 1,2109,53,0.94 [0.60-1.47],0.7746720617140641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D17,TBC1 domain family member 17,2394,74,0.64 [0.38-1.06],0.0817078844839759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D23,TBC1 domain family member 23,2451,77,0.92 [0.73-1.17],0.5070667292063151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D5,TBC1 domain family member 5,2454,77,1.14 [0.88-1.47],0.3101598102237249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCA,Tubulin-specific chaperone A,2079,50,0.71 [0.50-1.02],0.0616346509913132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCB,Tubulin-folding cofactor B,2441,76,0.81 [0.66-1.00],0.0472088706165857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCC,Tubulin-specific chaperone C,2441,76,0.80 [0.61-1.04],0.0953636989382584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,2398,75,0.83 [0.64-1.06],0.1283211700431948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBR1,T-box brain protein 1,2067,53,0.66 [0.33-1.29],0.2247936227886705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,2440,76,0.63 [0.52-0.76],1.2952888199150214e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,2417,77,0.99 [0.77-1.27],0.9471489102635362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN1,Transcobalamin-1,2069,54,1.02 [0.48-2.17],0.9573994090681792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,2481,78,6.72 [4.46-10.13],8.11326087423854e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCOF1,Treacle protein,2108,54,1.77 [0.81-3.86],0.1542960946294002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCP11,T-complex protein 11 homolog,2085,52,0.77 [0.42-1.43],0.4112163128138569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCTN3,Tectonic-3,2108,54,0.88 [0.39-1.97],0.7586575394652353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,2394,74,1.08 [0.95-1.24],0.2548054718848309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",2067,53,0.98 [0.49-1.96],0.9473944555860018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,2104,54,0.81 [0.51-1.28],0.3657898865764738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDRKH,Tudor and KH domain-containing protein,2394,74,0.97 [0.74-1.25],0.792310811456225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEF,Thyrotroph embryonic factor,2039,52,1.06 [0.54-2.09],0.8689366240150463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEK,Angiopoietin-1 receptor,2465,77,0.88 [0.36-2.12],0.7719897911642535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TERF1,Telomeric repeat-binding factor 1,2050,54,2.13 [1.00-4.52],0.0490121784489862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TET2,Methylcytosine dioxygenase TET2,2078,52,1.00 [0.78-1.28],0.9971110494523292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX101,Testis-expressed protein 101,2067,53,2.37 [1.63-3.45],6.601482576226933e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX33,Testis-expressed protein 33,2085,52,0.93 [0.46-1.89],0.835246236300013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TF,Serotransferrin,2114,54,0.21 [0.07-0.58],0.0026281272668362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,2041,52,0.89 [0.55-1.47],0.6606862858156393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,2456,77,2.28 [1.93-2.70],2.980659118154632e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,2470,77,2.59 [2.08-3.22],1.846298818728324e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,2440,76,0.82 [0.44-1.54],0.546567881498159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI,Tissue factor pathway inhibitor,2454,77,1.18 [0.71-1.96],0.5190043852855821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,2459,77,2.15 [1.54-3.00],7.449258662212742e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFRC,Transferrin receptor protein 1,2462,77,1.69 [1.09-2.63],0.0200436030190155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TG,Thyroglobulin,2104,54,1.18 [0.95-1.47],0.1322369222773023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,2454,77,2.69 [1.94-3.73],2.842911087757975e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,2477,77,1.91 [1.23-2.96],0.0037628639280293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,2104,54,0.92 [0.53-1.58],0.7554693285451151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,2443,77,0.62 [0.31-1.26],0.1859475947963974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,2050,54,4.61 [2.35-9.04],9.156991568419534e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,2465,77,5.83 [4.51-7.52],1.4718072737130254e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,2486,78,6.85 [4.51-10.42],2.281702316914924e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,2454,78,0.76 [0.59-0.98],0.0334546205643616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,2120,55,16.34 [9.49-28.14],7.1794467667547e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,2032,52,0.74 [0.50-1.10],0.1408231388541707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,2460,78,6.66 [4.66-9.53],2.5773186788056976e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS2,Thrombospondin-2,2467,77,1.68 [1.18-2.40],0.004372723802265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS4,Thrombospondin-4,2462,77,1.03 [0.69-1.56],0.8729568496975455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THOP1,Thimet oligopeptidase,2453,77,0.35 [0.20-0.59],0.0001199297169835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THPO,Thrombopoietin,2417,77,1.24 [0.76-2.00],0.3917996371151444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,2039,52,1.02 [0.80-1.29],0.8890572670976629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,2035,54,1.01 [0.48-2.14],0.9721336453313596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THTPA,Thiamine-triphosphatase,2100,54,0.69 [0.50-0.94],0.0192924517968594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,2480,77,12.86 [7.82-21.16],8.45115009847917e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,2395,77,0.83 [0.70-1.00],0.0458730804043017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,2486,78,0.81 [0.52-1.27],0.361090598132686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",2392,74,1.08 [0.68-1.71],0.7418923398591601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2085,52,1.52 [1.17-1.98],0.001752753955003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2464,77,1.49 [0.97-2.29],0.0695478630086749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,2108,54,0.81 [0.40-1.63],0.5530534720245188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,2109,53,0.68 [0.49-0.95],0.0255807455005946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,2422,76,5.71 [3.97-8.20],4.2097023449464174e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,2108,54,2.51 [1.63-3.87],3.069378284679219e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,2474,77,0.95 [0.82-1.12],0.5599550766494377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,2467,77,2.62 [1.75-3.92],3.1446341313439464e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,2457,78,13.05 [6.11-27.88],3.209512920658815e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJAP1,Tight junction-associated protein 1,2465,77,0.86 [0.67-1.11],0.2606810483820206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJP3,Tight junction protein ZO-3,2041,52,1.64 [1.05-2.55],0.028511026290975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TK1,"Thymidine kinase, cytosolic",2085,52,1.20 [0.67-2.15],0.5317549690852862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR1,Toll-like receptor 1,2050,54,2.35 [1.03-5.35],0.0426753907910129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR2,Toll-like receptor 2,2085,52,1.70 [0.53-5.43],0.3714813323506487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR3,Toll-like receptor 3,2482,77,1.20 [0.86-1.66],0.2887123655303913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR4,Toll-like receptor 4,2050,54,1.02 [0.40-2.59],0.9611790438120232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,2067,53,0.53 [0.30-0.95],0.0340443321522014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,2085,52,1.33 [0.87-2.03],0.1883504591853061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,2039,52,1.04 [0.57-1.88],0.9052920741548542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,2039,52,0.88 [0.51-1.49],0.6271914246774353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED8,Protein TMED8,2102,54,0.82 [0.64-1.07],0.1442211778243661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM106A,Transmembrane protein 106A,2104,54,0.75 [0.51-1.12],0.165525490594407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM132A,Transmembrane protein 132A,2062,49,1.08 [0.70-1.66],0.7256129079639755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM25,Transmembrane protein 25,2107,54,1.60 [0.95-2.69],0.0784337129727298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMOD4,Tropomodulin-4,2034,52,2.09 [1.34-3.25],0.0010997357342911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,2041,52,1.04 [0.73-1.49],0.8329481354487753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,2106,53,3.91 [2.70-5.67],6.55909252549833e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS15,Enteropeptidase,2451,77,1.29 [1.04-1.61],0.0225022613752631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS5,Transmembrane protease serine 5,2435,76,1.20 [0.71-2.02],0.5052766586045061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMSB10,Thymosin beta-10,2467,77,1.49 [1.12-1.97],0.0055143393067699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNC,Tenascin,2464,77,1.84 [1.25-2.72],0.0021527951093007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNF,Tumor necrosis factor,2416,77,2.53 [2.00-3.21],1.5125153153199656e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,2102,54,1.13 [0.67-1.90],0.6445864640137047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,2398,76,0.64 [0.36-1.15],0.1374589654912551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,2079,50,0.55 [0.33-0.91],0.0210086347639525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2441,76,3.71 [2.90-4.74],1.191988814854051e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2441,76,1.76 [1.56-1.99],6.76816411342709e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,2465,78,1.70 [1.10-2.62],0.0161551819796474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2482,77,7.59 [5.65-10.19],1.8824854435038403e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2459,77,3.26 [1.89-5.62],2.2458496552130127e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2465,77,8.87 [6.17-12.76],5.538369297715783e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2466,77,3.80 [2.89-5.01],1.5854602890966768e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2398,76,2.23 [1.50-3.33],8.404586845596101e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2466,77,7.24 [5.30-9.89],1.1161174073695832e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2079,50,4.40 [2.44-7.94],8.831753718070034e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2476,78,7.17 [5.36-9.60],3.4095261950309236e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2467,77,14.83 [10.30-21.35],1.126942819347426e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2467,77,2.51 [2.13-2.94],9.063884912378143e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2480,77,20.05 [11.74-34.22],4.4533199079837675e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2477,77,6.39 [4.63-8.83],2.6733624054759245e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2441,76,2.64 [2.07-3.38],1.0433282452464484e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2480,77,2.95 [2.09-4.15],6.095426739197529e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2441,76,3.46 [2.77-4.31],4.256380114622451e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,2482,77,1.58 [0.72-3.44],0.250477678513275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,2454,77,0.97 [0.69-1.36],0.858872431765598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,2482,77,0.47 [0.23-0.97],0.0408427502745074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,2474,77,8.66 [4.64-16.17],1.2075850463701322e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2483,78,2.50 [1.42-4.41],0.0015752436164101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,2441,76,0.89 [0.61-1.29],0.5350108841706439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,2117,52,1.99 [1.05-3.77],0.0349846501313933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,2109,53,0.71 [0.51-0.99],0.0443788644512986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNN,Tenascin-N,2117,52,1.21 [0.66-2.24],0.5399898637045288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",2417,77,1.63 [1.31-2.03],9.744091540072304e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNPO1,Transportin-1,2085,52,1.10 [0.49-2.45],0.8146008102482911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNR,Tenascin-R,2441,76,1.68 [1.06-2.66],0.0282079059518608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNXB,Tenascin-X,2467,77,0.68 [0.32-1.42],0.3006625361969203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,2108,54,1.00 [0.70-1.42],0.9913414183389928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1,DNA topoisomerase 1,2102,54,1.04 [0.84-1.30],0.7100082946240087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",2034,52,0.83 [0.44-1.56],0.5599135494606375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP2B,DNA topoisomerase 2-beta,2050,54,0.79 [0.56-1.13],0.2006900722675346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,2062,49,0.91 [0.52-1.59],0.7419551342102645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53,Cellular tumor antigen p53,2398,75,0.75 [0.47-1.22],0.2542128888991087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53BP1,TP53-binding protein 1,2050,54,1.32 [0.98-1.78],0.0690003236157958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,2025,48,0.53 [0.30-0.94],0.029384552153903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,2417,77,1.39 [0.82-2.35],0.2169522767145497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP73,Tumor protein p73,2067,53,0.59 [0.27-1.29],0.1850981480724207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPBGL,Trophoblast glycoprotein-like,2067,53,0.69 [0.32-1.47],0.3326937537347945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPD52L2,Tumor protein D54,2079,50,0.84 [0.65-1.09],0.1801942764745823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,2108,54,2.43 [0.98-6.06],0.056254500290264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPM3,Tropomyosin alpha-3 chain,2039,52,1.55 [1.08-2.24],0.0174165799636558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,2398,75,0.50 [0.37-0.68],5.599512480869669e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,2446,77,1.37 [0.94-1.99],0.0997433416869534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,2085,52,1.37 [1.09-1.73],0.0079439367658797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,2394,74,1.27 [0.78-2.08],0.34278082316864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPR,Nucleoprotein TPR,2039,52,1.18 [0.72-1.92],0.5120800983666027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,2034,52,1.19 [0.84-1.70],0.3275700531398018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,2480,77,2.04 [1.35-3.08],0.0007384252833832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSD1,Tryptase delta,2107,54,2.31 [1.46-3.66],0.0003472928093143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSG1,Tryptase gamma,2050,54,0.75 [0.28-2.05],0.5767971623665642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPT1,Translationally-controlled tumor protein,2398,76,0.95 [0.67-1.36],0.7945112082210914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF2,TNF receptor-associated factor 2,2454,77,0.87 [0.64-1.17],0.3548527958853588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",2050,54,0.57 [0.25-1.30],0.1802641391403413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,2039,52,0.83 [0.46-1.50],0.5375562865352868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,2085,52,0.70 [0.49-1.00],0.0473176409722616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREH,Trehalase,2117,52,1.05 [0.74-1.50],0.786994692803013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,2459,77,1.81 [1.31-2.50],0.0003135919449679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML1,Trem-like transcript 1 protein,2120,55,0.92 [0.55-1.53],0.7455213788952477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,2467,77,3.37 [2.06-5.51],1.3909900573604108e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,2476,78,1.50 [1.07-2.08],0.0171185062786658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,2454,77,0.79 [0.60-1.02],0.0720517196095003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,2083,52,0.78 [0.50-1.23],0.2839840422997081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,2102,54,0.83 [0.64-1.07],0.151868516535667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM26,Tripartite motif-containing protein 26,2034,52,0.82 [0.49-1.36],0.4355038961702639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,2067,53,0.78 [0.54-1.12],0.1774702026486667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM5,Tripartite motif-containing protein 5,2454,77,0.82 [0.64-1.04],0.0997426686147858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,2104,54,0.78 [0.58-1.06],0.1069172317522685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,2039,52,1.03 [0.60-1.77],0.909397607464674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC1,Hamartin,2050,54,0.95 [0.63-1.44],0.8139597007610231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC22D1,TSC22 domain family protein 1,2107,54,0.66 [0.42-1.03],0.066399389287586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSHB,Thyrotropin subunit beta,2460,78,0.76 [0.59-0.98],0.0357779302430737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSLP,Thymic stromal lymphopoietin,2417,77,0.86 [0.59-1.26],0.4367968900857817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSNAX,Translin-associated protein X,2039,52,0.30 [0.14-0.66],0.0025546398265053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN1,Tetraspanin-1,2417,77,0.99 [0.76-1.27],0.911713985427368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN15,Tetraspanin-15,2039,52,1.43 [0.97-2.09],0.0684062498730778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN7,Tetraspanin-7,2041,52,0.79 [0.55-1.14],0.2066382631722914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN8,Tetraspanin-8,2102,54,1.01 [0.79-1.30],0.9342040280446438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,2050,54,0.93 [0.46-1.86],0.8330795035141401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TST,Thiosulfate sulfurtransferase,2393,74,0.90 [0.67-1.20],0.4734416634451587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTF2,Transcription termination factor 2,2067,53,0.65 [0.36-1.18],0.1554125474541307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTN,Titin,2039,52,1.41 [1.00-1.98],0.0496235543934402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTR,Transthyretin,2094,54,0.37 [0.14-0.98],0.0447830178802363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TUBB3,Tubulin beta-3 chain,2041,52,2.74 [1.04-7.24],0.0423151293516682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TWF2,Twinfilin-2,2117,52,0.76 [0.54-1.06],0.1089560424998603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXK,Tyrosine-protein kinase TXK,2085,52,1.04 [0.75-1.45],0.793154528251521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXLNA,Alpha-taxilin,2441,76,0.82 [0.64-1.04],0.1009427927126872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXN,Thioredoxin,2085,54,0.49 [0.23-1.04],0.0621565930309802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,2465,77,1.06 [0.52-2.17],0.8660560669993574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,2480,77,1.63 [1.21-2.18],0.0011546288865007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,2109,53,0.59 [0.32-1.08],0.085195101546044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNL1,Thioredoxin-like protein 1,2038,52,0.93 [0.68-1.27],0.652915184586211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",2467,77,0.54 [0.34-0.87],0.0109780963379284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYMP,Thymidine phosphorylase,2443,77,0.85 [0.61-1.19],0.3403583221130267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,2460,78,2.67 [1.35-5.28],0.0048892693583956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2050,54,3.32 [2.08-5.30],5.38847163669982e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,2451,77,0.47 [0.27-0.83],0.0088328956578954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,2104,54,0.67 [0.25-1.83],0.4388327955251423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,2108,54,1.11 [0.70-1.76],0.6430059206296452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,2050,54,1.20 [0.77-1.88],0.4144392308454275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBQLN3,Ubiquilin-3,2039,52,1.44 [1.12-1.84],0.003731240946008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBXN1,UBX domain-containing protein 1,2079,50,0.67 [0.43-1.03],0.0658131549262294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,2102,54,0.87 [0.71-1.05],0.1451987376780542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,2039,52,0.87 [0.60-1.25],0.4512722071213475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,2039,52,1.01 [0.40-2.55],0.9838775128799754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,2441,76,8.69 [5.94-12.71],8.001490724549592e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,2475,77,0.33 [0.25-0.43],3.491037436319387e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC5D,Netrin receptor UNC5D,2050,54,3.41 [1.80-6.45],0.0001583356784074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC79,Protein unc-79 homolog,2034,52,0.86 [0.51-1.45],0.5645402355956926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNG,Uracil-DNA glycosylase,2104,54,0.73 [0.32-1.66],0.4518260493880343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPB1,Beta-ureidopropionase,2108,54,0.83 [0.64-1.09],0.1764906851610235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3A,Uroplakin-3a,2041,52,0.90 [0.52-1.55],0.7060752651246667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,2081,52,1.21 [0.83-1.75],0.3256972558971128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROD,Uroporphyrinogen decarboxylase,2079,50,0.48 [0.31-0.74],0.0009333681077889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROS,Uroporphyrinogen-III synthase,2067,53,0.60 [0.38-0.94],0.0257099478004437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USO1,General vesicular transport factor p115,2451,77,0.88 [0.70-1.10],0.2595152331432463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,2104,54,0.78 [0.53-1.15],0.2119127208650414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,2109,53,2.64 [1.86-3.75],5.7601032200619295e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,2039,52,0.95 [0.68-1.33],0.7518852676345942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,2417,77,0.71 [0.56-0.90],0.0055571209710892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,2398,75,0.84 [0.56-1.26],0.3978521312925852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,2417,77,1.27 [0.92-1.75],0.1540498698001319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,2050,54,0.83 [0.59-1.16],0.2787171130107484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,2454,77,0.73 [0.56-0.95],0.0197358365505919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,2420,77,6.94 [4.16-11.59],1.2192214265662346e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,2120,55,0.78 [0.53-1.13],0.1868747534442479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,2451,77,1.19 [0.45-3.15],0.7274333356778186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,2041,52,0.88 [0.66-1.17],0.3804116678507548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,2463,77,6.32 [3.70-10.81],1.5640409652940413e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAN,Versican core protein,2480,77,3.00 [1.59-5.68],0.0007113782318101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,2034,52,1.05 [0.78-1.42],0.7361040436576253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,2474,77,1.86 [1.35-2.55],0.0001428100625001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,2050,54,4.76 [2.11-10.71],0.0001651038998929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFC,Vascular endothelial growth factor C,2465,77,0.84 [0.59-1.21],0.3508078260864519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,2479,77,4.00 [2.63-6.09],1.087700923047844e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,2107,54,4.15 [2.63-6.57],1.167070821836284e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIM,Vimentin,2417,77,0.91 [0.77-1.07],0.2502613976971333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,2062,49,1.93 [0.61-6.09],0.2601657864338356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIT,Vitrin,2108,54,3.16 [1.90-5.26],9.29833479319999e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,2451,77,3.09 [2.25-4.24],2.5517969329502505e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN1,Pantetheinase,2120,55,0.78 [0.56-1.07],0.1210159950179593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,2451,77,1.32 [0.85-2.08],0.2199415896190204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,2085,52,0.59 [0.37-0.95],0.0279562876744786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,2451,77,0.92 [0.71-1.20],0.5426965687662306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,2104,54,0.74 [0.55-1.00],0.0508285241018286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,2451,77,0.86 [0.66-1.12],0.2652789985269342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,2104,54,0.91 [0.39-2.12],0.8334432813114856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,2039,52,1.87 [0.96-3.62],0.0648611012976882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,2104,54,2.19 [1.68-2.86],8.88537535310818e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,2462,76,8.04 [5.86-11.03],4.225312950712394e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,2457,78,1.01 [0.74-1.39],0.9353371871650972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSNL1,Visinin-like protein 1,2109,53,1.67 [0.96-2.92],0.0713305196059029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,2394,74,2.09 [1.48-2.95],2.5709911903053293e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,2085,52,0.53 [0.22-1.31],0.1716616215270033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2417,77,1.27 [0.95-1.69],0.1073978698828424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,2480,77,0.79 [0.59-1.07],0.1277169780564631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,2398,75,1.93 [1.23-3.04],0.0042035914637238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,2079,50,0.96 [0.58-1.59],0.876435809085369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,2471,78,0.95 [0.59-1.55],0.8418000585785037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,2034,52,1.04 [0.75-1.43],0.82779293727132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,2438,76,9.47 [6.35-14.13],3.13380163957994e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,2107,54,1.44 [0.93-2.23],0.0981302042010045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWF,von Willebrand factor,2486,78,1.07 [0.82-1.40],0.6113450401994315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",2467,77,1.17 [0.69-1.99],0.5632949415741779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,2398,76,0.90 [0.65-1.25],0.5292171571670408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,2417,77,0.82 [0.65-1.04],0.1019492359661609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,2394,74,0.92 [0.72-1.19],0.5480035339152567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASHC3,WASH complex subunit 3,2109,53,1.07 [0.74-1.55],0.7121835944942195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,2050,54,0.85 [0.52-1.39],0.525696530153343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WDR46,WD repeat-containing protein 46,2104,54,0.58 [0.26-1.32],0.1969721932987255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,2064,53,1.48 [1.11-1.99],0.0083342822967745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,2473,78,2.06 [1.59-2.67],5.611783417018452e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,2335,70,6.19 [4.72-8.11],5.5883343979697665e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",2434,76,0.57 [0.37-0.88],0.0109734606618857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2466,77,4.13 [2.36-7.22],6.857087262569422e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WIF1,Wnt inhibitory factor 1,2476,78,1.15 [0.64-2.04],0.6429087269260021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,2398,76,3.28 [2.45-4.39],1.3543112801283773e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,2441,76,0.60 [0.40-0.90],0.0145755656556933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,2476,78,2.07 [1.63-2.62],1.8368199952098327e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,2474,78,7.99 [5.65-11.28],5.191172754377244e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,2050,54,1.00 [0.61-1.64],0.9912373367259454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,2465,77,0.88 [0.73-1.06],0.1822570000031757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XRCC4,DNA repair protein XRCC4,2394,74,0.66 [0.36-1.21],0.1798792854998152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,2109,53,22.52 [12.41-40.88],1.3155753702521931e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",2102,54,0.89 [0.74-1.07],0.2180246751808934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YES1,Tyrosine-protein kinase Yes,2451,77,0.96 [0.80-1.14],0.6176391548083073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YJU2,Splicing factor YJU2,2104,54,0.61 [0.25-1.53],0.2953463605414202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,2039,52,0.50 [0.32-0.79],0.0025594014546172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YTHDF3,YTH domain-containing family protein 3,2398,76,0.78 [0.61-1.00],0.0489453791820274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YWHAQ,14-3-3 protein theta,2079,50,0.73 [0.49-1.08],0.1182228618036079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YY1,Transcriptional repressor protein YY1,2050,54,0.72 [0.26-1.98],0.5180759580292342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBP1,Z-DNA-binding protein 1,2050,54,1.29 [0.66-2.50],0.4603229710464979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,2398,75,0.89 [0.66-1.21],0.4670700495250093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,2417,77,2.02 [1.47-2.78],1.643140470326681e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,2039,52,0.93 [0.59-1.47],0.7480210841768637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,2102,54,0.81 [0.59-1.10],0.1733304667391162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,2109,53,1.25 [0.61-2.55],0.537855606712409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF174,Zinc finger protein 174,2050,54,1.56 [0.90-2.71],0.1122733661269113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF75D,Zinc finger protein 75D,2085,52,0.90 [0.57-1.43],0.6658809030711239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF830,Zinc finger protein 830,2104,54,1.13 [0.80-1.60],0.4857560484154637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRD2,Protein ZNRD2,2102,54,0.87 [0.60-1.27],0.4662090766039222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,2104,54,0.67 [0.40-1.14],0.1407230388065003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,2062,49,1.02 [0.92-1.13],0.7545146427991141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,2034,52,0.86 [0.35-2.08],0.7324195313054775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZPR1,Zinc finger protein ZPR1,2041,52,0.68 [0.46-1.01],0.0587274938075265
